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“Our greatest weakness lies in giving up. 
The most certain way to succeed 
 is always to try just one more time.”  
 
- Thomas A. Edison 
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ABSTRACT 
Bacterial pathogens cause severe infections in humans. The emergence of multiresistant 
bacteria requires the development of new antimicrobial strategies. Bacteria utilize various 
virulence mechanisms to promote their survival in the host organism. Among these 
virulence mechanisms, we may find novel targets for antimicrobial treatment.  
This thesis concerns a virulence mechanism of an oral bacterium that may disturb the 
human immune response and potentially increase bacterial virulence. The model 
organism for this study is Aggregatibacter actinomycetemcomitans, a gram-negative 
opportunistic pathogen that forms biofilms on the surface of teeth and causes an 
inflammatory oral disease called periodontitis. Bacteria living in biofilms are more 
resistant to antimicrobial compounds and the mechanisms associated with their virulence 
are poorly known. Previously, it was discovered that A. actinomycetemcomitans binds and 
uptakes human inflammatory cytokines, which may modulate the local inflammatory 
milieu and weaken the host defense.  
This thesis consists of four parts, each published as a separate article in scientific journals. 
In the beginning of this thesis I discovered a novel cytokine-binding outer membrane 
protein, BilRI, in A. actinomycetemcomitans. BilRI was located on the outer membrane of 
A. actinomycetemcomitans and interacted with the human cytokine IL-1β. The second 
article showed that BilRI binds multiple cytokines and has an intrinsically disordered 
structure. In the third article, I showed that a major bacterial cell wall component, 
lipopolysaccharide, interacted with certain cytokines. This interaction was shown in many 
A. actinomycetemcomitans serotypes using intact bacterial cells, outer membrane vesicles 
and isolated lipopolysaccharides. Further, some information was obtained about the 
location of the interaction site. In the fourth article, I found that a channel protein of A. 
actinomycetemcomitans, HofQ, binds human cytokines, such as IL-1β and IL-8. This 
protein has been previously associated with DNA uptake, providing a possible link 
between the naturally occurring uptake of extracellular DNA and the cytokine uptake 
mechanism in bacteria.  
This thesis showed the cytokine binding of A. actinomycetemcomitans outer membrane 
molecules and how they affected the physiology of the pathogen. Further research is needed 
regarding the roles of these molecules in the virulence of A. actinomycetemcomitans. 
63
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TIIVISTELMÄ 
Patogeeniset bakteerit aiheuttavat ihmisille vakavia infektioita. Nykyisille antibiooteille 
multiresistenttien bakteerien yleistyminen vaatii uusien antimikrobistrategioiden 
kehittämistä. Bakteerit käyttävät useita virulenssimekanismeja, jotka auttavat niitä 
selviytymään isäntäorganismissa. Näiden virulenssimekanismien joukosta saattaisi löytyä 
uusia  antimikrobihoidon kohteita. 
Väitöskirjassa tutkittiin suubakteerin virulenssimekanismia, joka saattaa häiritä ihmisen 
immuunipuolustusta ja lisätä bakteerin virulenssia. Työssä käytettiin malliorganismina 
Aggregatibacter actinomycetemcomitans –bakteeria, joka on gram-negatiivinen 
opportunistinen patogeeni. Se muodostaa biofilmejä hampaiden pinnalle ja aiheuttaa suun 
tulehdussairautta parodontiittia. Biofilmeissä elävät bakteerit ovat vastustuskykyisempiä 
antimikrobisille aineille ja niiden virulenssiin liittyviä mekanismeja tunnetaan huonosti. 
Aiemmin on havaittu, että A. actinomycetemcomitans sitoo ja siirtää sisäänsä ihmisen 
tulehduksenvälittäjäaineita, sytokiineja. Tämä saattaa muuttaa paikallista 
tulehdusympäristöä ja heikentää isännän puolustusta.  
Väitöskirjatutkimukseni koostuu neljästä osatyöstä, jotka on julkaistu erillisinä 
artikkeleina tieteellisissä lehdissä. Väitöskirjatutkimukseni alussa löysin A. 
actinomycetemcomitansista uuden sytokiineja sitovan ulkokalvon proteiinin, BilRI:n. 
BilRI tuottui bakteerin ulkokalvolle ja sitoutui IL-1β:aan. Toisessa osatyössä BilRI:n 
havaittiin sitovan useita sytokiineja ja olevan rakenteeltaan luonnostaan järjestäytymätön. 
Kolmannessa osatyössä osoitin, että bakteerin soluseinän komponetti lipopolysakkaridi 
vuorovaikuttaa joidenkin sytokiinien kanssa. Vuorovaikutus osoitettiin useiden eri A. 
actinomycetemcomitans serotyyppien kanssa kokonaisilla bakteerisoluilla, ulkokalvon 
vesikkeleillä sekä eristetyillä lipopolysakkarideillä. Lisäksi vuorovaikutuskohdan 
sijainnista saatiin tietoa. Neljännessä osatyössä havaitsin, että HofQ-kanavaproteiini sitoo 
myös ihmisen sytokiineja, kuten IL-1β:aa ja IL-8:aa. Aiemmin tämän kanavaproteiinin on 
havaittu osallistuvan DNA:n sisäänottoon, joten työ osoittaa mahdollisen yhteyden 
luonnollisen solunulkoisen DNA:n sisäänoton ja sytokiinien sisäänoton välillä. 
Väitöskirjassa osoitettiin  A. actinomycetemcomitansin ulkokalvon molekyylien sitoutuminen 
sytokiineihin sekä niiden vaikutuksia bakteerin fysiologiaan. Näiden molekyylien 
vaikutuksista A. actinomycetemcomitansin virulenssiin tarvitaan vielä lisää tutkimusta.
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1. INTRODUCTION 
Bacteria are everywhere. They live on all surfaces in nature, in deep oceans and even 
in extremely hot, cold, and dry conditions. They are living inside us humans, many as 
commensals that cohabitate peacefully with our own cells, but some are pathogenic 
and capable of causing infections.  
Bacterial infections are one of the most common diseases in humans. The severity of 
the disease depends on the pathogen as well as the host. When the immune system of 
an individual is compromised because of some other medical condition, the 
susceptibility to severe bacterial infections will increase. Additionally, the lethality of 
the infection increases in an immunocompromised host. In some cancers, the immune 
functions in the cancerous tissue microenvironments are dysregulated, which leads 
these tissues to be more susceptible to infections (Mantovani et al., 2008). 
Virulence factors are bacterial components that help bacteria survive and reproduce in 
the host as well as use the host for nutrition. These components include molecules for 
adhesion, nutrition acquisition and harming the host cells. In addition to virulence 
factors, bacteria have many additional structural and functional properties that support 
their survival in the host. Most bacteria live in biofilms, which are sessile bacterial 
communities formed on any surface in nature. Biofilms cause chronic infections and 
are more resistant to host clearance (Hall-Stoodley & Stoodley, 2009). The unique 
mechanisms underlying the virulence of biofilms require further research. 
In this era of increasing multiresistant bacterial strains, it is necessary to develop new 
ways to fight infections without promoting the development of antibiotic resistance. 
The various bacterial virulence mechanisms may provide new targets for 
antimicrobial therapy. Only detailed molecular knowledge of virulence mechanisms 
and how they affect the overall bacterial function will enable the development of 
effective novel antimicrobial strategies. While many traditional antibiotics target 
more general bacterial structures and functions, and are effective for multiple 
pathogens, new strategies may require a species-targeted approach. This approach 
naturally requires more detailed knowledge of each bacterium and its possible targets. 
The clinical challenge of this approach is that effective treatment can be started only 
after the exact pathogen is known. More targeted treatment, however, is less likely to 
promote the development of resistant strains, since the treatment affects only certain 
pathogens and is not used widely as are broad-range antibiotics.  
The host immune responses are mediated by inflammatory signaling molecules such 
as cytokines, chemokines and interferons. For instance, these molecules attract 
immune cells to the infection site or induce them to secrete other inflammatory 
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molecules. Cytokines, such as interleukin (IL)-1β, play a vital role in regulating the 
host immune responses (Parkin & Cohen, 2001). 
In this thesis, I will focus on the study of a virulence-associated mechanism that 
includes the binding and uptake of human cytokines. The model organism for this 
study is an oral opportunistic pathogen, Aggregatibacter actinomycetemcomitans 
(Zambon, 1985). This pathogen is linked to the onset of an aggressive form of 
periodontitis, presently renamed molar-incisor pattern periodontitis with rapid 
progression (Papapanou et al., 2018), which is a chronic inflammatory oral disease. A. 
actinomycetemcomitans grows as a biofilm that has increased resistance to host 
clearance. A. actinomycetemcomitans toxins induce cytokine production from human 
immune cells. In periodontitis, the inflammatory response is prolonged because the 
host is unable to destroy the biofilm. The overactivated host immune response instead 
destroys the teeth-supporting tissue and leads to resorption of the bone. 
In previous studies, A. actinomycetemcomitans was found to have the ability to bind 
and uptake the human proinflammatory cytokine IL-1β (Paino et al., 2011). 
Furthermore, this binding decreases the metabolic activity and increases the biofilm 
formation of A. actinomycetemcomitans. These effects are likely facilitated by the 
binding of IL-1β to intracellular proteins (Paino et al., 2011, 2012). 
This thesis focuses on finding and characterizing membrane protein(s) and other 
components of A. actinomycetemcomitans that interact with human cytokines. The 
other aim is to evaluate the role of these proteins in bacterial virulence-associated 
functions and survival in a hostile environment. 
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2. REVIEW OF THE LITERATURE 
2.1 Bacterial biofilms 
Biofilms are multicellular bacterial communities that are enclosed by a self-produced 
matrix, and attached to a surface or an interface. Their phenotype is also altered 
compared with freely suspended planktonic cells in regard to gene expression and 
growth rate (Donlan & Costerton, 2002). The majority of the bacteria in all 
ecosystems live in biofilms that can form on virtually all moist surfaces in nature. In 
some ways, the structural qualities of biofilms resemble those of tissues in higher 
organisms: they are multicellular organized structures enclosed with channels that 
allow the flow of nutrients, metabolites and waste to different parts of the biofilm 
(reviewed in Flemming et al., 2016). A large amount of the current knowledge of 
biofilms is concerning gram-negative Pseudomonas aeruginosa as it is the most 
widely used organism in biofilm studies. 
Biofilms are structurally very heterogeneous while constantly changing due to 
internal events as well as external signals. The development of biofilms follows a 
certain pattern: initial attachment to the surface is followed by the formation of 
microcolonies and maturation into matrix-enclosed biofilm. The mature biofilms 
release single planktonic cells that are dispersed into the environment to colonize new 
sites. To move from one phase to another, the activation of certain genes is required 
(McDougald et al., 2012). In natural environments, biofilms are usually composed of 
several bacterial species that coaggregate. Biofilms may have both aerobic and 
anaerobic bacteria that inhabit different layers. For example, the oral cavity is a 
specific niche that harbors versatile multispecies biofilms in which oxygen-requiring 
aerobes occupy the surfaces, while anaerobic bacteria thrive in the oxygen-limited 
inner parts of the biofilm. Each species in the biofilm contributes to the biofilm 
composition. The biofilm can be a mutualistic community where the species are 
recycling nutrients and genes with their neighboring cells. However, in many 
biofilms, there is ruthless competition among species over nutrients and space. Some 
species may even release antimicrobial compounds that are harmful to their neighbors 
in order to promote their survival (Nadell et al., 2016).  
Quorum sensing (QS) is a multicellular behavior that regulates many physiological 
processes, such as movement (swimming, swarming, twitching), biofilm formation 
and maturation. It is also linked to the production of virulence factors, aggregation, 
and production of antimicrobials and secreted products (reviewed in (Whiteley et al., 
2017)). The QS system is a population response that is switched on after a population 
reaches a certain level, “quorum”, of bacteria. The quorum level is sensed by bacteria 
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via the accumulation of small signal molecules, inducers. The common signal 
molecules for the QS systems in gram-negative bacteria are acyl-homoserine lactones 
(Parsek & Greenberg, 2000; Papenfort & Bassler, 2016) and quinolone derivatives 
(Pesci et al., 1999), both of which are found for instance in P. aeruginosa. In the oral 
pathogen A. actinomycetemcomitans, a QS signal molecule called autoinducer-2 as 
well as the two-component QS signal QseBC regulate biofilm formation and 
virulence (Novak et al., 2010; Weigel et al., 2015). 
2.1.1 Extracellular matrix of biofilms 
Bacteria in biofilms secrete molecules to form an extracellular matrix (EM) (reviewed 
in Flemming & Wingender, 2010). The main function of the EM is to maintain the 
biofilm structure and to protect biofilm cells from outside threats, such as 
antimicrobials. EM may also function as a buffer to cells in the biofilm so that they do 
not need to adapt to the ever-changing environments in nature. Additionally, EM may 
act itself as a reservoir of carbon and energy. EM is a dynamic environment with 
multiple microenvironments, and the overall composition of EM differs between 
different bacteria and even between different time points. The biofilm EM is formed 
from polysaccharides, DNA and proteins supplemented with other substances from 
the environment. 
The EM of bacterial biofilms is formed mainly of extracellular polymeric substance 
(EPS), which contains a mixture of large exopolysaccharides (Costerton et al., 1999); 
for example, alginate is a major exopolysaccharide in P. aeruginosa biofilms (Davies 
et al., 1993). The polysaccharide matrix is often viscous and quite elastic; it endures 
shear stress from the environment and reshapes instead of breaking apart. EPS 
production is affected by the available nutrients, especially carbon (Sutherland, 2001). 
EPS probably plays a role in antibiotic resistance in biofilms, as it may slow the 
penetration of antibiotics to the biofilm and inactivate some antibiotics (Donlan, 
2000). 
Extracellular DNA (eDNA) is also an important structural component in many 
bacterial biofilms. It forms a network by interacting with polysaccharides and 
proteins in the EPS (Wu & Xi, 2009). The eDNA in biofilms was previously 
presumed to be present solely as a product of cell lysis, but it has been shown to be 
deliberately secreted from cells either as bare DNA fragments or inside membrane-
derived vesicles (Hamilton et al., 2005; Jakubovics et al., 2013). eDNA in EM may 
resemble bacterial genomic DNA (Allesen-Holm et al., 2006; Wu & Xi, 2009). 
However, bacteria have also been shown to utilize the DNA of lysed 
polymorphonuclear leukocytes (PMNs) in the infection site (Walker et al., 2005). 
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Thus, unsuccessful eradication attempts of the host can sometimes help the bacteria to 
strengthen their biofilms.  
eDNA is important for biofilm formation, especially in the initial stages. The 
presence of DNase I in the growth medium prevents P. aeruginosa biofilm formation 
in younger biofilms (12-60 hours) but not in established biofilms (84 hours) 
(Whitchurch, 2002). Treatment with DNase I could therefore be used to prevent the 
formation of biofilms. The production of eDNA has been linked to the QS system in 
P. aeruginosa. While the basal level of eDNA in P. aeruginosa biofilm was not 
dependent on QS, the great majority of eDNA production was directly linked to QS-
regulating genes (Allesen-Holm et al., 2006). 
eDNA can have a shielding role on bacteria in biofilms by binding positively charged 
antibiotics, such as aminoglycosides. It has been shown that eDNA increases the 
tolerance of P. aeruginosa biofilm to the aminoglycosides (Chiang et al., 2013). In 
addition to having structural roles in biofilm EM, eDNA also plays an important role 
as a genetic material reservoir. The genes associated with virulence and antimicrobial 
resistance can spread in the biofilm population through horizontal gene transfer 
(HGT), a process by which bacteria exchange genetic material (von Wintersdorff et 
al., 2016). The role of eDNA in natural competence is described in the next section. 
Biofilm EM contains many proteins and enzymes that interact with other EM 
molecules (Sutherland, 2001). They may also act as adhesins that facilitate the 
binding of the bacterial cells to the EM and to each other. Carbohydrate-binding 
proteins called lectins are abundant in oral biofilms and are especially important in 
initial biofilm formation to coaggregate the bacteria of different species. 
2.1.2 Natural competence and DNA uptake in biofilms 
Many bacterial species spontaneously bind DNA from their surroundings and 
transport it to their cytosol; this is called natural competence. Natural competence is a 
mode of HGT, together with conjugation (through direct contact between the donor 
and recipient cells) and transduction (gene transfer by phages) (von Wintersdorff et 
al., 2016). Since the EM of bacterial biofilms is loaded with eDNA, constant 
exchange of genetic material occurs in the biofilms. Bacteria use the DNA as a 
nutrient (Finkel & Kolter, 2001), or if the uptaken sequences have enough similarity 
with the chromosomal DNA, various species can incorporate the DNA into their 
genome through homologous recombination. Natural competence is considered an 
advantage to bacteria. In addition to the nutrition that it provides, it may serve as a 
way for bacteria to receive genes that improve their survival, such as genes encoding 
antibiotic resistance or virulence factors.  
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The transport of linear DNA into gram-negative bacteria occurs in two stages 
(reviewed in Chen & Dubnau, 2004; Mell & Redfield, 2014). DNA is first transported 
through the outer cell membrane (DNA uptake) and then across the inner membrane 
(DNA translocation). The double-stranded DNA (dsDNA) is pulled through an outer 
membrane secretin pore by a retracting type IV pilus (TFP). The inner membrane of 
naturally competent strains has conserved membrane pores that will translocate one 
strand from the periplasm into the cytoplasm, while the other strand will become 
degraded and used as building blocks in DNA replication. The DNA transport in 
gram-positive bacteria occurs via similar mechanisms except that these bacteria do 
not require the first transport step because they lack an outer membrane (Chen et al., 
2005). 
The effect of uptaken DNA on the genome varies. If homologous recombination 
occurs between very similar strains, there might be no change at all, or a recently 
acquired new mutation might disappear. In heterogeneous populations, new gene 
combinations are possible, even though a newly acquired gene does not always 
promote fitness and can even contain lethal mutations (Redfield et al., 1997). In fact, 
the introduction of new genes into a species is not very efficient via homologous 
recombination since it requires a certain level of homology. However, homologous 
recombination is a very efficient mechanism for spreading a novel gene that is first 
introduced into the genome by another, non-homologous mechanism. (Mell & 
Redfield, 2014). 
There are bacteria that will take up any eDNA, while others prefer to uptake DNA 
homologous to their genome. The uptake signal sequences (USSs), or the DNA 
uptake sequences (DUSs), are short species-specific sequences that are taken up more 
efficiently by a certain species and are overrepresented in the genomes of that species 
(Smith et al., 1999). Two widely studied USS sequences are the 9-bp-long USS of 
Haemophilus (Danner et al., 1980) and the 10-bp-long Neisseria USS (Goodman & 
Scocca, 1988). 
2.1.3 Resistance mechanisms in biofilm diseases  
Biofilms are more resistant to antimicrobials than planktonic bacteria (reviewed in 
Hall & Mah, 2017). This resistance is derived from a combination of mechanisms that 
vary from species to species, and these mechanisms differentially affect each 
antimicrobial. The EM that surrounds the bacteria in the biofilms may limit the 
penetration of some antimicrobial agents into the biofilm. Further, various EM 
components may directly interact with antimicrobials. Polysaccharides, such as Psl in 
P. aeruginosa biofilm, can sequester certain antibiotics, preventing interaction with 
their targets (Billings et al., 2013). eDNA has been shown to increase the tolerance 
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for various antimicrobials (Chiang et al., 2013). Anionic eDNA may induce survival-
associated genes by modifying the local environment (by chelating cations or 
decreasing pH), or it can promote more efficient distribution of resistance genes 
through HGT. In Salmonella enterica biofilm, eDNA chelated Mg2+ ions, which 
increased the expression of the polymyxin resistance operon (Johnson et al., 2013). 
The secreted enzymes in EM can directly degrade antimicrobial substances; for 
instance, the β-lactamases produced by P. aeruginosa make these bacteria resistant to 
β-lactam antibiotics (Bagge et al., 2004). The second biofilm characteristic that 
decreases the effect of antibiotics is the reduced growth rate of the bacterial cells in 
biofilms. Many antibiotics target the synthesis of cell wall or proteins and therefore 
have the greatest effect on fast-growing cells. The biofilm contains a substantial 
population of cells in a slow- or non-growing state due to nutrition and oxygen 
limitations. Some of these non-growing cells are so-called persister cells, which are in 
a metabolically inactive, dormant state and can survive very high doses of 
antimicrobials (Lewis, 2010). Additionally, the metabolic state of bacteria varies 
greatly among biofilms, so there is a great possibility that some bacteria will always 
avoid antimicrobial effects and serve as a reservoir for the biofilm to re-establish. 
Additionally, antimicrobial efflux pumps, QS and genetic diversity (through HGT and 
an elevated mutation rate) have been shown to play a role in the antimicrobial 
resistance in biofilms (Hall & Mah, 2017). 
Bacterial biofilms are also more resistant to clearance by the host immune system. 
Bacterial presence attracts phagocytes to the site of a biofilm and while failing to 
ingest the biofilm-protected bacteria, the phagocytes still release phagocytic enzymes 
that instead damage the host tissue around the biofilm (Fig. 1) (Costerton et al., 
1999). Antibodies are usually not effective on biofilms since they are unable to 
penetrate the EM.  
Biofilms are associated with many chronic inflammatory diseases because they are 
difficult to eradicate by antimicrobials or by the host immunity (Costerton et al., 
1999). P. aeruginosa biofilms are commonly associated with persistent bacterial 
infections in the lungs of cystic fibrosis patients. Periodontitis is a severe chronic 
infection caused by oral biofilms (plaque) that will be discussed later in this review. 
Biofilm-associated diseases are seldom diagnosed in their early stages because slow-
growing biofilms show no overt symptoms. Biofilms are also readily formed on the 
surfaces of indwelling medical devices, such as mechanical heart valves, prosthetic 
joints, catheters, and contact lenses, and cause local or systemic infections (Donlan, 
2001).  
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Antibiotic treatment for a biofilm-borne infection can reduce symptoms temporarily 
because it will kill the planktonic cells shed from the biofilm. However, the 
symptoms will gradually return if there is any remaining biofilm. The most effective 
way to eradicate the biofilm is mechanical or surgical removal. Recently, the focus 
has been to discover new ways to treat biofilms by inhibiting unique mechanisms for 
biofilms, such as the formation of the EM or the QS system.  
 
  
Figure 1. Biofilm formation on medical devices. (a) Human immune response 
(neutrophils and antibodies) together with antibiotics clear the planktonic bacteria.          
(b) Biofilm starts to form on the surface of the medical device. Antibodies and antibiotics 
are no longer able to penetrate the biofilm matrix, so the clearance is ceased.                       
(c) Neutrophils are unable to ingest bacteria but are still releasing their lytic enzymes.      
(d) Biofilm growth and lytic enzymes start to destroy the tissue, but the biofilm remains. 
Planktonic cells that are released from the biofilm can colonize new sites once they escape 
the defenses. Figure from Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999). 
Bacterial biofilms: a common cause of persistent infections. Science, 284(5418), 1318–
1322. Reprinted with permission from AAAS. 
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2.2 Bacterial virulence 
Bacteria may cohabit in their environment peacefully as a commensal, or they might 
be pathogenic and cause diseases in the host organism. Pathogens are called 
opportunistic when they are acting as a commensal until they sense certain 
environmental cues, for example, signs that the host immunological state is getting 
weaker, and only then start expressing their virulence properties. However, many 
diseases are not caused by a single pathogen but rather by a dysbiosis in the 
indigenous multispecies biofilm; the divide of these species into commensals and 
pathogens is not straightforward. Instead, these species can be described, for instance, 
as the keystone pathogens (pathogens with low abundance but great pathogenic 
effect), pathobionts (commensals that can be triggered into pathogenic by changes in 
the host immunity) and accessory pathogens (commensals that support the virulence 
of pathogenic species) (Hajishengallis & Lamont, 2016).  
There are various ways that virulence is conveyed in bacteria. Bacteria produce 
molecules called virulence factors that boost the bacteria in their efforts to colonize a 
niche, to escape or inhibit host immune responses, to obtain nutrition from the host 
and to survive in the host without killing the host (Finlay & Falkow, 1989). Virulence 
factors include toxins that can damage host cells, adhesins that aid in bacterial 
adhesion to the host or to extracellular components, invasins that promote invasion 
and evasins that help bacteria evade host immunity. Toxins may also disturb essential 
host functions to aid other virulence factors in invasion or evasion. The sequestering 
of host cytokines, which is the main topic of this thesis, is a mechanism that bacteria 
use to evade host immunity. 
Virulence factors also include factors that help bacteria acquire nutrition from the 
host and factors that are needed for biofilm formation or for the QS system (Papenfort 
& Bassler, 2016). These factors work together dynamically to initiate and maintain 
infection. Virulence is often altered via HGT, since many virulence genes and 
antibiotic resistance genes are located in plasmids that are readily dispersed 
throughout the population. For instance, in pathogenic E. coli, most of the virulence-
associated genes are encoded by mobile genetic elements (Croxen et al., 2013). Many 
virulence factors are multifunctional so-called moonlighting proteins (Henderson & 
Martin, 2011). Virulence is expressed differently in different species, and all 
virulence behaviors in bacteria may not have even been discovered yet.  
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2.2.1 Lipopolysaccharide 
The outer leaflet of the outer membrane in gram-negative bacteria is mainly 
assembled out of lipopolysaccharide (LPS) (Fig. 2). It plays an important role in 
maintaining membrane structure and acting as a barrier to hydrophobic compounds 
such as antibiotics and detergents. It helps bacteria to survive in harsh environmental 
conditions and to resist antibiotics/antimicrobials (Papo & Shai, 2005). While LPS is 
essential for most gram-negative species, some viable LPS-deficient mutant strains 
have been discovered in Neisseria, Acinetobacter and Moraxella species (reviewed in 
Zhang et al., 2013). LPS is one of the main components of the outer membrane 
vesicles (OMVs) that bacteria release from their outer membrane (Mashburn-Warren 
& Whiteley, 2006). OMVs are small membrane-enclosed particles that are coated 
with lipids and LPS and can contain various virulence factors, such as toxins. 
The general LPS structure is conserved in all gram-negative species and consists of a 
lipid part (lipid A) and a polysaccharide part formed from core- and O-
polysaccharides (reviewed in Erridge et al., 2002; Raetz & Whitfield, 2002) (Fig. 3). 
Lipid A has a backbone of two acylated glucosamines bound by four to six lipid 
chains. These hydrophobic lipid chains attach LPS to the lipid membrane. The 
structure of lipid A is fairly conserved, but there is some variation between bacterial 
Figure 2. The structure of the gram-negative cell wall. The bacterial cell is enclosed by 
two lipid membranes and the peptidoglycan layer between the membranes. The outer leaflet 
of the outer membrane is mainly formed out of LPS. LPS is attached to the membrane with
lipid A part, which is linked to the core polysaccharide and the O-polysaccharide regions.     
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families. Lipid A is responsible for endotoxic activity, and its properties determine 
the level of its toxicity. 
 
Lipid A is attached to the core polysaccharide part of LPS, which is divided into inner 
core and outer core regions (Fig. 3). The inner core is usually made of uncommon 
sugars such as L-glycero-D-manno-heptose and 3-deoxy-D-manno-octulosonic acid 
(Kdo). In the majority of studied LPS molecules, Kdo is the starting sugar of the 
chain and the one bound to lipid A (Erridge et al., 2002). The smallest saccharide part 
of LPS is found in Haemophilus influenzae: only one Kdo is attached to lipid A 
(Helander et al., 1988). It seems that while bacteria can survive without the O-antigen 
and with a truncated core polysaccharide, this Kdo residue is most likely essential for 
the bacterial structure. The outer core is generally more diverse than the inner core 
and is made out of more conventional sugars, such as glucose, galactose and N-acetyl 
glucosamine.  
The hypervariable O-polysaccharide region is made from repeated oligosaccharide 
units (Fig. 3). The oligosaccharide units are usually formed from 1 to 8 glycosyl 
residues and can be repeated in the chain from a few up to 50 times (Erridge et al., 
2002). The diversity of the O-polysaccharide is substantial even within one species 
and derives from the complex structure of the O-polysaccharide. The oligosaccharide 
units can be formed from different monosaccharides with various modifications (e.g. 
glycosylation) and are connected to each other in various ways. Furthermore, in the 
chain of oligosaccharide units, the amount and position of the repeated 
Figure 3. The general structure of LPS.
The lipid A part of LPS is composed of one 
di-polysaccharide conjoined with lipid chains. 
The inner and outer core regions are formed 
out of diverse polysaccharides, while 3-deoxy-
D-manno-octulosonic acid (Kdo) is fairly 
conserved as the polysaccharide that connects 
the core with lipid A. The O-antigen 
polysaccharide is composed of repeated 
oligosaccharide units. Figure was modified 
from Maeshima & Fernandez 2013. 
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oligosaccharide units vary greatly, and the chain can be branched (reviewed in 
Erridge et al., 2002; Raetz & Whitfield, 2002). However, not all LPS molecules have 
O-polysaccharides. The O-polysaccharide is located furthest from the membrane 
surface, so it is the natural target for host recognition and immune responses. 
Therefore, it is also called the O-antigen. Since the structure of O-polysaccharide 
varies even within bacterial species, it has been used as a factor to divide bacterial 
species into different serotypes. The number of serotypes varies; for example, E. coli 
has over 180 different O-antigen serotypes (Fratamico et al., 2016).  
LPS, also called the endotoxin, is a highly immunogenic compound that induces an 
inflammatory response, for instance, the production of cytokines, from multiple 
human immune cells. A substantial amount of lipid A is released when the bacteria 
are lysed, and it activates the host immune responses even at picomolar 
concentrations. Lipid A is bound by the LPS-binding protein and CD14 opsonic 
receptor. The CD14 receptor does not have an intracellular part, so subsequent 
signaling requires the binding of this complex to toll-like-receptor 4 (TLR4) in the 
animal cell membrane (Hoshino et al., 1999; Aderem & Ulevitch, 2000). TLR4 is an 
innate immunity receptor that is expressed, for example, in macrophages and human 
gingival fibroblasts (Wang et al., 2000; McGettrick & O’Neill, 2007), but its 
expression has also been characterized in various cancer cell types (Pandey et al., 
2018). TLR4 activation in macrophages leads to the production of proinflammatory 
mediators, such as IL-1β and tumor necrosis factor α (TNF-α). The detection of lipid 
A leads to a vast immune response that can cause fever, diarrhea, and even septic 
shock. The proteins involved in LPS synthesis are promising targets for the 
development of new antibiotics. One example of this is a synthetic peptide that targets 
P. aeruginosa LptD, a LPS assembly protein, which displays antimicrobial properties 
against P. aeruginosa spp. but not towards other gram-negative or gram-positive 
species (Srinivas et al., 2010). 
2.2.2 Bacterial moonlighting proteins in virulence 
Proteins that perform more than one biologically relevant function within one 
polypeptide chain are called moonlighting proteins (Jeffery, 1999). The term 
“moonlight” is used to describe people working multiple jobs and is adopted here to 
refer the multiple jobs of a protein. Moonlighting means that a protein can perform 
multiple distinct functions without any proteolytic modifications, gene 
rearrangements or fusions. Under certain conditions, a monofunctional protein may 
acquire a secondary function (and may still maintain the primary function as well). In 
some moonlighting proteins, the functional regions are overlapping, while other 
proteins have those regions far apart, which enables them to perform multiple 
functions simultaneously. A moonlighting protein may have one or multiple 
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moonlighting functions. (Henderson, 2016). The presence of multiple functions in one 
protein is cost-effective for bacteria because they do not have to express so many 
proteins or have so many corresponding genes to replicate.  
There are various ways that moonlighting proteins switch between their functions 
(reviewed in Jeffery, 1999) (Fig. 4). Many bacterial moonlighting proteins may 
perform different functions in the intracellular environment than in the outer 
membrane or as a secreted protein. Some moonlighting proteins have different 
functions as monomers and multimers, when expressed in different cell types or when 
bound to a cofactor. Additionally, they might have different functions when bound to 
a protein complex, such as a ribosome, rather than on their own. Some proteins can 
sense changes in their environment, such as pH or the concentration of a ligand, and 
change their conformation and thus their function accordingly.  
Many of the identified moonlighting proteins play roles in cellular metabolism 
(glycolysis, tricarboxylic acid cycle, etc.) or act as chaperones (proteins that aid the 
folding of other proteins) (reviewed in Jeffery, 2018). The secondary (moonlighting) 
functions for these proteins are typically linked to adhesion or secretion of these 
proteins as signal molecules.  
Figure 4. Moonlighting mechanisms of proteins. (A) Moonlighting protein may have 
different functions in different organisms or B) in different cell types of the same organism. 
C) Protein may have different functions intracellularly compared to when secreted, or
D) whether they are located in the cytosol or bound to a membrane. E) Proteins may also 
harbor different functions when forming multimers or F) complexes with other proteins or    
G) when they are bound to a substrate, cofactor or other ligand. H) Moonlighting proteins 
may have multiple binding sites for different ligands in different parts of their polypeptide 
chain. 
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Bacteria utilize some of the cytosolic (housekeeping) proteins on their cell surface to 
bind the host or EM components. The first protein that was identified within this 
group of moonlighting proteins, was glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) in group A streptococci. GAPDH has cytosolic enzymatic activity but is 
also localized to the membrane and binds to plasmin, fibronectin and lysozyme 
(Pancholi & Fischetti, 1992). GAPDH has since become the archetypal example of 
moonlighting proteins, as it has been discovered in a variety of bacteria and has a 
variety of roles (in adhesion, DNA repair, evasion and many more) (Tristan et al., 
2011). 
Moonlighting proteins have been identified in all organisms, including humans. 
Currently, almost 400 moonlighting proteins have been characterized and all the 
found moonlighting proteins are collected in the Moonlighting proteins database 
(MoonProt, http://www.moonlightingproteins.org, Chen et al., 2018). It is interesting 
that many metabolic moonlighting proteins are evolutionarily very old and conserved 
from prokaryotes to eukaryotes (Henderson & Martin, 2014). Proteins with one 
function may have evolved into multifunctional proteins by modifying the parts of 
proteins that are not critical for the primary function. 
Many bacterial moonlighting proteins have one or multiple functions related to 
virulence. They act in all the main virulence factor classes: as adhesins, invasins, 
evasins, and toxins or in nutrition acquisition. However, for the currently known 
virulence-associated moonlighting proteins, the most common virulence function is 
adhesion (Henderson, 2016). These virulence-associated moonlighting functions 
could have evolved through coincidental virulence, which means that virulence traits 
originally evolved to protect bacteria from predatory protozoans in their natural 
environment (Adiba et al., 2010). Moonlighting proteins seem to play important 
biological roles in bacteria because they are commonly utilized by several different 
bacteria, and many moonlighting proteins bind their ligands with high affinity 
(Henderson, 2016).  
2.2.3 Bacterial proteins interacting with human cytokines 
Cytokines are signal molecules that are produced by host cells to initiate and regulate 
immune responses. In particular, cytokines play important roles in response to 
infections. To the best of our knowledge, bacteria may sense cytokines in their 
environment and obtain clues about the immunological conditions of the host. Based 
on this information, bacteria may alter their virulence properties. The expression of 
virulence properties consumes energy, so it is beneficial for the bacteria to sense their 
environment for these cues and act only when they sense threats to their survival. 
Some host immune molecules might directly activate virulence, and it has been 
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suggested that cytokines may be broken into peptides that directly act as transcription 
modulators (Kanangat et al., 2001). Human proinflammatory cytokines have been 
shown to enhance the growth of bacteria and affect bacterial virulence. Direct binding 
on bacterial cells has also been observed. Most of the binding was observed with IL-
1β, and the reported binding occurred with gram-negative Escherichia coli and 
Acinetobacter sp. and with gram-positive Staphylococcus aureus (Porat et al., 1991; 
Meduri et al., 1999; Kanangat et al., 2001). IL-1β is one of the cytokines that activate 
the immune response; therefore, binding IL-1β may disturb the inflammatory cascade. 
Virulent strains of E. coli bind IL-1β, and bacteria grow faster when supplemented 
with IL-1β. The enhancement of growth by IL-1β occurs only in the logarithmic 
phase of growth, resulting in the bacteria reaching the stationary phase faster (Porat et 
al., 1991). IL-1β has also been shown to enhance the growth of fresh isolates of 
Acinetobacter sp. and S. aureus (Meduri et al., 1999). S. aureus binds IL-1β to its 
surface, and IL-1β decreases the expression of leukotoxins and increases the levels of 
virulent adhesins that bind to EM molecules in S. aureus (Kanangat et al., 2001, 
2007). Thus, under high IL-1β concentrations, bacteria modulate their gene 
expression profile to survive within the host rather than to fight. In a later study, S. 
aureus biofilms were found to bind more IL-1β than did planktonic cells of the same 
strain. Growth enhancement of the biofilm but not the planktonic culture was 
observed with IL-1β, as well as TNF-α and macrophage inflammatory protein-1a 
(McLaughlin & Hoogewerf, 2006). This suggests that the biofilm cells upregulate the 
genes that respond to cytokines. 
TNF-α has been shown to bind gram-negative Shigella flexneri, E. coli and 
Salmonella typhimurium. S. flexneri bound TNF-α with high affinity (Kd = 2.5 nM) 
when studied using radiolabeled TNF-α (Luo et al., 1993). The same study also 
showed TNF-α binding to gram-positive S. aureus, Listeria monocytogenes and 
Streptococcus mitis, but this binding was significantly less than that to the tested 
gram-negative bacteria. Moreover, IL-6 (but not IL-1β or TNF-α) has been shown to 
enhance the growth of fresh isolates of gram-negative P. aeruginosa (Meduri et al., 
1999). The growth enhancement of S. aureus was also observed with IL-6 and TNF-α 
when the bacteria were grown in chemically defined synthetic medium (Meduri et al., 
1999). 
All the above-mentioned studies have shown the effect of cytokines at the cellular 
level without identifying the actual molecules on bacteria interacting with the 
cytokines. However, the bacterial proteins discovered to directly interact with 
cytokines are reviewed in the next paragraphs.   
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Caf1A of Yersinia pestis  
Yersinia pestis is a gram-negative coccobacillus that can cause plague. One of its 
major virulence features is its large capsule. The main component of the Y. pestis 
capsule is F1 (fraction 1), which is highly immunogenic. The interaction between 
radiolabeled recombinant IL-1β and Caf1A, the capsule F1 usher protein, was first 
shown using E. coli cells that expressed the Y. pestis capsule operon f1 from a 
plasmid. Caf1A was identified as the interaction partner by immunoblotting and 
further verified by the purified Caf1A inhibiting recombinant IL-1β binding to the 
cells (Zav’yalov et al., 1995). The capsule subunit Caf1 has structural similarity to 
human IL-1β and can bind the IL-1 receptor (on mouse fibroblasts), inhibiting IL-1β 
binding to it (Abramov et al., 2001).  
The f1 operon is responsible for the production and surface assembly of the F1 
capsule. This operon consists of four genes: caf1, caf1A, caf1M and caf1R. Caf1 is the 
structural subunit of the capsule (Galyov et al., 1990), and the other three genes are 
responsible for its assembly, transport and transcription regulation, respectively 
(Galyov et al., 1991; Karlyshev, Galyov, Abramov, et al., 1992; Karlyshev, Galyov, 
Smirnov, et al., 1992). Fibrillar F1 capsule assembly occurs with the chaperone/usher 
pathway using the donor strand exchange mechanism (Zavialov et al., 2003). The 
Caf1M chaperone in the periplasm aids the folding of the Caf1 subunit and presents it 
to the Caf1A usher. Caf1A adds Caf1 to the forming capsule fiber and serves as the 
channel for the fiber to go through (Fig. 5). The N-terminal part of Caf1A has been 
shown to interact with the Caf1:CafM complex in Y. pestis capsule assembly (Di Yu 
et al., 2012). 
Figure 5. Schematic presentation of the Y. pestis
capsule fiber assembly. (1) The fiber subunit Caf1 
is correctly folded in the periplasm by the Caf1M 
chaperone. (2) Caf1M:Caf1 complex binds with the 
N-terminal domain (N) of Caf1A usher protein.   
(3) Caf1A aids the Caf1 to polymerisize with the 
preceding Caf1 subunit. After that Caf1M is 
released back to the periplasm. Caf1A periplasmic 
domains are marked in the figure: middle domain 
(M), N-terminal domain (N), C-terminal domains 
(C1 and C2). Figure from Di Yu et al. 2012.   
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OprF of Pseudomonas aeruginosa 
P. aeruginosa is a gram-negative opportunistic pathogen causing severe lung 
infections, especially in patients with cystic fibrosis. The major non-specific outer 
membrane porin OprF of P. aeruginosa has multiple roles contributing to biofilm 
formation, adhesion to eukaryotic cells and formation of OMVs, and it also acts as a 
passage for small molecules (reviewed in (Chevalier et al., 2017)). However, the 
major role of 38-kDa (kilodalton) OprF is to maintain cell shape by anchoring the 
outer membrane to the periplasmic peptidoglycan layer with its C-terminal 
peptidoglycan-binding domain (Rawling et al., 1998). OprF also plays a major role in 
the overall virulence of P. aeruginosa since the absence of OprF disturbs the 
attachment to eukaryotic cells, altering the function of the type III signal secretion 
system and decreasing the QS system-induced virulence factors (Fito-Boncompte et 
al., 2011). The absence of OprF also leads to increase in the levels of secondary 
messenger cyclic-di-GMP, which increases the biofilm formation (Bouffartigues et 
al., 2015).  
OprF was shown to bind human interferon γ (IFN-γ) (Wu et al., 2005; Maccarini et 
al., 2017), which induced the expression of type I P. aeruginosa (PA-I) lectin, a 
central virulence factor (Wu et al., 2005), but did not have any effect on the channel 
functions of OprF (Maccarini et al., 2017). PA-I lectin is an adhesin that facilitates the 
contact of bacterial cells with epithelial cells. It significantly disturbs the barrier 
function of the host intestinal epithelium, leading to increased permeability of 
bacterial cytotoxins through the epithelium (Laughlin et al., 2000). The expression of 
PA-I lectin from the lacA gene is regulated by the QS system regulators (Winzer et 
al., 2000). Accordingly, IFN-γ also induces the expression of various QS-associated 
molecules in P. aeruginosa (Wu et al., 2005).  
OprF belongs to an OmpA protein family, of which the most studied protein is outer 
membrane porin OmpA of E. coli (Krishnan & Prasadarao, 2012). The three-
dimensional OmpA structure was used as a homologous model when the structure of 
OprF was modeled. Initially, OprF was presumed to form a wide channel like the 
OmpA, but the fact that the diffusion rate for various molecules was very low 
challenged that assumption. Sugawara and co-workers discovered that OprF actually 
exists in the membrane in two stable conformers: abundantly as the closed, two-
domain conformant and rarely (~5 %) as the open, one-domain conformant 
(Sugawara et al., 2006) (Fig. 6A). 
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In the closed conformant, the N-terminal region forms a barrel of eight β-sheets (Fig. 
6B), and the C-terminal region forms a globular domain (Fig. 6C) in the periplasmic 
space. The globular domain is the part of the protein that attaches the peptidoglycan. 
In the open form, the C-terminal part is also inserted in the membrane, forming a 
large channel of approximately 16 β-sheets. (Sugawara et al., 2006).  
  
Figure 6. Two putative conformers of P. aeruginosa OprF (A) Schematic representation 
of two conformers of OprF. The two-domain closed conformer is composed of an N-terminal 
β-barrel of 8 β-sheets and the C-terminal globular domain. The open conformer, on the other 
hand, forms only one domain, a large β-barrel of 16 β-sheets. The open conformer can also 
form multimers. 3D structures of the closed channel conformer domains have been solved:
(B) the N-terminal barrel (Protein Data Bank (PDB):4RLC) and (C) the C-terminal globular 
domain (PDB:5U1H). Domains are colored blue to orange from the N- to C-terminus. Figure 
was adapted from Sugawara et al., 2006 and Högbom & Ihalin, 2017.  
A 
B C 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   29 16.5.2019   9.12
30  Review of the literature 
 
 
 
PilQ and PilE of Neisseria meningitidis 
N. meningitidis is a gram-negative opportunistic pathogen that is found in the human 
respiratory tract as a commensal but can cause serious diseases such as meningitis and 
sepsis (Hill et al., 2010). The TFP subunit PilE and secretin PilQ of N. meningitidis 
have been shown to bind TNF-α and IL-8 (Mahdavi et al., 2013). TFP is an important 
virulence factor in N. meningitidis since it mediates movement and adhesion to the 
host (Hill et al., 2010). 
PilE is the pilus subunit that polymerizes to form the long chain through the channel 
formed by the PilQ secretin (Fig. 7, PilE and PilQ circled in figure) (Craig et al., 
2004). The structure of PilQ was modeled by Berry and co-workers using a 
combination of nuclear magnetic resonance (NMR), electron microscopy and 
homology modeling (Berry et al., 2012).  
 
Induction with TNF-α or IL-8 did not affect the growth of N. meningitidis. However, 
IL-8 and TNF-α were localized in the N. meningitidis cytoplasm, where TNF-α 
directly binds genomic DNA within specific genes (Mahdavi et al., 2013). The 
binding of cytokines to promoter areas may alter their structure, either promoting or 
preventing the binding of RNA-polymerase or transcription factors. Overall, 
induction with TNF-α or IL-8 altered the expression of 20-45 % of N. meningitidis 
genes. The majority of genes had unknown function, but those with known functions 
were responsible for adhesion, cell envelope, energy metabolism and bacterial 
Figure 7. The type IV pilus (TFP) of 
Neisseria spp. TFP assembly and 
disassembly are orchestrated by multiple Pil 
proteins. The prepilin peptidase PilD 
processes the pili subunit PilE and 
assembles that into the pilus fiber. The 
polymerization of PilE monomers is aided 
by the inner membrane protein PilG, and 
this process is powered by the ATPase PilF. 
Another ATPase PilT drives the 
disassembly process. PilQ is a secretin 
protein that forms the outer membrane 
channel, through which the forming pili can 
protrude. PilP and PilC assist with PilQ and 
pilus assembly, respectively. Figure was 
adapted from Chen & Dubnau 2004. 
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survival (Mahdavi et al., 2013). Most of these genes are likely important for virulence 
and pathogenicity, suggesting that IL-8 and TNF-α could increase the virulence of N. 
meningitidis. PilQ has been shown to bind DNA, and the deletion of pilQ made N. 
meningitidis deficient in transformation, implying the importance of PilQ in bacterial 
competence (Assalkhou et al., 2007; Lång et al., 2009). Additionally, the mutant 
strains with unglycosylated pili displayed less binding to cytokines, which indicates a 
role of PilE glycosylation in this interaction (Mahdavi et al., 2013). 
IrmA of Escherichia coli 
Uropathogenic E. coli (UPEC) causes urinary tract infections. IL receptor mimic 
protein A (IrmA) in UPEC was initially identified as a potential vaccine antigen 
C1275 (Moriel et al., 2010). A more detailed study of the virulence properties of 
IrmA revealed that it interacted with several cytokines (Moriel et al., 2016). 
IrmA is a secreted protein that exists as a stable domain-swapped dimer in aqueous 
solution. IrmA has a fibronectin III-like (FNIII) domain with seven antiparallel β-
sheets (Moriel et al., 2016) (Fig. 8). IrmA has no significant sequence similarity to 
other proteins with known functions. However, structural similarities can be observed 
with many proteins that have FNIII-like domains, such as extracellular domains of 
cytokine receptors: IL-2 receptor and IL-4 receptor, and, to a lesser extent, the IL-10 
receptor. The microplate assay showed that IrmA bound IL-2, IL-4 and IL-10 (Moriel 
et al., 2016).  
 
The irmA gene is prevalent in 70 % of sequenced UPEC strains, suggesting a 
potential role in pathogenesis. It is regulated by the global regulatory protein OxyR 
(Moriel et al., 2016). IrmA was also shown to be immunogenic: patients infected with 
irmA-positive UPEC had higher antibody titers against IrmA in their plasma than did 
non-infected individuals (Moriel et al., 2016). IrmA may participate in the 
manipulation of immune responses during urinary tract infections.  
Figure 8. 3D structure of E. coli IrmA 
dimer.  IrmA monomer (c. 13 kDa) is 
formed from seven antiparallel β-sheets. Two 
monomers form a domain-swap dimer where 
a short β-strand (red) at the C-terminal end 
extends into the other monomer. Domains 
are colored blue to red from the N- to C-
terminus. Figure was adapted from Högbom 
& Ihalin, 2017.  
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2.3 Aggregatibacter actinomycetemcomitans 
A. actinomycetemcomitans is a gram-negative coccobacillus that belongs to the 
Pasteurellaceae family (Zambon, 1985). A. actinomycetemcomitans was formerly 
known as Actinobacillus actinomycetemcomitans but reclassified in 2006 to form the 
new Aggregatibacter genus with Aggregatibacter aphrophilus and Aggregatibacter 
segnis (Nørskov-Lauritsen & Kilian, 2006). Haemophilus species are the closest 
relatives of the Aggregatibacter genus. 
 
A. actinomycetemcomitans is an opportunistic pathogen that inhabits the human oral 
cavity; the surface of teeth and periodontal pockets. It forms tenacious biofilms in 
gingival pockets/dento-gingival junctions with other oral bacteria (Fig. 9). A. 
actinomycetemcomitans is a facultatively anaerobic bacterium that grows well in an 
anaerobic environment or in the presence of 5 % carbon dioxide but can survive, 
while growing poorly, in the presence of oxygen (Zambon, 1985). A. 
actinomycetemcomitans forms small star-shaped colonies when grown on agar. The 
primary cultures are adherent phenotypes with bundled fimbriae (rough) but become 
non-adherent (smooth) after repeated culturing (Zambon, 1985).  
 
A. actinomycetemcomitans can be found as a part of normal oral microbiota in 
periodontally healthy individuals. However, it is strongly associated with oral 
inflammatory disease, periodontitis and especially periodontitis with a molar-incisor 
pattern and rapid progression (Papapanou et al., 2018), formerly known as localized 
aggressive periodontitis. Periodontitis is characterized by the progressive destruction 
Figure 9. Formation of oral biofilm in periodontal pockets. Biofilm forms in the junction 
between the tooth and the gingiva. The progression of periodontal disease is characterized by 
the attachment loss of the junctional epithelium and the formation of the gingival pocket. 
Figure was adapted from Pöllänen et al. 2012.  
The etymology of the name:  
aggregare (lat.), aggregate  
bacter (new lat.), bacterial rod  
actinomyces –etis (new lat.),        
an actinomycete (ray fungi) 
comitans (lat.), accompanying  
actinomycetemcomitans (new lat.), 
accompanying an actinomycete 
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of the tooth-supporting tissues and bone. Advancement of the disease will eventually 
lead to tooth loss.  
Periodontitis is a multifactorial disease that is initiated by polymicrobial biofilms of 
mainly gram-negative oral bacteria, such as Porphyromonas gingivalis, Tannerella 
forsynthia and Treponema denticola (Haffajee & Socransky, 1994; Lamont et al., 
2018). The onset of periodontitis is linked to both dysbiosis of the oral microbiota and 
to the elevated host inflammatory response (Darveau, 2010; Lamont et al., 2018). 
Dysbiosis occurs when a number of oral commensals is decreased while the number 
of pathogenic species is increased. Inflammation promotes the growth of certain 
pathogens, which increases the dysbiosis. The pathogens, on the other hand, produce 
compounds that promote inflammation, creating a feedforward loop that sustains both 
the dysbiosis and the inflammation (Lamont et al., 2018). Upon dysbiosis, the 
commensal species may support the virulence of pathogens. One of the oral 
commensals, Streptococcus gordonii, has been shown to promote the pathogenesis of 
A. actinomycetemcomitans by producing lactate that A. actinomycetemcomitans 
utilizes as an energy source (Ramsey et al., 2011). The initiation and progression of 
periodontitis also depends on host susceptibility and factors such as defects in 
immune responses, systemic diseases or smoking (Haffajee & Socransky, 1994).  
There are constant low levels of cytokines and chemokines present in healthy 
periodontium and these are highly important mediators for maintaining a healthy 
balance in the periodontium. Imbalance will lead to increased cytokine production, 
leukocyte activity and tissue destruction. A. actinomycetemcomitans is able to 
stimulate the production of proinflammatory cytokines from gingival epithelial cells 
or fibroblasts (Agarwal et al., 1995; Dongari-Bagtzoglou & Ebersole, 1996; Uchida et 
al., 2001). These cytokines will then induce the production of the receptor activator of 
NF-κB ligand (RANKL). Bone resorption is due to increased levels of RANKL 
compared to osteoprotegerin (OPG), which is an inhibitor of the RANK-RANKL 
interaction that leads to the release of bone-degrading enzymes (Darveau, 2010).  
As mentioned before, the role of cytokines and chemokines, especially IL-1β, IL-6 
(CXCL6), IL-8 (CXCL8), IFN-γ and TNF-α, in the tissue is pivotal for bone 
destruction in periodontitis (Graves, 2008). IL-1β is an important gatekeeper cytokine 
in inflammation that initiates the immune cascade and induces the production of other 
inflammatory markers as well as activates many leukocytes (Dinarello, 2018). IL-8 is 
a chemotactic agent for neutrophils and some other granulocytes (Rossi & Zlotnik, 
2000). It stimulates immune cells in the infection site. 
A. actinomycetemcomitans is also linked to the etiology of non-oral infections, such 
as cardiovascular diseases (Haraszthy et al., 2000; Kozarov et al., 2005; Hyvärinen et 
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al., 2012), endocarditis (Kaplan et al., 1989; Lützen et al., 2018), and brain abscesses 
(Rahamat-Langendoen et al., 2011). A. actinomycetemcomitans belongs to the 
HACEK group of gram-negative pathogenic bacteria that includes Haemophilus 
parainfluenzae, Aggregatibacter species, Cardiobacterium species, Eikenella 
corrodens, and Kingella species. The HACEK group of bacteria includes causative 
agents of infective endocarditis and is responsible for 1-3 % of cases (Paturel et al., 
2004; Revest et al., 2016). A. actinomycetemcomitans species that were found in other 
organs were most likely originated from the oral cavity, suggesting that poor dental 
conditions and recurring periodontal infections can lead to non-oral infections 
(Rahamat-Langendoen et al., 2011). 
2.3.1 Virulence properties of A. actinomycetemcomitans  
Biofilm formation 
Biofilm formation is an important virulence factor of A. actinomycetemcomitans, as 
mutants unable to form biofilms are unable to colonize or infect. The biofilm 
formation and integrity of A. actinomycetemcomitans have been shown to rely on 
polysaccharides, eDNA and proteinaceous adhesins (Inoue et al., 2003; Izano et al., 
2008). 
TFP, called Flp-pili (fimbriae), are the major proteinaceous adhesins in the A. 
actinomycetemcomitans biofilm (Inoue et al., 2003; Izano et al., 2008). Flp-pili are 
found in freshly isolated A. actinomycetemcomitans but are lost upon culturing in the 
laboratory after 30-40 generations (Rosan et al., 1988). The major subunit of the pili 
is the 6.5-kDa Flp1 protein (Inoue et al., 1998), which assembles helically to form the 
long pili strand (Kachlany et al., 2001). In A. actinomycetemcomitans, the pili are 
rarely observed as individual strands but rather form bundled fibrils of multiple 
parallel pili strands (Kachlany et al., 2000, 2001). The tight adherence (tad) locus, 
containing over 10 flp, rcp and tad genes, is required for Flp-pili assembly (Clock et 
al., 2008). The pili facilitate cell attachment to each other and the initial non-specific 
attachment to surfaces (Kachlany et al., 2001). Flp-pili are not essential for biofilm 
formation in vitro (Inoue et al., 2003), but flp mutant biofilms are more loosely 
packed than are wild type biofilms and are dispersed when treated with agents that 
break DNA or polysaccharides (Inoue et al., 2003). Additionally, other non-pili-
associated outer-membrane macromolecules regulate biofilm formation, such as the 
outer membrane collagen binding protein EmaA (Danforth et al., 2019). 
The most abundant polysaccharide in A. actinomycetemcomitans biofilms is poly-N-
acetylglucosamine (PGA). It is a polysaccharide containing hexosamine and is 
produced by all four genes in the pgaABCD locus (Izano et al., 2008). PGA is tightly 
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attached to bacterial cells and mediates adhesion between them in biofilms. PGA 
mutant strains are able to form biofilms, but they are more susceptible to dispersion 
by DNase I or proteinase K treatment (Izano et al., 2008). PGA may also protect A. 
actinomycetemcomitans biofilm by acting as a general diffusion barrier limiting the 
penetration of various antimicrobial agents to the biofilm (Izano et al., 2007, 2008) 
and protecting A. actinomycetemcomitans cells from being killed by macrophages 
(Venketaraman et al., 2008). 
Toxins 
A. actinomycetemcomitans secretes two exotoxins that are potent virulence factors: 
leukotoxin and cytolethal distending toxin. Both toxins may have been acquired via 
HGT (Kaplan & Fine, 1998; Mayer et al., 1999).  
Leukotoxin belongs to the family of repeats-in-toxins (RTX), a large group of 
exoproteins produced by gram-negative bacteria that are characterized by calcium 
ion-binding repeated nonapeptide sequences (reviewed in Linhartová et al., 2010). 
Leukotoxin is a pore-forming lipoprotein that selectively lyses human leukocytes by 
making pores in the membrane and rupturing the cells. Leukotoxin targets 
lymphocyte function-associated receptor 1, which is expressed only in circulating 
leukocytes (Lally et al., 1997), thus leaving human epithelial and endothelial cells 
unharmed. 
Leukotoxin kills PMNs (neutrophils, eosinophils, basophils), monocytes, erythrocytes 
and some lymphocyte populations (reviewed in Johansson, 2011). In 
monocytes/macrophages, leukotoxin activates the intracellular protease caspase-1, 
which cleaves the inactive pro-IL-1β and leads to IL-1β secretion (Kelk et al., 2003, 
2005). In addition to killing human cells, leukotoxin also protects A. 
actinomycetemcomitans cells from macrophage killing and phagocytosis (Johansson 
et al., 2000; Venketaraman et al., 2008). 
Leukotoxin operon ltxCABD codes four proteins with distinct functions. The ltxA 
protein is the actual toxin, and ltxC performs the post translational acylation of the 
toxin, which makes the toxin active. The ltxB and ltxD proteins, together with a third 
protein called TdeA, transport the toxin out of the cell via a type I secretion system ( 
Lally et al., 1991; Crosby & Kachlany, 2007). Additionally, the MorC protein, which 
maintains membrane morphology, is associated with leukotoxin secretion (Gallant et 
al., 2008). The differences in the expression levels of leukotoxin in certain strains are 
due to modifications in the promoter area that are located upstream of the ltxC. For 
instance, the 530 bp deletion (so-called JP2 genotype) and the 640 bp deletion in the 
leukotoxin promoter site have been linked to highly leukotoxic phenotypes (Brogan et 
al., 1994; Claesson et al., 2015). The leukotoxin expression levels in A. 
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actinomycetemcomitans isolates in the oral cavity have been shown to correlate with 
the severity of periodontitis (Höglund Åberg et al., 2014). 
Cytolethal distending toxin (CDT) is produced by the cdtABC operon in A. 
actinomycetemcomitans, and all three genes are required for toxin production. CDT 
causes swelling of mammalian cells and blocking of their cell cycle, leading to 
apoptosis (Sugai et al., 1998). Additionally, CDT induces the production of IL-1β, IL-
6 and IL-8 from peripheral blood mononuclear cells (Akifusa et al., 2001). In human 
periodontal ligament cells and gingival fibroblasts, CDT has been shown to arrest 
proliferation and increase RANKL expression (Belibasakis et al., 2002, 2004, 2005). 
The increase in RANKL induces bone resorption, which features in periodontitis. 
Lipopolysaccharide 
A. actinomycetemcomitans strains are divided into seven distinct serotypes (a to g) 
based on the different LPS O-antigen polysaccharides (Zambon et al., 1983; Kaplan 
et al., 2001; Lakio et al., 2003; Takada et al., 2010). Additionally, there are some 
strains that lack the O-antigen and are therefore non-serotypable (Kanasi et al., 2010). 
Overall, serotypes a, b and c are the most prevalent among the identified strains, 
while serotypes d and e are rare (Saarela et al., 1992). Information on the prevalence 
of the more recently discovered serotypes f and g is sparse. Serotype b is most 
commonly associated with periodontal disease, suggesting higher pathogenicity than 
other serotypes, and serotype c is found in periodontally healthy subjects (Asikainen 
et al., 1991). In the non-oral A. actinomycetemcomitans strains, the most commonly 
presented serotypes are b and c (Paju et al., 2000; Pietiäinen et al., 2018). Lipid A of 
A. actinomycetemcomitans is formed out of  glucosamine disaccharide with four 
attached fatty acid chains: two 3-hydroxymyristic acids and two 3-myristoylmyristic 
acids (Masoud et al., 1991). 
A. actinomycetemcomitans LPS plays a role mediating leukotoxin secretion; a defect 
in the O-antigen polysaccharide leads to increased membrane-bound leukotoxin and a 
decrease in secreted leukotoxin (Tang et al., 2012). A. actinomycetemcomitans LPS 
(strain Y4, serotype b) induced the production of IL-1β, IL-8, TNF-a and interleukin 
1 receptor antagonist from PMNs (Yoshimura et al., 1997). Serotype b is able to 
prime dendritic cells to activate more tissue-destructive T-lymphocyte responses 
(Díaz-Zúñiga et al., 2015). 
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DNA uptake and the natural competence for transformation 
There are both naturally competent and non-competent strains of A. 
actinomycetemcomitans (Jorth & Whiteley, 2012). The sequence analysis of several 
A. actinomycetemcomitans strains (genomes approximately 2.1-2.3 Mb) showed 
HGT, such as genomic islands (Jorth & Whiteley, 2012; Kittichotirat et al., 2016). 
The mechanisms of competence in A. actinomycetemcomitans are very similar to 
those of the widely studied Pasteurellaceae family member H. influenzae. A. 
actinomycetemcomitans preferentially uptakes DNA with a specific USS that is very 
similar to that of H. influenzae. The competence of A. actinomycetemcomitans can be 
induced by cyclic AMP (Wang et al., 2002). 
Some of the genes that are linked to the natural competence in A. 
actinomycetemcomitans have been identified. The gene cluster pilABCD is essential 
for the natural competence in A. actinomycetemcomitans since deleting any of those 
genes leads to a non-transformable phenotype (Wang et al., 2003). While the 
pilABCD operon is homologous to TFP-like gene clusters in other bacteria, it does not 
take part in fimbriae biosynthesis in A. actinomycetemcomitans (Wang et al., 2003). 
The regulatory gene tfoX turns on the competence genes in most A. 
actinomycetemcomitans strains (Bhattacharjee et al., 2007). Furthermore, the deletion 
of the urpA gene, which is located upstream of the flp operon, results in the loss of 
natural competence in A. actinomycetemcomitans (Tanaka et al., 2012). The urpA 
gene is non-homologous to any other known competence gene found in other 
bacteria. The encoded UrpA protein (uptake-related protein A) is predicted to be a 
cytoplasmic protein with cell surface association that has a function related to the 
uptake of DNA (Tanaka et al., 2012). 
2.3.2 A. actinomycetemcomitans interactions with cytokines 
As previously discussed, many human proinflammatory cytokines play a significant 
role in the progression of periodontitis. A. actinomycetemcomitans biofilms have been 
shown to bind and internalize IL-1β. Fimbriated strains bind IL-1β more efficiently 
than do non-fimbriated strains, but none of the tested tad locus proteins directly affect 
the binding (Paino et al., 2011). The binding requires a viable biofilm; when the 
biofilm viability is compromised by adding antibiotics to the culture medium, the 
binding and internalization of IL-1β are omitted, and IL-1β is detected in the culture 
medium (Paino et al., 2012).  
IL-1β in the growth medium increased the biofilm mass in A. actinomycetemcomitans 
D7S (serotype a) and SA1151 (serotype c) but decreased the metabolic activity of A. 
actinomycetemcomitans D7S (Paino et al., 2011). Planktonic A. 
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actinomycetemcomitans D7SS cells also showed a decrease in metabolic activity 
when incubated in the presence of IL-1β, except when the rcpA gene was deleted 
(Paino et al., 2011). Although RcpA was hypothesized to be the putative IL-1β 
receptor in A. actinomycetemcomitans because it has a similar role in Flp1 fimbria 
assembly as does IL-1β binding Caf1A in Y. pestis (Zav’yalov et al., 1995), binding 
between the N-terminal extramembranous domain of RcpA and IL-1β was not 
observed. Instead, IL-1β binds the trimeric form of F1F0 ATP-synthase subunit β 
(Paino et al., 2011). This might explain the effect of IL-1β on metabolic activity. The 
following studies also showed that the DNA-binding histone-like HU protein of A. 
actinomycetemcomitans bound IL-1β (Paino et al., 2012). The HU protein is 
conserved in bacteria, and in many bacteria, it regulates a substantial amount of genes 
(Oberto et al., 2009). Therefore, IL-1β binding to HU might have the potential to alter 
gene expression in A. actinomycetemcomitans. 
Based on these results, IL-1β binding might help bacteria evade host immune 
responses, as has been observed (reviewed in section 2.2.3).  
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3. HYPOTHESIS AND AIMS OF THE STUDY 
Hypothesis 
Based on previous knowledge, I hypothesized that the outer membrane of A. 
actinomycetemcomitans could harbor molecules that could bind cytokines. Moreover, 
there must be a specific route for their internalization since IL-1β has been found 
inside A. actinomycetemcomitans. The HofQ secretin in A. actinomycetemcomitans 
might interact with cytokines, as the HofQ homolog PilQ has been shown to play a 
role in the internalization of cytokines in N. meningitidis (Mahdavi et al., 2013). 
Aims 
The aim of this thesis was to investigate outer membrane proteins and other 
components that were associated with cytokine binding and uptake mechanisms using 
A. actinomycetemcomitans as a model organism. In addition, this thesis aimed to 
provide new knowledge on how the crosstalk between A. actinomycetemcomitans and 
the host signal molecules might change bacterial physiology, such as the biofilm 
formation and antimicrobial resistance, at the infection site. 
Specific aims of the thesis: 
1. To discover and characterize the first-line cytokine-binding 
molecule(s) from the A. actinomycetemcomitans membrane 
 
2. To identify the interaction areas in the first-line cytokine-binding 
molecules and cytokines   
 
3. To discover the route for cytokine internalization 
 
4. To uncover the effects of the studied proteins and the binding of 
cytokines on bacterial physiology  
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4. MATERIALS AND METHODS 
4.1 Bacterial strains 
The bacterial strains used in this study were mainly clinical A. 
actinomycetemcomitans isolates, of which the strain D7S was the most commonly 
used. All of the used A. actinomycetemcomitans strains are listed in Table 1. 
Commercially available E. coli strains XLI-blue (Stratagene), TOP10 
(Invitrogen/Thermo Fisher Scientific), BL21-Codon-Plus-(DE3)RIL (Stratagene) and 
C41(DE3)RIL (Lucigen) were used in this study as well as P. aeruginosa strain 
Boston 41501 (ATCC 27853). 
4.2 Cloning and expression of recombinant proteins [I - IV] 
The recombinant proteins that were produced during the study are listed in Table 2. 
Detailed descriptions of all purifications are found in the original publications [I - 
IV]. Most of the proteins were produced with histidine tags to facilitate purification 
and further utilization as markers for detection in downstream applications. 
Genes for the bacterial interleukin receptor I (BilRI) and extramembranous part of 
HofQ (emHofQ) were amplified from the A. actinomycetemcomitans D7S genome 
using specifically designed primers. Genes for the emHofQ mutants, IL-8, IL-1β, 
FgbA and ClfA were ordered as codon-optimized synthetic genes. Constructs for 
YadA production were kind gifts from Prof Mikael Skurnik from the University of 
Helsinki, Finland.  
The genes were cloned into the pET36b expression vector to produce proteins with C-
terminal 8xHis-tags or into the pET15b vector to produce proteins with N-terminal 
6xHis-tags. The proteins were expressed in the E. coli BL21-Codon-Plus-(DE3)RIL 
protein expression strain using Terrific Broth medium supplemented with antibiotics. 
Expression was induced with isopropyl β-D-1-thiogalactopyranoside (IPTG) when 
the cell density reached the target level (A600nm=0.8-1.3). Bacterial cultures were 
grown at 37°C for 2.5-3 hours before harvesting, except the emHofQ mutants grown 
at 16°C overnight. Proteins were separated from the cell lysate using a HisTrap HP 
affinity column and eluted using 250-500 mM imidazole. When needed, the His-tags 
were excised with thrombin. The eluted proteins were further purified with size-
exclusion chromatography. Protein purity was checked with sodium dodecylsulfate 
polyacrylamide gel electrophoresis (SDS-PAGE), and the concentration was 
determined with the Lowry method (Lowry et al., 1951). Diverging from the 
expression described above, IL-1β was produced in the pET-28bTEV plasmid, and 
the His-tag was cut with TEV protease. 
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Table 1. A. actinomycetemcomitans strains used in this thesis. 
strain serotype colony used in ref 
173s e smooth III (Höglund Åberg et al., 2013) 
D7S a rough I - IV 
(Chen et al., 2010;        
Wang et al., 2002) 
D7S bilRI 
overexpr. 
a rough II II 
D7S ΔbilRI a rough II II 
D7S ΔhofQ a rough IV IV 
D7S ΔhofQ::Spe a rough IV IV 
D7SS a smooth III (Wang et al., 2003) 
D7SΔflp1-
flp2::Spe 
a smooth III (Wang & Chen, 2005) 
HK1651 b smooth III (ATCC 700685) 
IDH781 d rough III 
(Haubek et al., 1995;      
May et al., 2016) 
NCTC 9710 c smooth III (ATCC 33384) 
O75U d smooth III (Claesson et al., 2017) 
S23A b smooth III (Huang et al., 2013) 
SA1151 c rough I 
(Asikainen et al., 1995; 
Ihalin & Asikainen, 2006) 
SA1151s c smooth III 
(Asikainen et al., 1995; 
Ihalin & Asikainen, 2006) 
SA1216 c smooth III (Asikainen et al., 1995) 
SA1398 b rough I (Ihalin & Asikainen, 2006) 
SA2146 b rough III (Saarela et al., 1992) 
SA2292 c rough III (Saarela et al., 1992) 
SA3138 a smooth III (Asikainen et al., 1995) 
SA3139 N/A smooth III (Kanasi et al., 2010) 
SA492 d smooth III (Saarela et al., 1992) 
SUNYab 75 a smooth III (ATCC 43717) 
Tr.GU 17-4 f smooth III (Kanasi et al., 2010) 
Y4 b smooth III (ATCC 43718) 
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Table 2. Recombinant proteins produced for this study. 
Protein Tag Residues Used in Production 
BilRI 
C-His 20-181 I I 
C-His   21-181* II II 
N-His   21-181* III III 
emHofQ 
C-His 27-195 IV IV 
   ‒ † 27-195 IV (Tarry et al., 2011) 
emHofQ mutants 
(L1, L2, L1L2) C-His 27-195 IV IV 
IL-8 
    ‒  † 28-99 II - IV II 
N-His 23-99 III III 
IL-1β    ‒  ‡ 117-296 IV IV 
FgbA N-His 20-105 II II 
ClfA N-His 230-542 II II 
YadA N-His 26-241 II (Nummelin et al., 2002) 
* BilRI variant without residue C20 was produced, as this residue caused unwanted dimer formation. 
† N-His-tag cleaved off with thrombin, ‡ N-His-tag cleaved off with TEV protease 
4.3 Isolation of cell components for the interaction studies  
4.3.1 LPS extraction from A. actinomycetemcomitans [III] 
LPS was extracted from different A. actinomycetemcomitans strains as well as from 
one P. aeruginosa and one E. coli strain. Cells were lysed using sonication, and the 
cell debris and the intact cells were removed by centrifugation. The cell membranes 
were harvested using high-speed ultracentrifugation. Inner membranes were dissolved 
by sodium lauroyl sarcosinate, and the insoluble outer membranes were collected by 
ultracentrifugation. LPS was dissolved from the outer membranes using buffer 
containing 2-mercaptoethanol and SDS, and residual proteins were digested with 
proteinase K. LPS was precipitated with sodium acetate and ice-cold ethanol and 
collected by centrifugation. The precipitation step was repeated using only ethanol. 
The LPS pellet was dissolved in ultrapure water and frozen for further use. 
Analysis of the extracted LPS 
The amount of LPS in isolated samples was determined by using a commercial kit 
(ToxiSensor™ Chromogenic LAL Endotoxin Assay Kit). Since LPS likely contains 
some residual EM components, the quantities of proteins, DNA and PGA in the 
samples were determined as described in section 4.6.4. The amounts of phosphorus in 
the LPS samples were examined using the method of Rouser and co-workers (Rouser 
et al., 1970). 
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4.3.2 Isolation of outer membrane vesicles [III] 
OMVs were isolated from A. actinomycetemcomitans by ultracentrifugation. Bacteria 
were grown for 3 days, harvested and centrifuged. Supernatants were filtered through 
0.45-μm and 0.2-μm filters. OMVs were collected by ultracentrifugation, and formed 
pellets were washed twice and frozen. The presence of bacterial contamination was 
checked by cultivating samples of OMVs in blood agar plates. 
4.3.3 Collection of human sera [IV] 
Venous blood samples were collected from 12 adult periodontitis patients who had A. 
actinomycetemcomitans detected in their subgingival biofilm samples prior to their 
periodontal treatment. Control blood samples were collected from twelve orally and 
systemically healthy dentistry students. All samples were collected with written 
informed consent by the healthcare professionals at the Community Dental Health 
Care Center of Turku or at the Unit for Specialized Oral Care in Helsinki 
Metropolitan Area and Kirkkonummi. 
4.4 Characterization of BilRI [I - II] 
4.4.1 Identification of BilRI by mass spectrometry [I] 
An electrophoretic mobility shift assay (EMSA) was used to detect the IL-1β binding 
membrane proteins from A. actinomycetemcomitans. The membrane protein fraction 
was first isolated from the D7S strain of A. actinomycetemcomitans and then 
solubilized in the mild detergent CHAPS, co-incubated with human recombinant IL-
1β and run on native-PAGE. Pure membrane protein fraction and IL-1β were used as 
controls. An additional control experiment was performed by replacing IL-1β with a 
soybean trypsin inhibitor (STI), a protein with a similar size. Immunoblotting was 
used to detect IL-1β using an anti-IL-1β antibody. All proteins in the samples were 
visualized by silver staining from the equivalent gel. The lane containing the 
interacting proteins was cut from the silver-stained gel, and the proteins were 
identified by high-performance liquid chromatography (HPLC) followed by tandem 
mass spectrometry (MS/MS). 
4.4.2 NMR spectroscopy to study the structure of BilRI [II] 
The structure of BilRI was studied with nuclear magnetic resonance (NMR). The H1 
NMR spectra from 4.6 mM of recombinant BilRI21-181 were measured at 600 MHz 
using a Varian INOVA 600 MHz NMR spectrometer (Agilent). The two-dimensional 
1H-15N HSQC spectra of BilRI at pH 5 were collected at 800 MHz using 
predetermined complex points for each dimension. The spectra were measured using 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   43 16.5.2019   9.12
44 Materials and methods 
 
 
 
a Varian INOVA 800 MHz NMR spectrometer. Spectra were processed and analyzed 
using VnmrJ and Sparky software. 
4.4.3 Effect of BilRI expression on E. coli [I]  
Full-length BilRI in the pET36b vector was expressed in the E. coli C41(DE3)RIL 
strain, and production was induced with IPTG. The location of expressed BilRI was 
determined by isolating the cytosolic, inner membrane and outer membrane fractions 
from the cells. The fractions were run on SDS-PAGE, and the presence of BilRI was 
detected by silver staining and HPLC-MS/MS. The purity of the outer member 
fractions was inspected by detecting the absence of the inner-membrane-located heme 
with a peroxidase substrate that interacts with it. 
The effect of the membrane-expressed BilRI on membrane stability was studied by 
inspecting the leakage of DNA from the cells after a freeze-thaw cycle. The relative 
amount of DNA in the samples was visualized on an agarose gel using a fluorescent 
DNA-binding stain and UV light. The amount of leaked DNA was compared with 
that in E. coli in which BilRI production was not induced. Adding glycerol (20-50 % 
(v/v)) to the cells before freezing decreased the cell breakage. 
The IL-1β binding capacity of BilRI-expressing E. coli was studied by flow 
cytometry. Induced and harvested cells were fixed with formaldehyde solution. The 
cells were co-incubated with biotinylated IL-1β or with biotinylated control protein 
STI and stained with avidin-fluorescein isothiocyanate. The samples were analyzed 
with a flow cytometer using excitation at 488 nm, and the emission signal was 
collected at 525 nm. The proportion of IL-1β-binding cells in the bacterial population 
was analyzed by comparing the fluorescence values with an identical sample set that 
was stained with a viability stain that stains nucleic acids in both live and dead 
bacteria.  
4.4.4 BilRI-recognizing antibody fragment screening [I] 
A synthetic M13 phage display library (Huovinen et al., 2013) was used to screen for 
BilRI-recognizing single-chain antibody fragments (scFvs). Recombinant BilRI was 
immobilized on magnetic polymer beads. Two rounds of incubation with the phage 
library were performed: first with the 5x1012 colony forming units (CFU) of phages 
and the second with the 5x1010 CFU. Bound phages were eluted with trypsin, cloned 
into pLK06H-vectors and produced as scFv-AP fusion proteins in E. coli XL1-blue. 
A sandwich-type immunoassay was used to test the binding of antibody fragments to 
BilRI. Ten active clones were identified, and western blotting was performed to 
verify the activity. 
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4.4.5 BilRI expression in A. actinomycetemcomitans [I] 
Biofilm cultures from A. actinomycetemcomitans D7S and clinical A. 
actinomycetemcomitans isolates were grown in rich culture medium overnight and in 
poor medium for an additional 3 hours before harvesting. Cells were broken down by 
sonication, and BilRI expression was analyzed from the cell lysates by SDS-PAGE 
followed by immunoblotting using anti-BilRI antibody clone 16B8. 
The surface exposure of BilRI was examined by treating intact A. 
actinomycetemcomitans D7S cells with proteinase K, which breaks down all the 
proteins that are exposed from the cell membrane. After 5 or 21 hours of treatment at 
37°C, proteinase K was inactivated. The antibiotics chloramphenicol and globomycin 
were used to inhibit the protein synthesis and maturation of outer membrane 
lipoprotein during the treatment. Cells were lysed with sonication, and the presence of 
BilRI was analyzed by immunoblotting as above.   
4.5 Molecular interactions 
4.5.1 Interaction studies in ligand-binding microplate assays [I, II, IV] 
A ligand-binding microplate assay was used as an initial screening method for 
possible interactions between certain molecules. The assays were performed in 96-
well plates that were coated with one interaction partner followed by the blocking of 
excess binding sites with bovine serum albumin (BSA). The interacting His-tagged 
protein was incubated in the wells, and the bound proteins were detected using 
conjugate binding to their His-tail (HisProbe™-HRP, Thermo Fisher Scientific). The 
addition of substrate (ABTS) to horseradish peroxidase (HRP) led to a color reaction 
in the solution that was measured with a spectrophotometer at 405 or 414 nm. The 
results are presented as percentages of the signal obtained from the negative binding 
control BSA. 
BilRI interaction with various cytokines [I, II] 
The binding of BilRI to IL-1β and a set of other cytokines was investigated using a 
ligand-binding microplate assay. A total of 100 ng of cytokine (IL-1β, IL-6, IL-8, IL-
10, TNF-α, IFN-γ or TGF-β1) was bound to the wells. After the blocking step, 5 μg of 
recombinant C-His BilRI20-181 (in study I) or 400 ng of recombinant C-His BilRI21-181 
(in study II) was added. BSA was used as a negative binding control, and additional 
controls, STI and the N-terminal domain of A. actinomycetemcomitans protein RcpA, 
were used in study I. 
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The interaction of collagen/fibrinogen with D7S wild type or D7S ΔbilRI [II] 
The interaction of BilRI with collagen or fibrinogen was studied at the cellular level 
using a microplate binding assay. A. actinomycetemcomitans D7S wild type or D7S 
ΔbilRI (section 4.6.2) cells were bound on microtiter wells that were coated with 1 μg 
of type V human collagen or 1 μg of human fibrinogen. After washing away the 
unbound bacterial cells, the bound cells were detected with anti-serotype A antibody 
and anti-rabbit IgG-HRP antibody combined with the HRP-substrate.  
emHofQ interaction with various cytokines [IV] 
The binding of emHofQ to a set of cytokines (IL-1β, IL-8, IL-6, TNF-α, IFN-γ) was 
performed by adding 6 pmol of cytokines to the wells, and after blocking, 490 nM of 
C-His emHofQ was added.  
4.5.2 Interaction studies with TRFIA [II - IV] 
A more sensitive microplate assay, time-resolved fluorometric immunoassay 
(TRFIA), was used to measure the interaction in a concentration-dependent manner. 
Assays were performed in 96-well plates, similarly to the ligand binding assay 
(section 4.5.1), but the bound proteins were detected using europium-labeled anti-His 
antibody (DELFIA, Perkin Elmer). Chelating detergent solution was added to 
dissociate the europium ion from the antibody, and fluorescence of the europium ion 
was measured using a time-resolved fluorometer. The results (except for those for 
collagen and fibrinogen) were presented by plotting the relative fluorescence units 
(RFUs) as a function of the concentration of His-tagged protein. The apparent 
dissociation constants of the interactions were calculated from the binding curves 
using a one-site binding model. 
BilRI interaction with collagen or fibrinogen [II]  
TRFIA was used to study BilRI binding to human EM molecules collagen and 
fibrinogen. The microtiter wells were coated with 1 μg of type V human collagen or 1 
μg of human fibrinogen. BSA was added as a blocking agent, followed by incubation 
with 1 μg of C-His BilRI21-181. Proteins that were previously shown to bind fibrinogen 
(FgbA, ClfA) or collagen (YadA) were used as positive binding controls. The results 
are presented as percentages of the negative binding control BSA. 
Interaction of BilRI and LPS with IL-8 [III] 
To investigate the affinity of the IL-8-BilRI interaction, the wells were coated with 6 
pmol of IL-8 and blocked with BSA. Recombinant N-His BilRI21-181 was added to 
wells in concentrations ranging from 0 to 56 μM. 
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To enhance the binding of LPS to the bottom of the microtiter wells, the wells were 
first coated with poly-L-lysine. The LPS extractions (section 4.3.1) from various A. 
actinomycetemcomitans strains (12x103 EU/well) were incubated in the wells, after 
which the remaining binding sites were blocked using a commercial blocking agent. 
Controls were prepared without any LPS. Recombinant N-His IL-8 was added in 
concentrations ranging from 0 to 46 μM. The inhibitory effect of polymyxin B (PMB) 
on this interaction was studied with an equivalent method, though using only 15 μM 
IL-8 and incubating 1-50 mg/ml PMB in the wells after the blocking step. The 
maximum solubility of PMB to water was 50 mg/ml. 
A. actinomycetemcomitans cells interacting with IL-8 [III]  
The interaction of IL-8 with whole A. actinomycetemcomitans cells of serotypes a-f 
was studied in a similar experiment with fixed A. actinomycetemcomitans cells bound 
to the microtiter wells, and N-His IL-8 was added at a concentration of 15 μM. 
EmHofQ interaction with IL-1β and IL-8 [IV] 
The binding affinity of emHofQ to IL-1β and IL-8 was studied using TRFIA. Wells 
were coated with 6 pmol of IL-8 or IL-1β and blocked with a commercial blocking 
reagent. The C-His emHofQ was added in concentrations ranging from 10 to 740 nM. 
The method for studying the interaction of emHofQ mutants (L1, L2 and L1L2) with 
IL-1β or IL-8 was the same, except that the amount of cytokines was 60 pmol during 
the coating step and the concentration range of C-His emHofQ mutants was 5 nM to 2 
μM. 
4.5.3 Interaction studies with surface plasmon resonance [IV] 
Surface plasmon resonance was used to study the binding of IL-1β or IL-8 to 
emHofQ that was bound on the surface. The C-His emHofQ was coupled on the 
surface of an NTA chip. IL-8 was injected at concentrations ranging from 1 to 15000 
nM, and binding was monitored with a Biacore device. An uncoupled chip was used 
as a reference. The peak values (RU) of each injection were plotted as a function of 
IL-8 and the dissociation constants were calculated using a one-site binding model. 
4.5.4 Exploring the interaction regions with chemical crosslinking [IV] 
The interaction site of emHofQ and IL-8 was studied by chemical crosslinking. The 
crosslinking agent bis(sulfosuccinimidyl)suberate (BS3) was used to chemically link 
the lysine residues in the studied proteins that were in close proximity to one another. 
The crosslinked protein samples were then run through SDS-PAGE and visualized by 
silver staining. The band corresponding to the crosslinked proteins, i.e., observed only 
when IL-8, emHofQ and BS3 were co-incubated, was excised, destained and digested 
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with dimethylated porcine trypsin. Digested samples were analyzed with HPLC-
MS/MS. Detected peptides were identified, the effects of the crosslinking agent were 
detected, and peptides were compared with the sequences of IL-8 and emHofQ.  
4.5.5 Interaction studies with EMSA [III, IV] 
Interaction of cytokines with LPS and OMVs [III] 
The interactions of certain cytokines with LPS and OMVs were studied using EMSA. 
The isolation of LPS and OMVs is described in sections 4.3.1 and 4.3.2, respectively. 
The cytokines (IL-8, IL-1β or IFN-γ) were co-incubated with LPS, run on native-
PAGE and visualized by silver staining. The interaction of IL-8 with LPS in isolated 
OMVs was studied by a similar experiment. 
Interaction of IL-8 and DNA [IV] 
The interaction of IL-8 with dsDNA was studied with EMSA. For this, 31 μg/ml 
linearized plasmid containing a USS was incubated with recombinant IL-8 in a 
concentration range from 20 ng/ml to 100 μg/ml. BSA was used as a negative binding 
control. Samples were supplemented with fluorescent DNA stain, run on an agarose 
gel and visualized under UV light. 
4.6 Effect of BilRI and HofQ on A. actinomycetemcomitans biofilm 
[II, IV] 
4.6.1 Organotypic gingival mucosal tissue co-culture model [II] 
The organotypic gingival mucosa tissue co-culture model was developed to mimic in 
composition and arrangement the gingival tissue in contact with A. 
actinomycetemcomitans biofilm (Paino et al., 2012). First, the human gingival 
fibroblasts were combined with a collagen solution, transferred into cell culture 
inserts and grown for one day submerged in the medium. Spontaneously 
immortalized human gingival keratinocytes (HGKs) were added on top of the 
fibroblast-collagen layer, and the model was cultured in submersion for another day. 
Then, the model was lifted on a customized metal grid and cultured on liquid-air 
interphase for 5 days. A. actinomycetemcomitans biofilms were grown separately on 
membrane discs and added to the top of the model so that the biofilm side was 
adjacent to the human cells. Antibiotics, streptomycin and penicillin were added to 
half of the cultures to decrease the biofilm viability. The biofilms were co-cultured 
with the tissue culture model for 24 hours, after which the co-cultures were collected 
and fixed. Samples from the culture medium were collected before and after the 24-
hour incubation and then frozen. 
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4.6.2 Preparation of D7S ΔbilRI [II] and D7S ΔhofQ [IV] deletion mutants 
Site-specific deletion of bilRI or hofQ genes was performed using a Cre/loxP system 
(Cheng et al., 2014; Fujise et al., 2008) to obtain markerless deletion into the A. 
actinomycetemcomitans D7S genome. A schematic of the method can be found in 
study IV (Fig. 7 in study IV). The pLox2-Spe and pAT-Cre plasmids used for the 
method were a kind gift from Professor Casey Chen from the University of Southern 
California. 
A single gene deletion of bilRI or hofQ was introduced into the genome using two 
primer pairs that were designed to flank the gene in question (bilRI or hofQ) from 
upstream and downstream. These sequences were ligated into a part of the pLox2-Spe 
plasmid, which contains a SpeR cassette with loxP cutting sites on each side. The 
linear DNA was transformed into A. actinomycetemcomitans D7S via natural 
transformation. Successful transformants that had the loxP-Spe-loxP fragment in 
place of the bilRI or hofQ gene were selected from the spectinomycin plates and 
verified with PCR. The loxP-Spe-loxP fragment was removed by the pAT-Cre 
plasmid, which contained cre recombinase and the tet(O) gene (Fujise et al. 2008). 
Cre recombinase catalyzed the recombination reaction between the loxP sites. The 
loss of both the loxP-Spe-loxP fragment and the pAT-Cre plasmid was checked by 
observing the sensitivity of the colonies to spectinomycin and tetracycline. Colonies 
sensitive to both antibiotics were considered markerless deletion mutants, and the 
deletions were verified by sequencing.  
Restoring the bilRI gene to the genome of A. actinomycetemcomitans D7S ΔbilRI was 
not successful, so expression was restored by a plasmid containing bilRI 
constitutively expressed by the leukotoxin promoter. However, high bilRI expression 
led to poor cell viability. 
4.6.3 Binding and uptake of IL-6, IL-8 and IL-1β by the biofilm [II] 
The binding of IL-6 and IL-8 by A. actinomycetemcomitans biofilms was determined 
by immunohistological staining. Biofilms were co-cultured with the gingival tissue 
culture model (4.6.1) for 24 hours. The medium samples, which were collected before 
and after the 24-hour co-culture, were analyzed with IL-6- and IL-8-specific enzyme-
linked immunosorbent assay (ELISA) kits to determine the expression levels of those 
cytokines with and without the bacterial biofilms. The co-cultures were collected and 
fixed overnight in 10 % formalin solution, embedded into paraffin and sectioned 
using standard histological techniques. De-paraffinized sections were treated with 
anti-IL-6 and anti-IL-8 antibodies. Bound antibodies were detected using the Dako 
REAL™ Detection System (Dako), and the samples were imagined under a light 
microscope. 
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The uptake of IL-6, IL-8 and IL-1β by A. actinomycetemcomitans biofilms was 
studied by immunoelectron microscopy. Biofilms were co-cultured with monolayers 
of HGKs for 24 hours. Then, the biofilms were fixed with 4 % paraformaldehyde for 
7 hours and stored at 4°C until they were cut into cryo-sections and treated with anti-
IL-6, anti-IL-8 or anti-IL-1β antibodies. Primary antibodies were detected with 
protein A-gold complexes (10 nm). Sections were examined with a transmission 
electron microscope. Labels were counted from 39-104 intact bacterial cells from 9-
18 representative pictures. The primary antibodies were omitted from negative 
controls. 
4.6.4 Characterization of biofilm formation and composition [II, IV] 
The effects of BilRI and HofQ on A. actinomycetemcomitans biofilm formation and 
composition were studied by comparing the D7S ΔbilRI and D7S ΔhofQ biofilms 
with wild type D7S biofilms grown under identical conditions. 
Biofilm formation was determined with crystal violet staining. Biofilms were grown 
overnight on 48-well plates, and then gram staining reagent was applied to the top of 
the biofilms. Excess stain was removed by washing, the bound stain was released 
with ethanol, and the absorbance was measured at 620 nm. The level of the most 
abundant A. actinomycetemcomitans polysaccharide, PGA, was determined from 
biofilms grown as described above. Congo red stain was added to the top of the 
biofilm, and after a washing step, the bound stain was detached with dimethyl 
sulfoxide. Absorbance was measured at 405 nm. 
For protein and eDNA determination, the biofilms were grown in cell culture bottles. 
The biofilm growth was mechanically detached, moved to microcentrifuge tubes and 
centrifuged. The proteins in the pellet were solubilized with SDS, and the insoluble 
material was separated by centrifugation. The protein concentration was determined 
with the Lowry method. For eDNA extraction, the cell pellets were treated with 
agents disrupting the polysaccharides and the proteins. Then, the samples were 
filtered through a membrane filter and placed in microtiter wells. The DNA levels in 
the samples were determined by adding propidium iodide and measuring the formed 
fluorescence using 535 nm excitation and 620 nm emission filters. The measured 
protein or eDNA amounts were proportioned to the mass of each biofilm sample. 
The effect of cytokines on wild type D7S biofilm formation and composition was 
studied by adding 10 ng/ml IL-8 or IL-1β to nutrient-poor culture medium. The 
amounts of biofilm components were compared with those in the biofilms that were 
grown without cytokine supplementation. Experiments were performed with D7S 
ΔbilRI and D7S ΔhofQ strains to evaluate how BilRI and HofQ affect the biofilm’s 
response to cytokines. 
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4.7 Studies on the transcription unit [II, IV] 
Operon prediction databases were utilized to predict whether bilRI and hofQ are 
stand-alone genes or transcribed as part of an operon. The Prokaryotic Operon 
Database (ProOPDB) was used to study the bilRI gene and the Database of 
prOkaryotic OpeRons (DOOR) to study the hofQ gene. 
The transcription of hofQ was further studied by RNA analysis. RNA was extracted 
from A. actinomycetemcomitans D7S and D7S ΔhofQ using a RiboPure™-Bacterial 
Kit (Ambion). Samples were treated with DNase I to remove DNA, and PCR with 
16S primers was performed to confirm that the samples were DNA-free. Reverse 
transcription PCR was used to confirm the hofQ deletion from the D7S at the 
transcriptional level, to determine whether hofQ is part of a transcription unit and to 
study hofQ expression in different culture conditions. The amplicons were visualized 
in agarose gel using fluorescent DNA stain and UV light. 
4.8 Exploring the potential role of HofQ in antimicrobial  
susceptibility and in host recognition [IV] 
4.8.1 Antimicrobial susceptibility test [IV] 
The antimicrobial susceptibility of A. actinomycetemcomitans D7S and D7S ΔhofQ 
was tested by plating the bacteria on Haemophilus test medium agar plates (Beckton 
Dickinson) and supplementing each plate with Etest-strips (BioMérieux) containing 
one of the tested antibiotics: ampicillin, amoxicillin/clavulanic acid, doxycycline or 
tetracycline. The minimum inhibitory concentration (MIC) values were read from the 
test strips after 45-48 hours of incubation. 
4.8.2 Measurement of ROS production by leukocytes [IV] 
The production of reactive oxygen species (ROS) from human leukocytes exposed to 
A. actinomycetemcomitans cells was examined by a luminol-amplified 
chemiluminescence experiment. The bacterial suspension was co-incubated with 
human plasma/serum (collection described in section 4.3.3), which opsonizes the 
bacteria, and with luminol, which produces chemiluminescence in the presence of 
ROS. Freshly isolated human leukocytes were added to the sample, after which the 
measurement of chemiluminescence was immediately started. The 
chemiluminescence was measured for 2 hours, and the peak value of each individual 
reaction was recorded.  
4.8.3 Anti-HofQ antibodies in patient sera examined by ELISA [IV] 
To study the possible immunogenic properties of emHofQ, the amounts of emHofQ-
specific antibodies were determined from serum samples (4.3.3) using ELISA. The 
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relative antibody amounts from sera collected from the individuals who tested 
positive for A. actinomycetemcomitans were compared with those from serum 
samples collected from healthy individuals. The emHofQ protein was used to coat the 
microtiter wells, and excess binding sites were blocked with BSA followed by 
incubation with serum samples. Bound serum was detected with anti-human IgG-
peroxidase antibody combined with the peroxidase substrate, and absorbance was 
measured at 405 nm.  
4.9 Ethics statement [I – II, IV] 
Blood samples for this study were collected from periodontitis patients who tested 
positive for A. actinomycetemcomitans and from healthy individuals with written 
informed consent. Permission to collect and use these samples was obtained from the 
Ethics Committee of the Hospital District of Southwest Finland.  
4.10 Statistics [I - IV] 
All the studies consisted of a small sample size (n=3-10). Therefore, most of the 
statistical tests used were non-parametric. The tests that were used were the Paired 
samples T-test (I, II), Friedman’s 2-way analysis of variance (II), Mann-Whitney U-
test (with Bonferroni corrections when needed) (II, IV), Spearman’s rank-order 
correlation (III, IV) and Kruskal Wallis test (IV). All statistical analyses were 
performed using IBM SPSS Statistics 22 software. Statistical significance is 
considered at p-values less than 0.05. 
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5. RESULTS  
5.1 Characterization of an outer membrane cytokine-binding 
protein  
5.1.1 Identification and structural characteristics [I]  
Discovery of IL-1β binding protein 
The binding of IL-1β to the A. actinomycetemcomitans biofilm and its interactions 
with intracellular A. actinomycetemcomitans proteins were shown by Paino and co-
workers (Paino et al., 2011, 2012). To discover the first-line IL-1β binding protein 
from the outer membrane, the membrane protein fraction isolated from A. 
actinomycetemcomitans D7S was co-incubated with IL-1β. The protein band with 
potential IL-1β binder was observed in EMSA (Fig. 10A). The band containing IL-1β 
together with the membrane proteins was significantly more intense in the silver-
stained gel than was the lane with IL-1β on its own (Fig. 10A, circled). The anti-IL-
1β antibody detected equal amounts of IL-1β in both samples (Fig. 10B). Therefore, 
the intense band likely contained other proteins besides IL-1β, and those might 
interact with IL-1β. No interaction was observed between the membrane proteins and 
the control protein STI (I: Fig. 1C). 
Figure 10. Putative A. actinomycetemcomitans membrane proteins interact with IL-1β. 
(A) Membrane proteins (MPs) isolated from A. actinomycetemcomitans D7S were incubated 
with IL-1β, the samples were run on native-PAGE, and the gel was silver stained to visualize 
the proteins. The intensity of the lane where MPs and IL-1β were co-incubated (marked with 
red circle) was significantly higher than that of the lane containing only IL-1β. (B) An 
immunoblot with the same samples showed equal amounts of IL-1β in the samples, with or 
without the MPs. The presence of IL-1β was detected with an anti-IL-1β antibody, and it 
was not observed in the MP sample. The figure was adapted from Fig. 1 from study I. 
B A 
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The lane of interest was excised, and the subsequent HPLC-MS/MS analysis 
identified a putative protein of A. actinomycetemcomitans with a high identity rate. 
The analyzed sample also contained IL-1β. The putative protein was previously 
uncharacterized and was named bacterial IL receptor I (BilRI).  
The structural characteristics of BilRI 
The amino acid sequence of BilRI was analyzed with the SignalP 4.1 server, which 
predicted the presence of a signal sequence at the beginning of the sequence (Fig. 11, 
marked in red). The signal sequence guides the protein to the outer membrane. The 
BilRI has a 40-amino-acid-long region that is repeated three times with little variance 
in its amino acid sequence (marked with alternating colors, Fig. 11). Another special 
characteristic of the sequence is that there are no aromatic amino acids in BilRI, and it 
is mostly made of small polar and charged amino acids (II: Fig. 1C).  
The database search of homologous sequences revealed almost identical sequences 
within the Aggregatibacter genus (I: Fig. 2B) and similar sequences in other bacteria, 
such as in Haemophilus influenzae and Pasteurella multocida, but none from species 
outside the Pasteurellaceae family (I: Fig. 3). The only homologous protein with a 
previously known function was the fibrinogen-binding FgbA protein in Haemophilus 
ducreyi (Bauer et al., 2009). 
The three-dimensional structure of BilRI was studied with NMR, which showed that 
BilRI did not adopt a stable fold. The one-dimensional NMR 1H spectra and the two-
dimensional 1H-15N correlation spectra showed poor signal dispersion (II: Fig. 1A-B), 
which led to the conclusion that BilRI was an intrinsically disordered protein (IDP). 
IDPs lack a stable three-dimensional fold on their own but can have various 
conformations when interacting with other molecules (Uversky, 2011). The 
intrinsically disordered nature of BilRI was also shown in its amino acid sequence 
Figure 11. The amino acid sequence of BilRI (181 amino acids). The predicted signal 
sequence of 19 amino acids is marked in red. The sequence contains four 10 amino acid 
long sequences (marked in green, blue, purple and gray) that are repeated three times in the 
same order. Figure was adapted from Fig. 2 in study I. 
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that contained only a few hydrophobic amino acids, which are required for the 
formation of a stable hydrophobic protein core.  
5.1.2 BilRI expression and its localization on the outer membrane [I] 
The localization of BilRI was first studied in E. coli, where the recombinant full-
length bilRI was expressed from the plasmid. The expressed product was observed in 
the isolated outer membrane protein fraction of E. coli in SDS-PAGE (I: Fig. 4A), 
and the overexpression of bilRI on the E. coli membrane made the cells more 
susceptible to breaking when frozen without glycerol (I: Fig. 4C-E). The IL-1β 
binding of the bilRI-expressing E. coli cells was measured with flow cytometry using 
fluorescently labeled IL-1β. The bilRI-expressing cells bound IL-1β more efficiently 
than the cells in which the expression was not induced (I: Fig. 5B). 
In A. actinomycetemcomitans D7S, BilRI was detected in the outer membrane protein 
fraction by the anti-BilRI antibody (I: Fig. 6A-B). The proteinase K treatment of the 
intact D7S cells deleted the BilRI from the outer membrane fraction, suggesting that 
BilRI was facing the extracellular space. BilRI was detected as two forms of different 
sizes in the outer membrane fractions and as three forms in the inner membrane 
fraction of A. actinomycetemcomitans (I: Fig. 6A-C). The outer membrane forms 
were hypothesized to be mature (35 kDa) and immature lipidated (70 kDa) forms of 
BilRI, while the inner membrane, which also contained the 70-kDa form, contained 
additional 17-kDa and 19-kDa forms suggested as the mature unlipidated and the 
proprotein forms of BilRI, respectively. 
5.2 Characterization of molecular interactions 
5.2.1 BilRI interacted with cytokines [I-III] 
To study BilRI and its interactions with other proteins in vitro, BilRI was produced as 
a recombinant protein. The recombinant BilRI was produced without its signal 
sequence and with a histidine tail to aid in purification and detection. Microplate 
assays demonstrated BilRI interaction with IL-1β in study I (I: Fig. 5C). No 
significant binding was observed between IL-1β and another A. 
actinomycetemcomitans outer membrane protein, RcpA. In study II, an additional set 
of cytokines was included in the microplate assay. The interactions between BilRI 
and IL-8, IL-10, IFN-γ, TGF-1β, TNF-α and IL-6 were observed (Fig. 12A). 
Compared with the negative binding control BSA, the interaction of BilRI with IL-6 
was the weakest, and the interaction with IL-8 was the strongest. The interaction 
between BilRI and IL-8 was studied in a concentration-dependent manner with 
TRFIA to obtain quantitative information about the binding. The specific binding 
between BilRI and IL-8 was observed compared with the BSA, but the measured 
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values remained in the linear part of the binding curve, even with a BilRI 
concentration of 56 μM (Fig. 12B). Since the maximum binding (Bmax) was not 
reached, determination of the dissociation constant (Kd) was not possible. 
 
Since BilRI was shown to interact with multiple structurally unrelated cytokines and 
its sequence is homologous to the fibrinogen binder FgbA, its binding to the abundant 
extracellular molecules collagen and fibrinogen, was studied. Recombinant BilRI did 
not bind human collagen or fibrinogen when tested with a microplate assay (II: Fig. 
2B). The lack of binding to collagen and fibrinogen was also observed at the cellular 
level, as the A. actinomycetemcomitans cells deficient in BilRI did not show any 
change regarding the binding of collagen or fibrinogen (II: Fig. 5C). 
5.2.2 IL-8 interactions with non-proteinaceous components [III-IV] 
IL-8 has a positive charge at neutral pH (pI-value of 9.3), while DNA, which is 
abundant in the EM of bacterial biofilm, is mainly negatively charged. The binding of 
recombinant IL-8 on the USS-containing dsDNA was shown in EMSA. The 
formation of DNA-IL-8 complexes was observed as immobile bands in the agarose 
Figure 12. Recombinant BilRI interacted with human cytokines. (A) The binding of 
recombinant BilRI to various cytokines was detected in a microplate assay. The interaction 
between BilRI and IL-8 was high compared with that of the control (p=0.008, paired samples 
T-test). Data is presented as percentages compared with the binding control BSA (=100 %). 
The mean values ± SD from three independent experiments are presented. (B) The 
concentration-dependent IL-8-BilRI interaction was studied with TRFIA using 6 pmol of IL-8 
and 0-56 μM of BilRI. The binding of BilRI to IL-8 was significantly higher than that of the 
control (BSA), but the maximum binding was not reached. Data is presented as the mean 
values ± SD from three independent experiments. Figure was adapted from Figs. 2A in study 
II and 1C from study III. 
A B 
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gel (Fig. 13A). No interaction was observed between negatively charged IL-1β (pI 
5.9, data not shown) and DNA, suggesting that the interaction is likely electrostatic. 
The interaction of DNA and IL-8 has also been shown by Perks & Shute (Perks & 
Shute, 2000).  
The observation of electrostatic interactions between IL-8 and DNA originated the 
study of possible interactions between IL-8 and LPS, which is a bacterial outer 
membrane component with negatively charged phosphate groups. The interaction 
between IL-8 and LPS was also studied with EMSA. The recombinant IL-8 enhanced 
the mobility of LPS, which was extracted from different A. actinomycetemcomitans 
strains, in native gel (Fig. 13B). A similar phenomenon was observed between LPS 
and IFN-γ (pI 9.5) but not between LPS and IL-1β (III: Fig. 1). The lack of interaction 
with negatively charged IL-1β supports the theory that the interaction between LPS 
and IL-8 or IFN-γ might be at least partly due to opposite charges. 
The concentration dependency of the IL-8-LPS interaction was studied with TRFIA. 
Specific binding was observed between IL-8 and LPS extracted from A. 
actinomycetemcomitans serotypes a to f, and a saturated level of binding was reached 
with each tested LPS (Fig 14). The obtained Kd values of these interactions ranged 
Figure 13. IL-8 interacted with 
dsDNA and with LPS of                    
A. actinomycetemcomitans.                    
(A) Recombinant IL-8 was co-
incubated with USS-DNA (31 μg/ml), 
and the DNA was visualized in the 
agarose gel using fluorescent DNA 
stain. At high IL-8 concentrations, 
DNA and IL-8 formed complexes that 
were immobile in the agarose gel. 
BSA was used as a negative binding 
control. (B) Incubation with IL-8 
increased the mobility of LPS in 
native-PAGE. LPS was extracted from 
various A. actinomycetemcomitans
strains (serotype in parenthesis). 
Virtually no movement in the silver-
stained gel was observed in the control 
samples that contained only LPS. 
Figure was adapted from Fig. 3 in 
study IV and Fig. 1 in study III.  
 A 
 B 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   57 16.5.2019   9.12
58  Results 
 
 
 
from 1.2 to 17 μM (Table 3), and they were not correlated with the serotype. 
Therefore, the binding affinities were not serotype specific. To elucidate whether the 
interaction between IL-8 and LPS is a universal phenomenon among gram-negative 
bacteria, the LPS extracted from E. coli and P. aeruginosa was subjected to the same 
experiment. Subsequently, IL-8 also bound the LPS of E. coli and P. aeruginosa but 
with lower affinity than most of the tested A. actinomycetemcomitans LPS (Fig. 14, 
the last panel).  
 
Figure 14. LPS of different A. actinomycetemcomitans serotypes interacted with IL-8. 
The interaction between IL-8 and LPS isolated from A. actinomycetemcomitans serotypes a-f 
was studied with TRFIA. LPS was used in equal amounts, and IL-8 was used in 
concentrations from 0 to 46 μM. The controls were prepared without any LPS. All tested 
LPS variants interacted with IL-8. The Kd and Bmax values were calculated from the binding   
curves and listed in Table 3. LPS from other bacterial species moderately bound IL-8. Data 
is presented as the mean values ± SD from three independent experiments. Figure was 
adapted from Fig. 2 in study III. 
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Table 3. The Kd and Bmax values of the IL-8 interaction with bacterial LPS. 
Strain serotype Kd  (μM) Bmax (kRFU) 
A. actinomycetemcomitans    
SA1216 c 1.2 ± 0.3 1 200 ± 54 
S23A b 2.4 ± 0.6 1 400 ± 75 
D7SΔflp1-flp2::Spe a 2.8 ± 0.5 1 500 ± 62 
173s e 3.8 ± 1.3   1 400 ± 120 
SA492 d 4.0 ± 1.2    760 ± 62 
Y4 b 4.1 ± 0.7 1 700 ± 77 
SA1151s c 4.2 ± 1.4    470 ± 42 
O75U d 4.6 ± 1.2 1 000 ± 74 
Tr.GU 17-4 f 4.9 ± 1.2   1 400 ± 100 
SUNYab 75 a 6.9 ± 0.6 1 300 ± 38 
SA3138 a 7.8 ± 0.9 1 200 ± 47 
HK1651 b 17 ± 3.1 1 200 ± 99 
NCTC 9710 c 17 ± 2.0 1 100 ± 58 
Other    
P. aeruginosa 11 ± 3.0 1 000 ± 100 
E. coli 17 ± 4.8 1 100 ± 130 
control (without any LPS)  3.8 ± 0.8 340 ± 18 
 
The binding of IL-8 to intact A. actinomycetemcomitans cells and to the OMVs of A. 
actinomycetemcomitans was studied with TRFIA and EMSA, respectively. OMVs are 
released from the outer membrane and contain plenty of LPS. The fixed A. 
actinomycetemcomitans cells from serotypes a to f bound IL-8 at equal levels (III: 
Fig. 2C). IL-8 altered the mobility of OMVs from serotypes a-e (III: Fig. 4a) in the 
native-PAGE. The same effect was observed with OMVs from the nonserotypable A. 
actinomycetemcomitans strain SA3139 (III: Fig. 4b), which lacks the O-antigen, 
suggesting that O-antigen plays no role in LPS binding to IL-8. Alternatively, the 
negative charges in the phosphate groups in the inner core of LPS are possible 
binding partners for the positively charged IL-8. The phosphorus contents in different 
LPS samples were analyzed and compared with the binding affinities. Although the 
LPS with the highest phosphorus content had the highest binding to IL-8, no 
correlation was observed between the amount of phosphorus and the binding affinities 
in the whole sample set (III: Fig. 5). To explore the role of the lipid A part of LPS in 
the interaction, the lipid A-binding antibiotic PMB, was added to the microplate 
assay. PMB had a small inhibitory effect on the LPS-IL-8 interaction under the tested 
conditions. However, even when the highest PMB concentration of 50 mg/ml was 
used, approximately 80 % of the binding was still detected (Fig. 15). This result 
suggests that the lipid A part of LPS may function in the interaction but is not the 
primary interaction site between IL-8 and LPS. 
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Extracted LPS samples will unavoidably contain proteins, polysaccharides and eDNA 
as impurities. They might affect the binding of IL-8, so the amounts of those 
impurities were determined from each sample. No correlation was found between the 
levels of proteins or eDNA in LPS samples and their binding affinity to IL-8 (III: Fig. 
5). The amount of polysaccharide PGA in the samples was below the detection limit. 
5.2.3 emHofQ interacted with cytokines [IV] 
HofQ is a transmembrane outer protein of A. actinomycetemcomitans that plays a role 
in DNA translocation. The structure of the extramembranous part of HofQ (emHofQ) 
was determined by Tarry and co-workers (Tarry et al., 2011), who also showed that 
emHofQ directly interacted with DNA. The uptake of DNA has been demonstrated in 
A. actinomycetemcomitans (Wang et al., 2003), and while the actual mechanism of 
that is not yet discovered, the DNA uptake in Neisseria species has been proposed to 
occur through a secretin homologous to HofQ (Assalkhou et al., 2007; Krüger & 
Stingl, 2011). Since the HofQ homolog, called PilQ, in N. meningitidis was shown to 
bind cytokines (Mahdavi et al., 2013), the cytokine binding of HofQ was explored. 
The recombinant emHofQ with a C-terminal His-tag was produced, and its binding to 
an array of cytokines was studied in a microplate assay. The steady-state binding of 
IL-8, IL-6, IFN-γ and IL-1β to emHofQ was observed (Fig. 16A). The binding of 
emHofQ to IL-8 (the high binder) and IL-1β (the low binder) was studied with 
Figure 15. PMB slightly inhibited the interaction between IL-8 and LPS. PMB was 
incubated with LPS (of the A. actinomycetemcomitans strain S23A) prior to IL-8 binding, 
which was detected in a microplate assay. PBM concentrations of 1-50 mg/ml were used, 
with 50 mg/ml being its maximum solubility in water. The data is presented as percentages 
from the binding without the PMB. The control experiment was performed without any LPS. 
Data from four independent experiments is presented, with a horizontal line indicating the 
mean value. Figure was adapted from Fig. 5 from study III.  
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TRFIA to obtain quantitative values for the interaction. The Kd values for emHofQ-
IL-8 and emHofQ-IL-1β interactions were 43 ± 4 nM and 140 ± 20 nM, respectively 
(Fig. 16B). In vivo, emHofQ is immobilized in the outer membrane. Therefore, 
surface plasmon resonance was used to study the binding of IL-8 to the immobilized 
emHofQ. The binding affinity was approximately 50 times weaker than in the static 
environment, with a Kd value of 2.4 ± 1.3 μM (IV: Fig. 1C). The affinity of IL-1β to 
the immobilized emHofQ was not obtained because the binding curve did not reach 
equilibrium, even with very high IL-1β concentrations (data not shown). 
The interaction sites of emHofQ and IL-8 were explored using the crosslinking 
method. The two studied proteins were covalently crosslinked together from the 
lysine residues that are in close proximity to one another. Analysis of the crosslinked 
peptides identified by HPLC-MS/MS revealed that Lys139 in emHofQ was in close 
proximity to Lys15 in IL-8. The previously solved emHofQ homodimer structure was 
utilized to demonstrate the location of Lys139 in the loop area between the secondary 
structure elements α3 and β5 in the C-terminal domain of emHofQ (Fig. 17). The 
crosslinking experiment of emHofQ and IL-1β did not provide any information about 
Figure 16. emHofQ interacted with various cytokines. (A) The binding of recombinant 
emHofQ to multiple cytokines was detected in a microplate assay. High binding was 
observed between IL-8 and emHofQ compared with the control (p= 0.029, Mann-Whitney 
U-test). Data (mean values ± SD) is presented as percentages of the emHofQ binding to 
control protein BSA (=100 %) and obtained from four independent experiments.
(B) Concentration-dependent binding was observed between emHofQ and IL-8, as well as 
between emHofQ and IL-1β in TRFIA. Equal amounts of cytokines were bound to wells, 
and emHofQ was used in concentrations from 0 to 740 nM. BSA was used as a negative 
binding control. Data is presented as the mean values ± SD obtained from three independent 
experiments. Figure was adapted from Fig. 1 in study IV. 
A B 
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Figure 17. K139 in the emHofQ type I 
KH domain was close to the interaction 
site with IL-8. The emHofQ-IL-8 
interaction site in emHofQ (PDB:2Y3M) 
is localized in the loop area containing 
K139 by the crosslinking experiment. The 
loop is flanked by α3 and β5 secondary 
structure elements (marked in the figure). 
Monomer A of emHofQ is colored blue-
red from the N- to C- terminus and a part 
of monomer B is shown in gray. Figure 
was adapted from Fig. 2 in study IV. 
Figure 18. The amino acids in emHofQ 
that were chosen for the mutational 
analysis. A total of five one-amino-acid 
substitutions were made in two loop areas in 
the emHofQ (PDB:2Y3M) type I KH 
domain. Three mutations were made in loop 1 
(L1, in yellow): H136A, F137A and K139A 
and two in loop 2 (L2, in green): D165A and
R166A. Monomer A structures of emHofQ 
are colored in grey and monomer B structures 
in purple. Figure was adapted from Fig. 2 in 
study IV. 
the interaction since the interaction between them was probably too weak (data not 
shown). 
Further verification of the interaction site was performed with mutational analysis. 
Three emHofQ mutant proteins were produced as His-tagged recombinant proteins. 
The first mutant, named emHofQ-L1, had three amino acids (His136, Phe137, 
Lys139) substituted with alanine in the emHofQ loop structure (loop 1), where the 
interaction was located (Fig. 18, the yellow loop). The emHofQ-L2 mutant had 
alanine substitutions of two amino acids (Asp165, Arg166) in the second loop (loop 
2) right next to the L1 (Fig. 18, the green loop). The third emHofQ mutant had all five 
of the above-mentioned mutations and was called emHofQ-L1L2. The binding 
affinities of these emHofQ mutants to IL-8 and IL-1β, were assessed with TRFIA and 
compared with those of the non-mutated emHofQ (referred herein as the emHofQ-
wt). All emHofQ mutants bound both tested cytokines with lower affinity (Fig. 19). A 
two- to fourfold decrease was observed in the emHofQ-IL-8 interaction, and a four- 
to fivefold decrease was observed in the emHofQ-IL-1β interaction. The Kd and Bmax 
values from all interactions are listed in Table 4. 
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Table 4. The Kd and Bmax values of the cytokine – emHofQ variant interactions. 
 IL-8 IL-1β BSA 
emHofQ 
variant 
Kd ± SD  
(nM) 
Bmax ± SD  
(kRFU) 
Kd ± SD  
(nM) 
Bmax ± SD  
(kRFU) 
Kd ± SD  
(nM) 
Bmax ± SD  
(kRFU) 
WT 44 ± 7 930 ± 60 90 ± 170 940 ± 510 260 ± 60 630 ± 90 
L1 190 ± 60 1,000 ± 150 450 ± 160 1,100 ± 200 1,400 ± 260 890 ± 140 
L2 110 ± 10 900 ± 80 330 ± 70 1,000 ± 120 670 ± 100 710 ± 90 
L1L2 200 ± 40 1,100 ± 90 440 ± 70 1,000 ± 100 1,600 ± 240 910 ± 100 
 
Although the cytokine binding of N. meningitidis PilQ was previously shown 
(Mahdavi et al., 2013), its cytokine-binding region has not yet been established. The 
type I KH domain of emHofQ shares 26 % sequence identity with the N1 domain of 
PilQ. This level of sequence identity suggests these proteins have a shared fold. The 
overall structure of PilQ has been modeled (Berry et al., 2012), and in that model 
(PDB: 4AV2) the N1 domain of PilQ adopts the same fold as the type I KH domain 
of emHofQ (IV: Fig. 2D), suggesting that the N1 domain might function in the 
cytokine binding of N. meningitidis PilQ. 
Figure 19. Mutations in the type I KH domain of emHofQ decreased its binding to IL-8 
and IL-1β. The binding of emHofQ to IL-8 or IL-1β to the emHofQ mutant proteins L1, L2 
and L1L2 was studied with TRFIA. The amounts of IL-8 or IL-1β were kept constant and the 
emHofQ proteins were added in concentrations ranging from 0 to 2 μM. The detected 
binding was slightly lower in all the emHofQ mutants compared with the emHofQ-wt (the 
black curve). BSA was used as the negative control (IV: Fig. 2C). Data was obtained from 
three independent experiments and presented as the mean values ± SD. Figure was adapted
from Fig. 2 in study IV. 
0 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   63 16.5.2019   9.12
64  Results 
 
 
 
5.3 Effects of BilRI and HofQ on biofilm [II, IV] 
5.3.1 Genetic organization of bilRI and hofQ genes 
The bilRI gene is flanked by the septum site-determining protein minC downstream 
and the phosphohistidine phosphatase sixA and phosphoglucosamine mutase glmM 
upstream (Fig. 20A). Using the operon prediction databases, bilRI was predicted to be 
a stand-alone gene, which seems logical, as the distance between the upstream sixA 
and bilRI is over 200 nucleotides and the downstream minC is transcribed in a 
different direction. The hofQ was predicted to be part of the comABCD operon (Fig. 
20B) located upstream. However, reverse transcription PCR showed that hofQ is co-
transcribed with only the flanking comD gene (IV: Fig. 4C). 
5.3.2 Deletion of bilRI or hofQ altered the biofilm composition [II, IV] 
The bilRI or the hofQ gene was deleted from A. actinomycetemcomitans D7S with the 
Cre-LoxP system, and the deletion was verified at the genetic level by sequencing. 
The deletion of hofQ was further verified at the transcriptional level by reverse 
transcription PCR (IV: Fig. 4A). Deletion of bilRI did not have a large impact on the 
A. actinomycetemcomitans D7S phenotype. The D7S ΔbilRI strain was grown in 
similar rough colonies on agar plates (II: Fig. 4A). However, the bilRI-overexpressing 
strain (D7S bilRI rev) grew very poorly on agar plates, and the biofilm formation was 
completely abolished (II: Fig. 4C). Electron microscope images revealed that the 
Figure 20. Genetic organization of A. actinomycetemcomitans D7S gene regions flanking 
bilRI and hofQ genes. (A) The bilRI gene is preceded by minC and followed by sixA and 
glmA. The arrows show the transcription direction and the proportional sizes of the genes. 
The distance between bilRI and sixA is marked in the figure. (B) The hofQ gene is preceded 
by the comABCD operon (black) and followed by the shikimate kinase. Figure was adapted 
from Fig. 4 in study IV. 
A 
B 
A 
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outer membranes of the D7S bilRI rev cells were completely ruptured (Fig. 21), 
explaining the poor growth and survival of these cells. 
 The effect of bilRI and hofQ on the formation of A. actinomycetemcomitans biofilm 
was studied by staining the D7S, D7S ΔbilRI and D7S ΔhofQ biofilms with crystal 
violet. All of the main biofilm components (eDNA, PGA and proteins) were 
separately analyzed in equivalent biofilms. The D7S ΔbilRI biofilm mass was 
comparable to the wild type D7S biofilm, but the D7S ΔhofQ biofilm mass was only 
half that of the wild type D7S biofilm mass (Table 5). The D7S ΔbilRI biofilm had 
significantly higher amounts of proteins and PGA and less eDNA relative to the wild 
type D7S biofilm, while the D7S ΔhofQ biofilm had significantly lower levels of all 
the main biofilm components (Table 5). 
Table 5. Effects of the bilRI or hofQ deletions on the D7S biofilm.  
 Percentage of the wild type 
Strain Biofilm mass eDNA PGA Total protein 
D7S ΔbilRI (II) 
101 ± 5 
.. 
80 ± 5 
(0.021*) 
117 ± 5 
(0.029 *)  
134 ± 13 
(0.009*) 
D7S ΔhofQ (IV) 45 ± 22 
(0.029*) 
57 ± 12 
(0.029*) 
78 ± 9 
(0.029*) 
54 ± 13 
(0.029*) 
* p-value (Mann-Whitney U-test), PGA = poly-N-acetylglucosamine 
Figure 21. Deletion of bilRI did not impact the cell morphology of                               
A. actinomycetemcomitans D7S, but its overexpression lysed the outer cell 
membranes. D7S wild type (wt) and D7S ΔbilRI (bilRI-) strains shared similar sizes and 
morphologies when fixed cells were observed by electron microscopy. In contrast, the 
cells of the D7S bilRI rev strain were smaller, and only one cellular membrane was 
observed. Arrows indicate  A. actinomycetemcomitans cells in pictures where parts of the 
membrane filter are present. Figure was adapted from Fig. 4 in study II. 
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The amounts of biofilm components in the D7S biofilm were altered when the growth 
medium was supplemented with either IL-1β or IL-8 for 22 hours compared with the 
control biofilm without the cytokines (Table 6). The experiment with the D7S strain 
was performed in both studies II and IV to obtain a reliable, equivalent control for the 
D7S ΔbilRI (study II) and the D7S ΔhofQ (study IV) strains. The greatest and most 
consistent change in the wild type D7S biofilm was the decrease in eDNA in response 
to both tested cytokines. The deletion of bilRI or hofQ omitted this change. Cytokine 
supplementation did not significantly alter the overall biofilm mass or amounts of 
PGA or proteins in any of the tested strains (Table 6).  
Table 6. Effects of cytokines on the D7S wild type (wt), ΔbilRI or ΔhofQ biofilms. 
  Percentage of the control (without cytokines) 
Cytokine Strain Biofilm mass eDNA PGA Total protein 
IL-1β 
D7S wt       (II) 
94 ± 7 
. 
56 ± 16 
(0.018*) 
89 ± 8 
. 
86 ± 17 
. 
                   (IV) 
.       
103 ± 7 
. 
70 ± 14 
(0.029*) 
105 ± 5 
(0.029*) 
85 ± 11 
(0.029*) 
D7S ΔbilRI (II) 92 ± 5 106 ± 26 94 ± 7 89 ± 9 
D7S ΔhofQ (IV) 95 ± 15 116 ± 29 98 ± 5 102 ± 8 
IL-8 
 
D7S wt       (II) 
96 ± 12 
. 
63 ± 23 
(0.028*) 
88 ± 15 
. 
88 ±19 
. 
                   (IV) 
. 
96 ± 2 
(0.029*) 
65 ± 18 
(0.029*) 
88 ± 19 
. 
90 ± 20 
. 
D7S ΔbilRI (II) 104 ± 11 103 ± 22 89 ± 9 94 ± 32 
D7S ΔhofQ (IV) 89 ± 15 113 ± 39 97 ± 7 100 ± 29 
* p-value (Mann-Whitney U-test), PGA = poly-N-acetylglucosamine 
 
Viable A. actinomycetemcomitans biofilm was previously shown to bind IL-1β when 
it was co-cultured with organotypic gingival tissue culture (Paino et al., 2011). In this 
study, the binding of IL-6 and IL-8 to the viable biofilm was detected using anti-IL-6 
and anti-IL-8 antibodies. In the presence of penicillin and streptomycin, the biofilm 
viability was compromised, and less IL-6 and IL-8 were observed bound to the 
biofilm (II: Fig. 3A). The role of BilRI in the uptake of cytokines was analyzed by 
immunoelectron microscopy from the immunostained bacterial samples that were co-
incubated with gingival keratinocytes that naturally produce cytokines. Less bound 
anti-IL-1β antibody was observed inside the D7S ΔbilRI cells than inside the wild 
type D7S cells (II: Fig. 6). Therefore, the deletion of bilRI from A. 
actinomycetemcomitans D7S decreased the transport of IL-1β inside the bacterial 
cells. The uptake of IL-6 and IL-8, however, was not affected (II: Fig. 6).  
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5.4 The potential role of HofQ in host recognition and in 
antimicrobial susceptibility [IV] 
Outer membrane proteins are potential targets for host recognition and the onset of 
immune responses. ROS production from human leukocytes is induced, for example, 
by bacterial products. The possible role of HofQ in this induction was studied with an 
experiment in which isolated human leukocytes were exposed to A. 
actinomycetemcomitans D7S or D7S ΔhofQ, and the subsequent ROS production by 
the leukocytes was measured. No significant difference was detected between the 
signal levels induced by the two strains (Fig. 22A). The pretreatment of bacteria with 
A. actinomycetemcomitans-positive sera resulted in slightly higher ROS production 
upon exposure to the wild type D7S or D7S ΔhofQ, but no significant difference 
between the strains was detected (Fig. 22B). The only statistically significant increase 
in ROS production was observed between the D7S ΔhofQ that was pretreated with A. 
actinomycetemcomitans-positive sera and the same strain that was treated with the 
control sera (p=0.005, Mann-Whitney U-test, Fig 22B). 
Figure 22. HofQ did not alter ROS 
production. (A) The ROS production from the 
leukocytes in the presence of bacteria was 
measured as luminol-amplified 
chemiluminescence. Bacteria were pretreated 
with plasma collected from a healthy 
individual. The deletion of hofQ from D7S did 
not significantly affect ROS production 
compared with the D7S wild type (WT). Data 
(mean ± SD) is presented as percentages from 
the D7S WT. (B) ROS production was elevated 
when the bacteria were pretreated with the A. 
actinomycetemcomitans-positive (Aa+) serum 
instead of the healthy control serum. The ROS 
production with the Aa+ sera was slightly 
higher when stimulated with D7S ΔhofQ than 
when stimulated with D7S WT, while only a 
significant difference was observed between the 
Aa+ and control sera with the D7S ΔhofQ
(p=0.005, Mann-Whitney U-test). The mean 
values of each sample set are marked with a 
line. Figure was adapted from Fig. 6 in study 
IV. 
A 
B 
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The presence of anti-emHofQ antibodies in A. actinomycetemcomitans-positive serum 
samples was studied with ELISA. The emHofQ was immobilized, and bound anti-
bodies were detected with anti-human antibodies. No significant difference in 
antibody levels was discovered between the A. actinomycetemcomitans-positive 
serum samples and samples obtained from healthy individuals (IV: Fig. 6C). 
The effect of HofQ on the antimicrobial susceptibility was tested with a panel of four 
antibiotics: amoxicillin/clavulanic acid, ampicillin, doxycycline and tetracycline. 
Deletion of hofQ did not alter the susceptibility of A. actinomycetemcomitans to 
doxycycline or tetracycline but made the bacteria more susceptible to β-lactam 
antibiotics amoxicillin/clavulanic acid and ampicillin (Fig. 23).  
5.5 Summary of the results 
In this study, a novel outer membrane protein, BilRI, was discovered in A. 
actinomycetemcomitans. The sequence of BilRI was unique, consisting of repeated 
sequences and no aromatic amino acids. BilRI did not adopt a stable three-
dimensional fold, hence being an IDP. In A. actinomycetemcomitans, BilRI was 
localized in the outer membrane facing the extracellular space. The recombinant 
BilRI bound various cytokines with low affinity but not the human EM components 
collagen or fibrinogen.  
IL-8 interacted with DNA and the abundant outer membrane component LPS. The 
LPS extracted from six A. actinomycetemcomitans serotypes bound IL-8 with 
different affinities, but the affinities were not coupled with the serotypes. The binding 
Figure 23. The  deletion of hofQ  made          
A. actinomycetemcomitans more susceptible to 
β-lactam antibiotics. The susceptibility of A. 
actinomycetemcomitans D7S wild type (wt) and 
D7S ΔhofQ to amoxicillin/clavulanic acid (amc),
ampicillin (amp), doxycycline (dox) and 
tetracycline (tet) was tested by growing the 
bacteria in Haemophilus test plates with 
antibiotic test strips. After 45-48 hours, the MIC 
values were read from the strips. The D7S
ΔhofQ was less resistant to the β-lactam 
antibiotics amc and amp, while the susceptibility 
to dox and tet was not altered. Figure was 
adapted from Fig. 5 in study IV.  
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of IL-8 was not clearly correlated with any of the tested LPS regions: the O-antigen, 
the lipid A part or the phosphates in the inner core.  
Channel protein secretin HofQ of A. actinomycetemcomitans was proposed to play a 
role in DNA uptake. The recombinant emHofQ bound multiple cytokines, of which 
IL-8 and IL-1β with moderate affinity. This suggests a possible link between DNA 
uptake and cytokine uptake. The KH I-type domain in the C-terminal end of emHofQ 
participated in the interaction with IL-8 and IL-1β. EmHofQ did not possess 
immunogenic properties. 
Deletion of hofQ or bilRI from A. actinomycetemcomitans had a little effect on the 
phenotype. The deletion of bilRI decreased the internalization rate of IL-1β, and the 
deletion of hofQ made the bacterium more susceptible to β-lactam antibiotics. Both 
deletions decreased the amount of eDNA in the A. actinomycetemcomitans biofilms 
and abolished the cytokine-induced decrease of eDNA in the biofilm.  
Figure 24. Summary of the results. This thesis showed that human cytokines 
interacted with the flexible outer membrane protein BilRI, the abundant outer 
membrane component LPS, dsDNA and the extramembranous part of HofQ in
A. actinomycetemcomitans. The HofQ secretin was previously connected with DNA 
uptake, providing a possible link between DNA and cytokine uptake systems. Cytokines 
have been observed inside cells, but the internalization route is still unknown. The 
competence-associated Pil and Com proteins might play a role in the cytokine
internalization in A. actinomycetemcomitans. 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   69 16.5.2019   9.13
70 Discussion 
 
 
 
6. DISCUSSION 
Bacteria utilize multiple virulence mechanisms to survive in a hostile environment. 
Binding inflammatory mediators may be beneficial to bacteria (Meduri et al., 1999; 
Kanangat et al., 2001, 2007; Wu et al., 2005; Mahdavi et al., 2013). The effect of 
cytokines on the overall survival of bacteria has not been studied much, but IL-1β was 
shown to increase the growth rate of E. coli, Acinetobacter sp. and S. aureus (Porat et 
al., 1991; Meduri et al., 1999). It also seems that in the presence of IL-1β, S. aureus 
expresses a phenotype that promotes survival in the host, rather than fighting against 
the host (Kanangat et al., 2007). By sequestering the cytokines at the site of 
inflammation, the bacterial biofilm potentially alters the concentrations of 
inflammatory markers locally. This could significantly obstruct the host immune 
response and halt bacterial clearance because many responses require appropriate 
cytokine levels. For example, the formation of an IL-8 gradient at the infection site is 
highly important for neutrophil migration, and disturbance of the gradient will greatly 
weaken the immune responses. 
In the quest for the outer membrane interaction partner of IL-1β in A. 
actinomycetemcomitans, a small uncharacterized lipoprotein was discovered and 
named BilRI. BilRI was the first cytokine-binding outer membrane protein identified 
in A. actinomycetemcomitans and was the first identified in all oral pathogens. BilRI 
had no previously known function, unlike all the other cytokine-binding proteins that 
have been discovered in other species. These already had at least one known function 
other than cytokine binding, such as assembly protein of the capsule (Zav’yalov et al., 
1995), multifunctional porin (Wu et al., 2005) or secretion path for the TFP (Mahdavi 
et al., 2013).  
The highly soluble BilRI did not crystallize so the approach for determining the three-
dimensional structure of BilRI was NMR instead of X-ray crystallography. The NMR 
spectra showed poor signal dispersion, which strongly indicated that BilRI was an 
IDP. IDPs are common in nature and play versatile roles in signaling, regulation and 
assembly (Uversky, 2011). Determining the three-dimensional structure of BilRI 
could have resulted in the discovery of structurally homologous proteins that could 
have given us information about its possible functions. However, information about 
the common properties of intrinsic proteins may also provide some concepts that 
could apply to BilRI. IDPs are flexible with no rigid structures, while binding to their 
interaction partner will trigger them to fold into an ordered form. IDPs can interact 
with multiple binding partners (even simultaneously) and are often seen in reversible 
signaling interactions that need high-specificity and low-affinity binding (Uversky, 
2011). Indeed, BilRI interacted to some extent with all of the tested cytokines: IL-8, 
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IL-6, IL-1β IL-10, TNF-α, TGF-1β and IFN-γ. Even the strongest observed 
interaction, between BilRI and IL-8, was still too weak for the binding constant to be 
determined in TRFIA. Since the binding affinity of BilRI to all tested cytokines was 
low, the interactions are probably reversible and temporary in nature. Our studies 
localized BilRI to the outer cell membrane of A. actinomycetemcomitans facing the 
extracellular space. This result fits well with our hypothesis that BilRI interacts with 
extracellular cytokines. The flexibility of an IDP brings it many advantages for 
interactions: it can increase the speed and spatial reach of interactions (Uversky, 
2011). Therefore, BilRI with its flexible IDP structure could have many unknown 
important functions. 
In this study, human cytokine interaction with bacterial LPS was shown for the first 
time. The interaction between LPS and cytokines was likely based on the net charges 
of the molecules since only the tested molecules with positive charge in neutral pH, 
i.e., IL-8 and IFN-γ, but not the negatively charged IL-1β, interacted with LPS. 
Interaction of IL-8 was observed with LPS isolated from six A. 
actinomycetemcomitans serotypes. The LPS structures on these serotypes differ in 
their O-antigen polysaccharide structures. The fact that IL-8 binds to all serotypes and 
even OMVs from a nonserotypable strain that lacks the O-antigen suggests that the 
interaction does not occur in the O-polysaccharide region. The PMB antibiotic, which 
binds the lipid A part of LPS, inhibited the interaction between IL-8 and LPS only 
lightly, suggesting that the interaction site of LPS and IL-8 might be somewhat 
different than that of PMB. The affinity of PMB to A. actinomycetemcomitans lipid 
A, however, is not known. While the core region of LPS has several phosphate groups 
that may bind positively charged IL-8, the amount of phosphorus in the samples did 
not correlate with the binding affinities. Compounds that affect the relative charges of 
molecules could be utilized to investigate this interaction further. Overall, our results 
were inconclusive about the interaction site between IL-8 and LPS. The results 
suggested that neither the O-antigen, lipid A nor the negative phosphate groups in the 
core are the primary interaction site between LPS and IL-8.  
The extramembranous part of the A. actinomycetemcomitans HofQ porin, emHofQ, 
interacted with various cytokines in the static setting. Moderate binding affinities for 
emHofQ interactions with IL-8 and IL-1β were obtained. The Kd values for the 
interactions were 43 nM and 140 nM, respectively. The immobilized emHofQ bound 
IL-8 in a liquid flow with approximately 50 times lower affinity (2.4 μM). The 
disrupting forces present in the dynamic environment could explain the lower binding 
affinity. The setting in the dynamic experiment, however, more accurately 
represented the biological situation where the HofQ is membrane bound and IL-8 is 
diffusing freely. Moderate binding affinities were expected because the interaction 
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between emHofQ and cytokines is likely temporary before cytokines are passed 
forward in the uptake machinery. The HofQ homolog PilQ of N. meningitidis has 
been shown to bind IL-8 and TNF-α using mutant strains, but no binding constants 
have been reported (Mahdavi et al., 2013). Zav’yalov and co-workers obtained high 
binding affinity (Kd = 140 ± 14 pM) between IL-1β and the usher protein ClfA1 of Y. 
pestis (Zav’yalov et al., 1995). However, the experiment was not performed with 
purified proteins but by expressing recombinant ClfA1 in the outer membrane of E. 
coli, so it is impossible to compare these binding constants. 
The interaction site between IL-8 and the A. actinomycetemcomitans emHofQ was 
studied with crosslinking, which identifies the lysine residues in the two proteins that 
are in close proximity to one another. In emHofQ, the detected lysine was Lys139, 
which was located in the C-terminal type I KH domain. The mutational assay was 
conducted with two, three or five amino acids substituted in the loop containing 
Lys139 and/or from the neighboring loop. That assay was designed to give a rough 
estimate of the interaction region, not to provide information about the roles of 
individual amino acids in the interaction. All mutations decreased the binding affinity 
of emHofQ to both IL-8 and IL-1β; therefore, these two loop regions contributed to 
the interaction. According to our studies, loop 1 has a greater role in the interaction 
because the mutations in that loop decreased the Kd more than mutations in loop 2. At 
the same time, these loop regions are in very close proximity, and the amino acids in 
them might interact. Therefore, changes in one of the loops might also change the 
conformation of the other. The interesting result was that the mutations in the loops 
also decreased emHofQ binding to IL-1β. This indicates that the type I KH domain in 
the emHofQ interacts with both IL-1β and IL-8. Structural comparison of the 
emHofQ of A. actinomycetemcomitans and the PilQ of N. meningitidis showed a 
homologous type I KH domain in the PilQ. Our results suggest that the type I KH 
domain is a possible cytokine-binding site in PilQ.  
The overall structure of HofQ secretin has not been determined, but the structures of 
other homologous secretins could provide a clue. Secretins are usually formed out of 
12 or 14 subunits that form channels across the outer membrane, and the usual 
channel diameter is approximately 6-8 nm (Bayan et al., 2006). Tarry and co-workers 
showed the structural homology between emHofQ and the EscC and GspD proteins 
from E. coli (Tarry et al., 2011). Homology was observed between emHofQ and the 
periplasmic regions of EscC and GspD (Korotkov et al., 2009; Spreter et al., 2009), 
suggesting that the emHofQ part is on the periplasmic side of the outer membrane 
rather than towards the EM. 
The A. actinomycetemcomitans emHofQ was previously shown to bind linearized 
dsDNA both with and without the presence of USS (Tarry et al., 2011). Further, it 
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was suggested that HofQ is a possible channel transferring the DNA inside the cells 
because homologous secretins in the TFP system play a role in DNA uptake (Chen & 
Dubnau, 2004; Assalkhou et al., 2007). I showed that the interaction between IL-8 
and dsDNA is likely electrostatic between negatively charged DNA and positively 
charged IL-8. The binding of human placental DNA and IL-8 has been shown by 
Perks and Shute (Perks & Shute, 2000), which supports our finding. IL-8 binding to 
DNA may have an important biological effect because eDNA is abundantly available 
in the extracellular space as one of the main components of the biofilm matrix 
(Whitchurch, 2002; Izano et al., 2008). 
The possible roles of BilRI or HofQ in different aspects of A. actinomycetemcomitans 
physiology were studied using deletion mutants. The deletion of bilRI of hofQ did not 
significantly alter the phenotype or growth of A. actinomycetemcomitans. This result 
suggested that neither of these proteins are essential to the species and that their 
functions may be compensated by other proteins or that their essentiality did not 
manifest in the tested conditions. The overexpression of bilRI, on the other hand, 
decreased the membrane integrity and overall viability in both E. coli and A. 
actinomycetemcomitans. The deletion of bilRI decreased the uptake of IL-1β but not 
of IL-6 or IL-8. In the gingival fluid, the concentration of IL-1β is considerably lower 
than those of IL-6 and IL-8. The in vitro gingival tissue model produced 
approximately 200 ng of IL-8, 20 ng of IL-6 and 200 pg of IL-1β during the same 
time period (Paino et al., 2012). Based on this knowledge, the role of BilRI was 
suggested to be important when the cytokine concentrations in the environment are 
low. Overall, the immunostained bacterial samples did not have sufficient negative 
controls in this study, so the unspecific binding of the cytokine antibodies could not 
be disregarded. However, the samples in these experiments were identically prepared, 
so it could be suspected that the unspecific background in all the samples is 
approximately the same level. 
The deletion of hofQ significantly decreased the formation of biofilm and all of its 
main components. Biofilm formation is an important virulence factor of A. 
actinomycetemcomitans, and HofQ clearly plays a pivotal role in that. The HofQ 
homolog PilQ in N. meningitidis has been shown to play a crucial role in natural 
transformation since its deletion disrupted N. meningitidis transformation (Lång et al., 
2009). In our studies, the ΔhofQ strain was not transformable, suggesting that HofQ 
could also affect the competence of A. actinomycetemcomitans.  
Many antibiotics enter cells through secretins or porins, leading to the hypothesis that 
in the absence of the HofQ, the penetration of antibiotics would be decreased and 
therefore the resistance to antibiotics increased. The susceptibility of D7S ΔhofQ to 
tetracyclines was not altered compared with that of the wild type D7S. However, the 
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resistance of D7S ΔhofQ to tested β-lactams decreased. This unexpected discovery 
could be explained by the notion that some EM components, such as the eDNA, are 
also found to decrease the effectivity of certain antibiotics (Chiang et al., 2013; 
Cavaliere et al., 2014). The deletion of hofQ decreased the amounts of all matrix 
components, including the eDNA, and increased its susceptibility to β-lactams. Those 
results suggest that matrix components, especially eDNA, may protect biofilm cells 
from β-lactams.  
However, the mechanism concerning the antibiotic susceptibility of A. 
actinomycetemcomitans do not possess great clinical significance since the primary 
treatment for periodontitis is a mechanical removal of biofilm from tooth surfaces. 
Antibiotics can be used as an adjunct therapy to that but their effectivity and benefit  
are clearly shown only in some patient groups (Pretzl et al., 2018). Since the host 
inflammatory response is contributing to the development of periodontitis, promising 
results have recently been obtained by treating periodontitis with anti-inflammatory 
susbtances (anti-IL-23 antibodies) (Moutsopoulos et al., 2017). It has been shown that 
the periodontal keystone pathogen P. gingivalis can induce host inflammation, 
promoting dysbiosis and at the same time inhibiting the killing functions of immune 
cells (Maekawa et al., 2014). The cytokine binding of A. actinomycetemcomitans 
might also have a role in regulating host inflammation.  
Bacterial outer membrane proteins are potential targets for recognition by human 
immune cells. For example, the cytokine-binding protein IrmA in E. coli is 
immunogenic (Moriel et al., 2016). In our studies, we did not discover any 
immunogenic effects of HofQ. The healthy control sera had very low levels of anti-A. 
actinomycetemcomitans antibodies compared with the A. actinomycetemcomitans-
positive patient sera (unpublished results). The amounts of anti-emHofQ antibodies 
detected in A. actinomycetemcomitans-positive patient sera, however, were not higher 
than those of healthy controls, and the deletion of hofQ did not affect the stimulatory 
power that A. actinomycetemcomitans had on the leukocytes. These results are 
consistent with the view that emHofQ is likely facing the periplasmic space and 
therefore, that no antibodies against it will be formed. 
In this study, I showed that BilRI interacted with various human cytokines but not 
with the extracellular molecules collagen or fibrinogen. BilRI homolog FgbA in H. 
ducreyi has shown binding to fibrinogen (Bauer et al., 2009), although another study 
proposed a completely different protein, DsrA, as the primary fibrinogen binder in H. 
ducreyi (Fusco et al., 2013). Our results suggest that the role of BilRI is more likely 
associated with the evasion mechanism (binding to human cytokines) than with 
cellular attachment to the EM. However, our experiments were mainly performed in a 
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static environment in a microplate, so no conclusion can be drawn about the 
interaction in a more dynamic environment or in vivo. 
The notion that emHofQ interacts with DNA and IL-8 and that these molecules also 
interact with each other, suggested a possible link between the DNA and cytokine 
uptake mechanisms. The secretin channels are usually approximately 6-8 nm wide 
(Bayan et al., 2006) and can easily fit dsDNA (2.5 nm). On the other hand, the 
maximal diameter of IL-8 is approximately 4 nm (Högbom & Ihalin, 2017), so the IL-
8 could possibly fit to the secretin channel bound with the DNA. Overall, the cytokine 
binding of emHofQ was an important discovery, even though it has not yet been 
verified if HofQ is the actual channel internalizing the cytokines. 
LPS is highly abundant in the outer membrane of bacteria, so its binding to cytokines 
might have a greater biological impact than BilRI, which has a low presence on the 
membrane. LPS also plays an important role in the initiation of immune responses. 
The idea that LPS would also dampen the immune response by binding IL-8 and 
other cytokines is intriguing. The stable IL-8 gradient, which guides neutrophils and 
macrophages in the healthy gingival epithelium, is lost during periodontal infection 
(Tonetti et al., 1998). Our findings may suggest that the oral bacteria might play a 
role in disturbing the IL-8 gradient. 
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7. CONCLUDING REMARKS AND FUTURE PROSPECTS 
Cytokine binding of A. actinomycetemcomitans outer membrane proteins BilRI and 
HofQ and of the outer membrane component LPS is shown in this thesis. The 
interactions were inspected with various methods and the binding affinities of 
emHofQ and LPS to certain cytokines were obtained as well as information about the 
interaction sites. The HofQ secretin has previously been associated with DNA 
binding and uptake; thus, this thesis suggests a possible connection between the 
uptake of DNA and the cytokine uptake mechanism. BilRI was shown to bind 
cytokines with low affinity, and its role in the cytokine uptake mechanism is most 
likely minor. This thesis also showed that LPS likely plays a role in cytokine binding, 
which is a notable discovery, as LPS already has many other important functions in 
bacterial virulence. 
This thesis provides new knowledge of the virulence mechanism of an oral pathogen. 
On a larger scale, it offers a novel perspective of how the bacteria can interact with 
host molecules. However, the results obtained in this thesis just scratch the surface of 
this bacterial evasion mechanism and reveal a research area that could be explored 
further. Not much is known about BilRI and HofQ proteins, nor about their functions 
in general or their relation to bacterial virulence. If BilRI and HofQ are moonlighting 
proteins, like many virulence-associated proteins, they might have multiple functions 
in different parts of the cell or in different environmental conditions. The 
moonlighting functions of the proteins are difficult to discover intentionally, and most 
of those functions have been found serendipitously. Analysis of the expression levels 
of bilRI and hofQ in different culture conditions may provide new ideas for their 
potential roles. Other functions could be found especially from BilRI, as its role in 
cytokine binding seems vague and because it is an IDP that has a flexible structure 
enabling it to perform different functions. The suspected role of HofQ as a channel 
that transfers cytokines inside the cell also needs to be investigated. If HofQ is not the 
route for cytokines, then other possible internalization methods need to be explored.  
The cytokine uptake mechanism in A. actinomycetemcomitans most likely involves 
many molecules in the cytosol, on the membrane and even in the biofilm EM that 
need to be discovered. For instance the Pil and Com proteins of A. 
actinomycetemcomitans are considered as being involved in the same secretion 
system as is HofQ (Zijnge et al., 2012), therefore their participation on the cytokine 
binding and uptake may be explored.  
Cytokine binding has already been shown in many bacterial species, and it might be 
discovered in even more species. Additionally, the cytokine binding of LPS from 
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other gram-negative species would be an interesting study target. In nature, bacteria 
usually occur as multispecies biofilms. To gain insight into how the cytokine uptake 
mechanism might work in nature, more complex experimental setup with multiple 
bacterial species is required.  
The effects of human cytokines on bacterial virulence are still relatively little studied. 
Cytokines are important host regulators in the infection site, and it seems that bacteria 
can utilize those for their own benefit; to regulate their gene expression or the 
inflammatory milieu. This thesis concentrated on some of the consequences that the 
cytokine binding and uptake have on the bacteria. In the future, it would be 
interesting to study how the cytokine uptake of bacteria affects the host. Tissue 
culture models, such as the organotypic gingival mucosal tissue model used in this 
thesis, could be utilized to investigate some of those effects for host cells. 
Bacterial cytokine-binding mechanism could have potential clinical implications for 
the treatment or prevention of bacterial infections, but extensive research about the 
mechanims is still needed. Detailed information should be obtained about how the 
cytokine-binding effects both bacteria and the host as well as the structure of the 
active sites of cytokine-binding bacterial molecules. Only after sufficient information 
is gathered, the possibility for the development of effector molecules could be 
evaluated. 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   77 16.5.2019   9.13
78 Acknowledgements 
 
 
 
ACKNOWLEDGEMENTS 
The majority of this study was performed in the department of Biochemistry and 
some work was performed in the Institute of Dentistry. I would like to thank 
Professors Jyrki Heino and Pekka Vallittu as well as Adjunct Professors Eeva 
Söderling and Vuokko Loimaranta for providing the excellent research facilities.  
The biggest thank you goes to my supervisor Riikka Ihalin, who has been the brains 
and the heart behind everything. She was the one who tempted me into working for 
the thesis in the first place and has supported me immensely during my thesis work. 
She is the one with all the answers and always provides some words of 
encouragement (both when experiments go well and when they do not). Thank you 
for trusting me and helping me to develop into a scientist I have become. 
I thank my other supervisor, Heidi Tuominen, for sharing her vast knowledge about 
protein purification, interaction studies and protein structures and for also supporting 
me throughout this journey. Lately, she has worked in industry and been guiding me 
with her expertise from that field.  
I am grateful for my outstanding advisory committee members Mattias Svensson and 
Perttu Permi for their invaluable guidance and support during the thesis work. I really 
enjoyed our yearly meetings. Thank you Perttu for collaboration in the NMR-studies 
and Mattias for providing me an opportunity to work for a month in your laboratory. 
Great thanks goes to Associate professor Lotta-Riina Sundberg and Professor Deirdre 
Devine for reviewing my thesis and giving invaluable feedback on it. 
I sincerely thank Professor Mikael Skurnik from the University of Helsinki for acting 
as my opponent. 
I thank the University of Turku Graduate School and the Doctoral Programme in 
Molecular Life Sciences for providing good study opportunities and for financial 
support. Funding from the Finnish Cultural Foundation has supported my thesis work 
for two and a half years and I express my gratitude for that. 
I would like to thank all current and former members of our research group for their 
contributions in my thesis: Annamari Torittu, Terhi Maula, Nelli Vahvelainen, Laura 
Kovesjoki, Noora Virtanen, Milla Tulkki, Marja Pöllänen, Heli Elovaara, Arzu 
Beklen, Indre Navickaite, Kajal Panchal and Mahada Omar. Working with these “Aa-
girls” has been great and we have shared numerous fun and colorful moments over 
the years both in the laboratory and on seminar trips. Together, we have experienced 
the ups and downs of working in science and of life in general. Additionally, I would 
like to thank other people who have worked in our lab for even short periods during 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   78 16.5.2019   9.13
Acknowledgements  79 
 
 
 
my thesis work: Emmiliisa, Eeva, Huda, Jemna, Minna, Mitchell, Outi, Reijo, Salli 
and Sami. 
All my co-authors Maria Lahti, Urpo Lamminmäki, Martin Högbom, Hannamari 
Välimaa, Jan Oscarsson and Sergo Kasvandik are thanked for the fruitful 
collaboration. Jari Nuutila is thanked for his help with the flow cytometry and the 
ROS production test. Raija Sormunen and Ilkka Miinalainen in the Biocenter Oulu 
are acknowledged for their valuable help with immunostaining and electron 
microscopy. 
I want to thank my fellow “Aa-researchers” in the European Network for 
Aggregatibacter actinomycetemcomitans Research (ENAaR) for their support and 
collaboration, and all the fun times we have had while exchanging ideas. 
I want to thank the biochemistry core facility Anu Hirvensalo, Teija Luotohaara, Heli 
Kalevo and Jani Sointusalo, for their valuable assistance in practical issues. The 
wonderful laboratory staff at the Institute of Dentistry, especially Katja Sampalahti 
and Mariia Valkama, have helped me out a lot with my experiments and always made 
me feel welcome. Thank you! 
I would like to thank all the biochemistry staff I have worked with, especially Anu 
Salminen, Jarmo Käpylä and Janne Atosuo for all their practical help. Other current 
and former PhD students (Erika, Heidi, Vilja, Matti, Kalle, Natalia, Maria, Janne, 
Marjaana, Johannes, Katri, Abbi, Biku, Keith, Benjamin and probably few others that 
I don’t remember to mention) are thanked for their peer support. I especially would 
like to thank Erika, who experienced this whole journey with me from the lab next 
door. Enormous thanks is given for all the shared lunches, all great practical tips, and 
the immense mental support and for being such a good friend to me. 
Haluan kiittää kaikkia ystäviäni, jotka ovat olleet tukenani tarvittaessa ja kestäneet 
sen että välillä tapaamiset ovat olleet harvassa. Teidän kanssanne on jaettu monia 
iloja ja suruja; kiitos erityisesti Vilma, Johanna, Linda, Anni sekä Tomi. Kiitos 
Anulle ja kaikille ihanille TCYC-kuorosiskoilleni (nykyisille ja entisille), teidän 
seurassanne on koettu monia hienoja musiikillisia hetkiä Suomessa ja ulkomailla; 
laulettu, naurettu ja soitettu käsikelloja. Kuoroharrastus on ollut supertärkeää 
vastapainoa intensiiviselle tutkimustyölle. 
Kiitos perheelleni; iskälle, Soinnulle, Jokelle ja Nuutille sekä Pyrylle, siitä että olette 
aina tukena ja apuna. Olette rakkaita! Kiitos myös muille sukulaisille ja tuttaville 
kannustuksesta. Kiitos Teemulle kaikesta tuesta ja rakkaudesta. 
Turku, May 2019  
Tuuli
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   79 16.5.2019   9.13
80 References 
 
 
 
REFERENCES
Abramov, V. M., Vasiliev, A. M., 
Vasilenko, R. N., Kulikova, N. L., 
Kosarev, I. V., Khlebnikov, V. S., 
Ishchenko, A. T., MacIntyre, S., 
Gillespie, J. R., Khurana, R., Korpela, T., 
Fink, A. L., & Uversky, V. N. (2001). 
Structural and Functional Similarity 
between Yersinia pestis Capsular Protein 
Caf1 and Human Interleukin-1β. 
Biochemistry, 40(20), 6076–6084. 
Aderem, A., & Ulevitch, R. J. (2000). Toll-
like receptors in the induction of the 
innate immune response. Nature, 
406(August), 782–787. 
Adiba, S., Nizak, C., van Baalen, M., 
Denamur, E., & Depaulis, F. (2010). 
From grazing resistance to pathogenesis: 
The coincidental evolution of virulence 
factors. PLoS One, 5(8), 1–10. 
Agarwal, S., Baran, C., Piesco, N. P., 
Quintero, J. C., Langkamp, H. H., Johns, 
L. P., & Chandra, C. S. (1995). Synthesis 
of proinflammatory cytokines by human 
gingival fibroblasts in response to 
lipopolysaccharides and interleukin-
1beta. J. Periodontal Res., 30(6), 382–
389. 
Akifusa, S., Poole, S., Lewthwaite, J., 
Henderson, B., & Nair, S. P. (2001). 
Recombinant Actinobacillus 
actinomycetemcomitans cytolethal 
distending toxin proteins are required to 
interact to inhibit human cell cycle 
progression and to stimulate human 
leukocyte cytokine synthesis. Infect. 
Immun., 69(9), 5925–5930. 
Allesen-Holm, M., Barken, K. B., Yang, L., 
Klausen, M., Webb, J. S., Kjelleberg, S., 
Molin, S., Givskov, M., & Tolker-
Nielsen, T. (2006). A characterization of 
DNA release in Pseudomonas aeruginosa 
cultures and biofilms. Mol. Microbiol., 
59(4), 1114–1128. 
Asikainen, S., Chen, C., & Slots, J. (1995). 
Actinobacillus actinomycetemcomitans 
genotypes in relation to serotypes and 
periodontal status. Oral Microbiol. 
Immunol., 10(2), 65–68. 
Asikainen, S., Lai, C.-H., Alaluusua, S., & 
Slots, J. (1991). Distribution of 
Actinobacillus actinomycetemcomitans 
serotypes in periodontal health and 
disease. Oral Microbiol. Immunol., 6(2), 
115–118. 
Assalkhou, R., Balasingham, S., Collins, R. 
F., Frye, S. A., Davidsen, T., Benam, A. 
V., Bjørås, M., Derrick, J. P., & Tønjum, 
T. (2007). The outer membrane secretin 
PilQ from Neisseria meningitidis binds 
DNA. Microbiology, 153(5), 1593–1603. 
Bagge, N., Hentzer, M., Andersen, J. B., 
Ciofu, O., Givskov, M., & Høiby, N. 
(2004). Dynamics and Spatial 
Distribution of β-Lactamase Expression 
in Pseudomonas aeruginosa Biofilms. 
Antimicrob. Agents Chemother., 48(4), 
1168–1174. 
Bauer, M. E., Townsend, C. A., Doster, R. 
S., Fortney, K. R., Zwickl, B. W., Katz, 
B. P., Spinola, S. M., & Janowicz, D. M. 
(2009). A fibrinogen-binding lipoprotein 
contributes to the virulence of 
Haemophilus ducreyi in humans. J Infect 
Dis, 199(5), 684–692. 
Bayan, N., Guilvout, I., & Pugsley, A. P. 
(2006). Secretins take shape. Mol. 
Microbiol., 60(1), 1–4. 
Belibasakis, G. N., Johansson, A., Wang, 
Y., Chen, C., Kalfas, S., & Lerner, U. H. 
(2005). The cytolethal distending toxin 
induces receptor activator of NF-kappaB 
ligand expression in human gingival 
fibroblasts and periodontal ligament cells. 
Infect. Immun., 73(1), 342–351. 
Belibasakis, G. N., Johansson, A., Wang, 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   80 16.5.2019   9.13
References  81 
 
 
 
Y., Claesson, R., Chen, C., Asikainen, S., 
& Kalfas, S. (2002). Inhibited 
proliferation of human periodontal 
ligament cells and gingival fibroblasts by 
Actinobacillus actinomycetemcomitans: 
involvement of the cytolethal distending 
toxin. Eur. J. Oral Sci., 110(5), 366–373. 
Belibasakis, G. N., Mattsson, A., Wang, Y., 
Chen, C., & Johansson, A. (2004). Cell 
cycle arrest of human gingival fibroblasts 
and periodontal ligament cells by 
Actinobacillus actinomycetemcomitans: 
Involvement of the cytolethal distending 
toxin. APMIS, 112(10), 674–685. 
Berry, J.-L. L., Phelan, M. M., Collins, R. 
F., Adomavicius, T., Tønjum, T., Frye, S. 
A., Bird, L., Owens, R., Ford, R. C., 
Lian, L.-Y. Y., & Derrick, J. P. (2012). 
Structure and Assembly of a Trans-
Periplasmic Channel for Type IV Pili in 
Neisseria meningitidis. PLoS Pathog., 
8(9), e1002923. 
Bhattacharjee, M. K., Fine, D. H., & 
Figurski, D. H. (2007). tfoX (sxy)-
dependent transformation of 
Aggregatibacter (Actinobacillus) 
actinomycetemcomitans. Gene, 399(1), 
53–64. 
Billings, N., Ramirez Millan, M., Caldara, 
M., Rusconi, R., Tarasova, Y., Stocker, 
R., & Ribbeck, K. (2013). The 
Extracellular Matrix Component Psl 
Provides Fast-Acting Antibiotic Defense 
in Pseudomonas aeruginosa Biofilms. 
PLoS Pathog., 9(8), e1003526. 
Bouffartigues, E., Moscoso, J. A., 
Duchesne, R., Rosay, T., Fito-
Boncompte, L., Gicquel, G., Maillot, O., 
Bénard, M., Bazire, A., Brenner-Weiss, 
G., Lesouhaitier, O., Lerouge, P., Dufour, 
A., Orange, N., Feuilloley, M. G. J., 
Overhage, J., Filloux, A., & Chevalier, S. 
(2015). The absence of the Pseudomonas 
aeruginosa OprF protein leads to 
increased biofilm formation through 
variation in c-di-GMP level. Front. 
Microbiol., 6, 630. 
Brogan, J. M., Lally, E. T., Poulsen, K., 
Kilian, M., & Demuth, D. R. (1994). 
Regulation of Actinobacillus 
actinomycetemcomitans leukotoxin 
expression: Analysis of the promoter 
regions of leukotoxic and minimally 
leukotoxic strains. Infect. Immun., 62(2), 
501–508. 
Cavaliere, R., Ball, J. L., Turnbull, L., & 
Whitchurch, C. B. (2014). The biofilm 
matrix destabilizers, EDTA and DNaseI, 
enhance the susceptibility of nontypeable 
Hemophilus influenzae biofilms to 
treatment with ampicillin and 
ciprofloxacin. Microbiologyopen, 3(4), 
557–567. 
Chen, Casey, Kittichotirat, W., Chen, W., 
Downey, J. S., Si, Y., & Bumgarner, R. 
(2010). Genome sequence of naturally 
competent Aggregatibacter 
actinomycetemcomitans serotype a strain 
D7S-1. J. Bacteriol., 192(10), 2643–
2644. 
Chen, Chang, Zabad, S., Liu, H., Wang, W., 
& Jeffery, C. (2018). MoonProt 2.0: an 
expansion and update of the 
moonlighting proteins database. Nucleic 
Acids Res., 46(D1), D640–D644. 
Chen, I., Christie, P. J., & Dubnau, D. 
(2005). The ins and outs of DNA transfer 
in bacteria. Science, 310(5753), 1456–
1460. 
Chen, I., & Dubnau, D. (2004). DNA 
uptake during bacterial transformation. 
Nat. Rev. Microbiol., 2(3), 241–249. 
Cheng, Y.-A., Jee, J., Hsu, G., Huang, Y., 
Chen, C., & Lin, C.-P. (2014). A 
markerless protocol for genetic analysis 
of Aggregatibacter 
actinomycetemcomitans. J. Formos. Med. 
Assoc., 113(2), 114–123. 
Chevalier, S., Bouffartigues, E., Bodilis, J., 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   81 16.5.2019   9.13
82 References 
 
 
 
Maillot, O., Lesouhaitier, O., Feuilloley, 
M. G. J., Orange, N., Dufour, A., & 
Cornelis, P. (2017). Structure, function 
and regulation of Pseudomonas 
aeruginosa porins. FEMS Microbiol. Rev. 
41(5),698-722. 
Chiang, W. C., Nilsson, M., Jensen, P. Ø., 
Høiby, N., Nielsen, T. E., Givskov, M., & 
Tolker-Nielsen, T. (2013). Extracellular 
DNA shields against aminoglycosides in 
Pseudomonas aeruginosa biofilms. 
Antimicrob. Agents Chemother., 57(5), 
2352–2361. 
Claesson, R., Gudmundson, J., Åberg, C. 
H., Haubek, D., & Johansson, A. (2015). 
Detection of a 640-bp deletion in the 
Aggregatibacter actinomycetemcomitans 
leukotoxin promoter region in isolates 
from an adolescent of Ethiopian origin. J. 
Oral Microbiol., 7(1), 26974. 
Claesson, R., Höglund-Åberg, C., Haubek, 
D., & Johansson, A. (2017). Age-related 
prevalence and characteristics of 
Aggregatibacter actinomycetemcomitans 
in periodontitis patients living in Sweden. 
J. Oral Microbiol., 9(1), 13334504. 
Clock, S. A., Planet, P. J., Perez, B. A., & 
Figurski, D. H. (2008). Outer membrane 
components of the tad (tight adherence) 
secreton of Aggregatibacter 
actinomycetemcomitans. J. Bacteriol., 
190(3), 980–990. 
Costerton, J. W., Stewart, P. S., & 
Greenberg, E. P. (1999). Bacterial 
biofilms: a common cause of persistent 
infections. Science, 284(5418), 1318–
1322. 
Craig, L., Pique, M. E., & Tainer, J. A. 
(2004). Type IV pilus structure and 
bacterial pathogenicity. Nat. Rev. 
Microbiol., 2(5), 363–378. 
Crosby, J. A., & Kachlany, S. C. (2007). 
TdeA, a TolC-like protein required for 
toxin and drug export in Aggregatibacter 
(Actinobacillus) actinomycetemcomitans. 
Gene, 388(1–2), 83–92. 
Croxen, M. A., Law, R. J., Scholz, R., 
Keeney, K. M., Wlodarska, M., & Finlay, 
B. B. (2013). Recent advances in 
understanding enteric pathogenic 
Escherichia coli. Clin. Microbiol. Rev., 
26(4), 822–880. 
Danforth, D. R., Tang-Siegel, G., Ruiz, T., 
& Mintz, K. P. (2019). A Nonfimbrial 
Adhesin of Aggregatibacter 
actinomycetemcomitans Mediates 
Biofilm Biogenesis. Infect. Immun., 
87(1), e00704-18. 
Danner, D. B., Deich, R. A., Sisco, K. L., & 
Smith, H. O. (1980). An eleven-base-pair 
sequence determines the specificity of 
DNA uptake in Haemophilus 
transformation. Gene, 11(3–4), 311–318. 
Darveau, R. P. (2010). Periodontitis: a 
polymicrobial disruption of host 
homeostasis . Nat. Rev., 8(7), 481–490. 
Davies, D. G., Chakrabarty, A. M., & 
Geesey, G. G. (1993). Exopolysaccharide 
production in biofilms: substratum 
activation of alginate gene expression by 
Pseudomonas aeruginosa . Appl. Environ. 
Microbiol., 59(4), 1181–1186. 
Di Yu, X., Dubnovitsky, A., Pudney, A. F., 
MacIntyre, S., Knight, S. D., & Zavialov, 
A. V. (2012). Allosteric mechanism 
controls traffic in the chaperone/usher 
pathway. Structure, 20(11), 1861–1871. 
Díaz-Zúñiga, J., Melgar-Rodríguez, S., 
Alvarez, C., Monasterio, G., Benítez, A., 
Ciuchi, P., Díaz, C., Mardones, J., 
Escobar, A., Sanz, M., & Vernal, R. 
(2015). T-lymphocyte phenotype and 
function triggered by Aggregatibacter 
actinomycetemcomitans is serotype-
dependent. J. Periodontal Res., 50(6), 
824–835. 
Dinarello, C. A. (2018). Overview of the 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   82 16.5.2019   9.13
References  83 
 
 
 
IL-1 family in innate inflammation and 
acquired immunity. Immunol. Rev., 
281(1), 8–27. 
Dongari-Bagtzoglou, A. I., & Ebersole, J. L. 
(1996). Production of inflammatory 
mediators and cytokines by human 
gingival fibroblasts following bacterial 
challenge. J. Periodontal Res., 31(2), 90–
98. 
Donlan, R. M. (2000). Role of biofilms 
antimicrobial resistance. ASAIO J., 46(6), 
S47–S52. 
Donlan, R. M. (2001). Biofilms and device-
associated infections. Emerg. Infect. Dis., 
7(2), 277–281. 
Donlan, R. M., & Costerton, J. W. (2002). 
Biofilms: Survival Mechanisms of 
Clinically Relevant Microorganisms. 
Clin. Microbiol. Rev., 15(2), 167–193. 
Erridge, C., Bennett-Guerrero, E., & 
Poxton, I. R. (2002). Structure and 
function of lipopolysaccharides. 
Microbes Infect., 4(8), 837–851. 
Finkel, S. E., & Kolter, R. (2001). DNA as a 
Nutrient: Novel Role for Bacterial 
Competence Gene Homologs. J. 
Bacteriol., 183(21), 6288–6293. 
Finlay, B. B., & Falkow, S. (1989). 
Common themes in microbial 
pathogenicity. Microbiol. Rev., 53(2), 
210–230. 
Fito-Boncompte, L., Chapalain, A., 
Bouffartigues, E., Chaker, H., 
Lesouhaitier, O., Gicquel, G., Bazire, A., 
Madi, A., Connil, N., Véron, W., Taupin, 
L., Toussaint, B., Cornelis, P., Wei, Q., 
Shioya, K., Déziel, E., Feuilloley, M. G. 
J. J., … Chevalier, S. (2011). Full 
virulence of Pseudomonas aeruginosa 
requires OprF. Infect. Immun., 79(3), 
1176–1186. 
Flemming, H.-C., & Wingender, J. (2010). 
The biofilm matrix. Nat. Rev. Microbiol., 
8(9), 623–633. 
Flemming, H.-C., Wingender, J., Szewzyk, 
U., Steinberg, P., Rice, S. A., & 
Kjelleberg, S. (2016). Biofilms: an 
emergent form of bacterial life. Nat. Rev. 
Microbiol., 14(9), 563–575. 
Fratamico, P. M., Baranzoni, G. M., 
DebRoy, C., Feng, P., Liu, Y., & 
Needleman, D. S. (2016). Advances in 
Molecular Serotyping and Subtyping of 
Escherichia coli†. Front. Microbiol., 
7(May), 1–8. 
Fujise, O., Wang, Y., Chen, W., & Chen, C. 
(2008). Adherence of Aggregatibacter 
actinomycetemcomitans via serotype-
specific polysaccharide antigens in 
lipopolysaccharides . Oral Microbiol. 
Immunol., 23(3), 226–233. 
Fusco, W. G., Elkins, C., & Leduc, I. 
(2013). Trimeric autotransporter DsrA Is 
a major mediator of fibrinogen binding in 
haemophilus ducreyi. Infect. Immun., 
81(12), 4443–4452. 
Gallant, C. V., Sedic, M., Chicoine, E. A., 
Ruiz, T., & Mintz, K. P. (2008). 
Membrane morphology and leukotoxin 
secretion are associated with a novel 
membrane protein of Aggregatibacter 
actinomycetemcomitans. J. Bacteriol., 
190(17), 5972–5980. 
Galyov, E. E., Karlishev, A. V., 
Chernovskaya, T. V., Dolgikh, D. A., 
Smirnov, O. Y., Volkovoy, K. I., 
Abramov, V. M., & Zavyalov, V. P. 
(1991). Expression of the envelope 
antigen F1 of Yersinia pestis is mediated 
by the product of caf1M gene having 
homology with the chaperone protein 
PapD of Escherichia coli. FEBS Lett., 
286(1–2), 79–82. 
Galyov, E. E., Smirnov, O. Y., Karlishev, 
A. V., Volkovoy, K. I., Denesyuk, A. I., 
Nazimov, I. V., Rubtsov, K. S., 
Abramov, V. M., Dalvadyanz, S. M., & 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   83 16.5.2019   9.13
84 References 
 
 
 
Zav’yalov, V. P. (1990). Nucleotide 
sequence of the Yersinia pestis gene 
encoding F1 antigen and the primary 
structure of the protein. Putative T and B 
cell epitopes. FEBS Lett., 277(1–2), 230–
232. 
Goodman, S. D., & Scocca, J. J. (1988). 
Identification and arrangement of the 
DNA sequence recognized in specific 
transformation of Neisseria gonorrhoeae. 
Proc. Natl. Acad. Sci. U. S. A., 85(18), 
6982–6986. 
Graves, D. (2008). Cytokines That Promote 
Periodontal Tissue Destruction. J. 
Periodontol., 79(8s), 1585–1591. 
Haffajee, A. D., & Socransky, S. S. (1994). 
Microbial etiological agents of 
destructive periodontal diseases . 
Periodontol. 2000, 5, 78–111. 
Hajishengallis, G., & Lamont, R. J. (2016). 
Dancing with the Stars: How 
Choreographed Bacterial Interactions 
Dictate Nososymbiocity and Give Rise to 
Keystone Pathogens, Accessory 
Pathogens, and Pathobionts. Trends 
Microbiol., 24(6), 477–489. 
Hall-Stoodley, L., & Stoodley, P. (2009). 
Evolving concepts in biofilm infections. 
Cell. Microbiol., 11(7), 1034–1043. 
Hall, C. W., & Mah, T.-F. (2017). 
Molecular mechanisms of biofilm-based 
antibiotic resistance and tolerance in 
pathogenic bacteria. FEMS Microbiol. 
Rev., 41(3), 276–301. 
Hamilton, H. L., Domínguez, N. M., 
Schwartz, K. J., Hackett, K. T., & 
Dillard, J. P. (2005). Neisseria 
gonorrhoeae secretes chromosomal DNA 
via a novel type IV secretion system. 
Mol. Microbiol., 55(6), 1704–1721. 
Haraszthy, V. I., Zambon, J. J., Trevisan, 
M., Zeid, M., & Genco, R. J. (2000). 
Identification of Periodontal Pathogens in 
Atheromatous Plaques. J. Periodontol., 
71(10), 1554–1560. 
Haubek, D., Poulsen, K., Asikainen, S., & 
Kilian, M. (1995). Evidence for absence 
in northern Europe of especially virulent 
clonal types of Actinobacillus 
actinomycetemcomitans. J. Clin. 
Microbiol., 33(2), 395–401. 
Helander, I. M., Lindner, B., Brade, H., 
Altmann, K., Lindberg, A. A., Rietschel, 
E. T., & Zähringer, U. (1988). Chemical 
structure of the lipopolysaccharide of 
Haemophilus influenzae strain I-69 Rd-
/b+. Description of a novel deep-rough 
chemotype. Eur. J. Biochem., 177(3), 
483–492. 
Henderson, B. (2016). Overview of Protein 
Moonlighting in Bacterial Virulence. In 
Moonlighting Proteins: Novel Virulence 
Factors in Bacterial Infections. John 
Wiley & Sons, Inc., Hoboken, NJ, USA 
Henderson, B., & Martin, A. (2011). 
Bacterial Virulence in the Moonlight: 
Multitasking Bacterial Moonlighting 
Proteins Are Virulence Determinants in 
Infectious Disease. Infect. Immun., 79(9), 
3476–3491.  
Henderson, B., & Martin, A. (2014). Protein 
moonlighting: a new factor in biology 
and medicine. Biochem. Soc. Trans., 
42(6), 1671–1678. 
Hill, D. J., Griffiths, N. J., Borodina, E., & 
Virji, M. (2010). Cellular and molecular 
biology of Neisseria meningitidis 
colonization and invasive disease. Clin. 
Sci., 118(9), 547–564. 
Hoshino, K., Takeuchi, O., Kawai, T., 
Sanjo, H., Ogawa, T., Takeda, Y., 
Takeda, K., & Akira, S. (1999). Cutting 
edge: Toll-like receptor 4 (TLR4)-
deficient mice are hyporesponsive to 
lipopolysaccharide: evidence for TLR4 as 
the Lps gene product. J. Immunol., 
162(7), 3749–3752. 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   84 16.5.2019   9.13
References  85 
 
 
 
Huang, Y., Kittichotirat, W., Mayer, M. P. 
A., Hall, R., Bumgarner, R., & Chen, C. 
(2013). Comparative genomic 
hybridization and transcriptome analysis 
with a pan-genome microarray reveal 
distinctions between JP2 and non-JP2 
genotypes of Aggregatibacter 
actinomycetemcomitans. Mol. Oral 
Microbiol., 28(1), 1–17. 
Huovinen, T., Syrjanpaa, M., Sanmark, H., 
Brockmann, E.-C., Azhayev, A., Wang, 
Q., Vehniainen, M., & Lamminmaki, U. 
(2013). Two ScFv antibody libraries 
derived from identical VL-VH 
framework with different binding site 
designs display distinct binding profiles. 
Protein Eng. Des. Sel., 26(10), 683–693. 
Hyvärinen, K., Mäntylä, P., Buhlin, K., 
Paju, S., Nieminen, M. S., Sinisalo, J., & 
Pussinen, P. J. (2012). A common 
periodontal pathogen has an adverse 
association with both acute and stable 
coronary artery disease. Atherosclerosis, 
223(2), 478–484. 
Högbom, M., & Ihalin, R. (2017). 
Functional and structural characteristics 
of bacterial proteins that bind host 
cytokines. Virulence, 8(8), 1592–1601. 
Höglund Åberg, C., Antonoglou, G., 
Haubek, D., Kwamin, F., Claesson, R., & 
Johansson, A. (2013). Cytolethal 
Distending Toxin in Isolates of 
Aggregatibacter actinomycetemcomitans 
from Ghanaian Adolescents and 
Association with Serotype and Disease 
Progression. PLoS One, 8(6), e65781. 
Höglund Åberg, C., Kelk, P., & Johansson, 
A. (2014). Aggregatibacter 
actinomycetemcomitans: Virulence of its 
leukotoxin and association with 
aggressive periodontitis. Virulence, 6(3), 
188–195. 
Ihalin, R., & Asikainen, S. (2006). 16S 
rDNA PCR-denaturing gradient gel 
electrophoresis in determining 
proportions of coexisting Actinobacillus 
actinomycetemcomitans strains. J. 
Microbiol. Methods, 65, 417–424. 
Inoue, T., Shingaki, R., Sogawa, N., 
Sogawa, C. A., Asaumi, J., Kokeguchi, 
S., & Fukui, K. (2003). Biofilm 
formation by a fimbriae-deficient mutant 
of Actinobacillus 
actinomycetemcomitans. Microbiol. 
Immunol., 47(11), 877–881. 
Inoue, T., Tanimoto, I., Ohta, H., Kato, K., 
Murayama, Y., & Fukui, K. (1998). 
Molecular Characterization of Low-
Molecular-Weight Component Protein, 
Flp, in Actinobacillus 
actinomycetemcomitans Fimbriae. 
Microbiol. Immunol., 42(4), 253–258. 
Izano, E. A., Sadovskaya, I., Wang, H., 
Vinogradov, E., Ragunath, C., 
Ramasubbu, N., Jabbouri, S., Perry, M. 
B., & Kaplan, J. B. (2008). Poly-N-
acetylglucosamine mediates biofilm 
formation and detergent resistance in 
Aggregatibacter actinomycetemcomitans. 
Microb. Pathog., 44(1), 52–60. 
Izano, E. A., Wang, H., Ragunath, C., 
Ramasubbu, N., & Kaplan, J. B. (2007). 
Detachment and Killing of 
Aggregatibacter actinomycetemcomitans 
Biofilms by Dispersin B and SDS. J. 
Dent. Res., 86(7), 618–622. 
Jakubovics, N. S. S., Shields, R. C. C., 
Rajarajan, N., & Burgess, J. G. G. (2013). 
Life after death: The critical role of 
extracellular DNA in microbial biofilms. 
Lett. Appl. Microbiol., 57(6), 467–475. 
Jeffery, C. J. (1999). Moonlighting proteins. 
Trends Biochem. Sci., 24(1), 8–11. 
Jeffery, C. J. (2018). Protein moonlighting: 
what is it, and why is it important? 
Philos. Trans. R. Soc. B Biol. Sci., 
373(1738), 20160523. 
Johansson, A. (2011). Aggregatibacter 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   85 16.5.2019   9.13
86 References 
 
 
 
actinomycetemcomitans leukotoxin: A 
powerful tool with capacity to cause 
imbalance in the host inflammatory 
response. Toxins (Basel)., 3(3), 242–259. 
Johansson, A., Sandstrom, G., Claesson, R., 
Hanstrom, L., & Kalfas, S. (2000). 
Anaerobic neutrophil-dependent killing 
of Actinobacillus 
actinomycetemcomitans in relation to the 
bacterial leukotoxicity. Eur. J. Oral Sci., 
108(2), 136–146. 
Johnson, L., Horsman, S. R., Charron-
Mazenod, L., Turnbull, A. L., Mulcahy, 
H., Surette, M. G., & Lewenza, S. (2013). 
Extracellular DNA-induced antimicrobial 
peptide resistance in Salmonella enterica 
serovar Typhimurium. BMC Microbiol., 
13(1), 1–8. 
Jorth, P., & Whiteley, M. (2012). An 
Evolutionary Link between Natural 
Transformation and CRISPR Adaptive 
Immunity. MBio, 3(5), e00309-12. 
Kachlany, S. C., Planet, P. J., Bhattacharjee, 
M. K., Kollia, E., DeSalle, R., Fine, D. 
H., & Figurski, D. H. (2000). Nonspecific 
adherence by Actinobacillus 
actinomycetemcomitans requires genes 
widespread in Bacteria and Archaea. J. 
Bacteriol., 182(21), 6169–6176. 
Kachlany, S. C., Planet, P. J., DeSalle, R., 
Fine, D. H., Figurski, D. H., & Kaplan, J. 
B. (2001). Flp-1, the first representative 
of a new pilin gene subfamily, is required 
for non-specific adherence of 
Actinobacillus actinomycetemcomitans. 
Mol. Microbiol., 40(3), 542–554. 
Kanangat, S., Bronze, M. S., Meduri, G. U., 
Postlethwaite,  a, Stentz, F., Tolley, E., & 
Schaberg, D. (2001). Enhanced 
extracellular growth of Staphylococcus 
aureus in the presence of selected linear 
peptide fragments of human interleukin 
(IL)-1beta and IL-1 receptor antagonist. 
J. Infect. Dis., 183(1), 65–69. 
Kanangat, S., Postlethwaite, A., Cholera, S., 
Williams, L., & Schaberg, D. (2007). 
Modulation of virulence gene expression 
in Staphylococcus aureus by interleukin-
1beta: novel implications in bacterial 
pathogenesis . Microbes Infect., 9(3), 
408–415. 
Kanasi, E., Doǧ, B., Karched, M., Thay, B., 
Oscarsson, J., & Asikainen, S. (2010). 
Lack of serotype antigen in A. 
actinomycetemcomitans. J. Dent. Res., 
89(3), 292–296. 
Kaplan, A. H., Weber, D. J., Oddone, E. Z., 
& Perfect, J. R. (1989). Infection due to 
actinobacillus actinomycetemcomitans: 
15 cases and review. Rev. Infect. Dis., 
11(1), 46–63. 
Kaplan, J. B., & Fine, D. H. (1998). Codon 
usage in Actinobacillus 
actinomycetemcomitans. FEMS 
Microbiol. Lett., 163(1), 31–36. 
Kaplan, J. B., Perry, M. B., MacLean, L. L., 
Furgang, D., Wilson, M. E., & Fine, D. 
H. (2001). Structural and genetic analyses 
of O polysaccharide from Actinobacillus 
actinomycetemcomitans serotype f. 
Infect. Immun., 69(9), 5375–5384. 
Karlyshev, A. V., Galyov, E. E., Abramov, 
V. M., & Zav’yalov, V. P. (1992). Caf1R 
gene and its role in the regulation of 
capsule formation of Y. pestis. FEBS 
Lett., 305(1), 37–40. 
Karlyshev, A. V., Galyov, E. E., Smirnov, 
O. Y., Guzayev, A. P., Abramov, V. M., 
& Zav’yalov, V. P. (1992). A new gene 
of the f1 operon of Y. pestis involved in 
the capsule biogenesis. FEBS Lett., 
297(1–2), 77–80. 
Kelk, P., Claesson, R., Hänström, L., 
Lerner, U. H., Kalfas, S., & Johansson, 
A. (2005). Abundant secretion of 
bioactive interleukin-1β by human 
macrophages induced by Actinobacillus 
actinomycetemcomitans leukotoxin. 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   86 16.5.2019   9.13
References  87 
 
 
 
Infect. Immun., 73(1), 453–458. 
Kelk, P., Johansson, A., Claesson, R., 
Hänström, L., & Kalfas, S. (2003). 
Caspase 1 involvement in human 
monocyte lysis induced by Actinobacillus 
actinomycetemcomitans leukotoxin. 
Infect. Immun., 71(8), 4448–4455. 
Kittichotirat, W., Bumgarner, R. E., & 
Chen, C. (2016). Evolutionary 
Divergence of Aggregatibacter 
actinomycetemcomitans. J. Dent. Res., 
95(1). 
Korotkov, K. V., Pardon, E., Steyaert, J., & 
Hol, W. G. J. (2009). Crystal Structure of 
the N-Terminal Domain of the Secretin 
GspD from ETEC Determined with the 
Assistance of a Nanobody. Structure, 
17(2), 255–265. 
Kozarov, E. V., Dorn, B. R., Shelburne, C. 
E., Dunn, W. A., & Progulske-Fox, A. 
(2005). Human Atherosclerotic Plaque 
Contains Viable Invasive Actinobacillus 
actinomycetemcomitans and 
Porphyromonas gingivalis. Arterioscler. 
Thromb. Vasc. Biol., 25(3), e17–e18. 
Krishnan, S., & Prasadarao, N. V. (2012). 
Outer membrane protein A and OprF: 
versatile roles in Gram-negative bacterial 
infections. FEBS J., 279(6), 919–931. 
Krüger, N. J., & Stingl, K. (2011). Two 
steps away from novelty - principles of 
bacterial DNA uptake. Mol. Microbiol., 
80(4), 860–867. 
Lakio, L., Paju, S., Alfthan, G., Tiirola, T., 
Asikainen, S., & Pussinen, P. J. (2003). 
Actinobacillus actinomycetemcomitans 
serotype d-specific antigen contains the O 
antigen of lipopolysaccharide. Infect. 
Immun., 71(9), 5005–5011. 
Lally, E. T., Golub, E. E., Kieba, I. R., 
Taichman, N. S., Decker, S., Berthold, P., 
Gibson, C. W., Demuth, D. R., & 
Rosenbloom, J. (1991). Structure and 
function of the B and D genes of the 
Actinobacillus actinomycetemcomitans 
leukotoxin complex. Microb. Pathog., 
11(2), 111–121. 
Lally, E. T., Kieba, I. R., Sato, A., Green, C. 
L., Rosenbloom, J., Korostoff, J., Wang, 
J. F., Shenker, B. J., Ortlepp, S., 
Robinson, M. K., & Billings, P. C. 
(1997). RTX toxins recognize a beta2 
integrin on the surface of human target 
cells. J. Biol. Chem., 272(48), 30463–
30469. 
Lamont, R. J., Koo, H., & Hajishengallis, G. 
(2018). The oral microbiota: dynamic 
communities and host interactions. Nat. 
Rev. Microbiol., 16(12), 745–759. 
Laughlin, R. S., Musch, M. W., Hollbrook, 
C. J., Rocha, F. M., Chang, E. B., & 
Alverdy, J. C. (2000). The key role of 
Pseudomonas aeruginosa PA-I lectin on 
experimental gut-derived sepsis. Ann. 
Surg., 232(1), 133–142. 
Lewis, K. (2010). Persister Cells. Annu. 
Rev. Microbiol., 64(1), 357–372. 
Linhartová, I., Bumba, L., Mašn, J., Basler, 
M., Osička, R., Kamanová, J., 
Procházková, K., Adkins, I., 
HejnováHolubová, J., Sadílková, L., 
Morová, J., & Šebo, P. (2010). RTX 
proteins: A highly diverse family secreted 
bya common mechanism. FEMS 
Microbiol. Rev., 34(6), 1076–1112. 
Lowry, O. H., Rosebrough, N. J., Farr, A. 
L., & Randall, R. J. (1951). Protein 
measurement with the Folin phenol 
reagent. J. Biol. Chem., 193(1), 265–275. 
Luo, G., Niesel, D. W., Shaban, R. A., 
Grimm, E. A., & Klimpel, G. R. (1993). 
Tumor necrosis factor alpha binding to 
bacteria: Evidence for a high- affinity 
receptor and alteration of bacterial 
virulence properties. Infect. Immun., 
61(3), 830–835. 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   87 16.5.2019   9.13
88 References 
 
 
 
Lützen, L., Olesen, B., Voldstedlund, M., 
Christensen, J. J., Moser, C., Knudsen, J. 
D., Fuursted, K., Hartmeyer, G. N., Chen, 
M., Søndergaard, T. S., Rosenvinge, F. 
S., Dzajic, E., Schønheyder, H. C., & 
Nørskov-Lauritsen, N. (2018). Incidence 
of HACEK bacteraemia in Denmark: A 
6-year population-based study. Int. J. 
Infect. Dis., 68, 83–87. 
Lång, E., Haugen, K., Fleckenstein, B., 
Homberset, H., Frye, S. A., Ambur, O. 
H., & Tønjum, T. (2009). Identification 
of neisserial DNA binding components. 
Microbiology, 155(3), 852–862. 
Maccarini, M., Gayet, L., Alcaraz, J. P., 
Liguori, L., Stidder, B., Watkins, E. B., 
Lenormand, J. L., & Martin, D. K. 
(2017). Functional Characterization of 
Cell-Free Expressed OprF Porin from 
Pseudomonas aeruginosa Stably 
Incorporated in Tethered Lipid Bilayers. 
Langmuir, 33(38), 9988–9996. 
Maekawa, T., Krauss, J. L., Abe, T., 
Jotwani, R., Triantafilou, M., 
Triantafilou, K., Hashim, A., Hoch, S., 
Curtis, M. A., Nussbaum, G., Lambris, J. 
D., & Hajishengallis, G. (2014). 
Porphyromonas gingivalis manipulates 
complement and TLR signaling to 
uncouple bacterial clearance from 
inflammation and promote dysbiosis. Cell 
Host Microbe, 15(6), 768–778. 
Maeshima, N., & Fernandez, R. C. (2013). 
Recognition of lipid A variants by the 
TLR4-MD-2 receptor complex. Front. 
Cell. Infect. Microbiol., 3, 1–13. 
Mahdavi, J., Royer, P. J., Sjolinder, H. S., 
Azimi, S., Self, T., Stoof, J., Wheldon, L. 
M., Brannstrom, K., Wilson, R., 
Moreton, J., Moir, J. W., Sihlbom, C., 
Boren, T., Jonsson, A. B., Soultanas, P., 
& Ala’Aldeen, D. A. (2013). Pro-
inflammatory cytokines can act as 
intracellular modulators of commensal 
bacterial virulence . Open Biol., 3(10), 
130048. 
Mantovani, A., Allavena, P., Sica, A., & 
Balkwill, F. (2008). Cancer-related 
inflammation. Nature, 454(7203), 436–
444. 
Mashburn-Warren, L. M., & Whiteley, M. 
(2006). Special delivery: Vesicle 
trafficking in prokaryotes. Mol. 
Microbiol., 61(4), 839–846. 
Masoud, H., Weintraub, S. T., Wang, R., 
Cotter, R., & Holt, S. C. (1991). 
Investigation of the structure of lipid A 
from Actinobacillus 
actinomycetemcomitans strain Y4 and 
human clinical isolate PO 1021‐7. Eur. J. 
Biochem., 200, 775-779. 
May, A. C., Ehrlich, R. L., Balashov, S., 
Ehrlich, G. D., Shanmugam, M., Fine, D. 
H., Ramasubbu, N., Mell, J. C., & 
Cugini, C. (2016). Complete Genome 
Sequence of Aggregatibacter 
actinomycetemcomitans Strain IDH781. 
Genome Announc., 4(6), e01285-16. 
Mayer, M. P. A., Bueno, L. C., Hansen, E. 
J., & Dirienzo, J. M. (1999). 
Identification of a cytolethal distending 
toxin gene locus and features of a 
virulence-associated region in 
Actinobacillus actinomycetemcomitans. 
Infect. Immun., 67(3), 1227–1237. 
McDougald, D., Rice, S. A., Barraud, N., 
Steinberg, P. D., & Kjelleberg, S. (2012). 
Should we stay or should we go: 
mechanisms and ecological consequences 
for biofilm dispersal. Nat. Rev. 
Microbiol., 10(1), 39–50. 
McGettrick, A. F., & O’Neill, L. A. J. 
(2007). Toll-like receptors: Key 
activators of leucocytes and regulator of 
haematopoiesis. Br. J. Haematol., 139(2), 
185–193. 
McLaughlin, R. A., & Hoogewerf, A. J. 
(2006). Interleukin-1beta-induced growth 
enhancement of Staphylococcus aureus 
occurs in biofilm but not planktonic 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   88 16.5.2019   9.13
References  89 
 
 
 
cultures . Microb. Pathog., 41(2–3), 67–
79. 
Meduri, G. U., Kanangat, S., Stefan, J., 
Tolley, E., & Schaberg, D. (1999). 
Cytokines IL- 1beta, IL-6, and TNF-
alpha enhance in vitro growth of bacteria. 
Am. J. Respir. Crit. Care Med., 160(3), 
961–967. 
Mell, J. C., & Redfield, R. J. (2014). 
Natural competence and the evolution of 
DNA uptake specificity. J. Bacteriol., 
196(8), 1471–1483. 
Moriel, D. G., Bertoldi, I., Spagnuolo, A., 
Marchi, S., Rosini, R., Nesta, B., 
Pastorello, I., Corea, V. A. M., Torricelli, 
G., Cartocci, E., Savino, S., Scarselli, M., 
Dobrindt, U., Hacker, J., Tettelin, H., 
Tallon, L. J., Sullivan, S., … Serino, L. 
(2010). Identification of protective and 
broadly conserved vaccine antigens from 
the genome of extraintestinal pathogenic 
Escherichia coli. Proc. Natl. Acad. Sci. 
U. S. A., 107(20), 9072–9077. 
Moriel, D. G., Heras, B., Paxman, J. J., Lo, 
A. W., Tan, L., Sullivan, M. J., Dando, S. 
J., Beatson, S. A., Ulett, G. C., & 
Schembri, M. A. (2016). Molecular and 
structural characterization of a novel 
Escherichia coli interleukin receptor 
mimic protein. MBio, 7(2), e02046-15. 
Moutsopoulos, N. M., Zerbe, C. S., Wild, 
T., Dutzan, N., Brenchley, L., 
DiPasquale, G., Uzel, G., Axelrod, K. C., 
Lisco, A., Notarangelo, L. D., 
Hajishengallis, G., Notarangelo, L. D., & 
Holland, S. M. (2017). Interleukin-12 and 
Interleukin-23 Blockade in Leukocyte 
Adhesion Deficiency Type 1. N. Engl. J. 
Med., 376(12), 1141–1146. 
Nadell, C. D., Drescher, K., & Foster, K. R. 
(2016). Spatial structure, cooperation and 
competition in biofilms. Nat. Rev. 
Microbiol., 14(9), 589–600. 
Nørskov-Lauritsen, N., & Kilian, M. 
(2006). Reclassification of Actinobacillus 
actinomycetemcomitans, Haemophilus 
aphrophilus, Haemophilus paraphrophilus 
and Haemophilus segnis as 
Aggregatibacter actinomycetemcomitans 
gen. nov., comb. nov., Aggregatibacter 
aphrophilus comb. nov. and 
Aggregatibacter. Int. J. Syst. Evol. 
Microbiol., 56(9), 2135–2146. 
Novak, E. A., Shao, H., Daep, C. A., & 
Demuth, D. R. (2010). Autoinducer-2 and 
QseC Control Biofilm Formation and In 
Vivo Virulence of Aggregatibacter 
actinomycetemcomitans. Infect. Immun., 
78(7), 2919–2926. 
Nummelin, H., El Tahir, Y., Ollikka, P., 
Skurnik, M., & Goldman, A. (2002). 
Expression, purification and 
crystallization of a collagen-binding 
fragment of Yersinia adhesin YadA. Acta 
Crystallogr. Sect. D Biol. Crystallogr., 
58(6 II), 1042–1044. 
Oberto, J., Nabti, S., Jooste, V., Mignot, H., 
& Rouviere-Yaniv, J. (2009). The HU 
regulon is composed of genes responding 
to anaerobiosis, acid stress, high 
osmolarity and SOS induction. PLoS 
One, 4(2), e4367. 
Paino, A., Lohermaa, E., Sormunen, R., 
Tuominen, H., Korhonen, J., Pöllänen, 
M. T., Ihalin, R., Pöllanen, M. T., & 
Ihalin, R. (2012). Interleukin-1beta is 
internalised by viable Aggregatibacter 
actinomycetemcomitans biofilm and 
locates to the outer edges of nucleoids. 
Cytokine, 60, 565–574. 
Paino, A., Tuominen, H., Jaaskelainen, M., 
Alanko, J., Nuutila, J., Asikainen, S. E., 
Pelliniemi, L. J., Pollanen, M. T., Chen, 
C., & Ihalin, R. (2011). Trimeric form of 
intracellular ATP synthase subunit beta 
of Aggregatibacter 
actinomycetemcomitans binds human 
interleukin-1beta. PLoS One, 6(4), 
e18929. 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   89 16.5.2019   9.13
90 References 
 
 
 
Paju, S., Carlson, P., Jousimies-Somer, H., 
& Asikainen, S. (2000). Heterogeneity of 
Actinobacillus actinomycetemcomitans 
strains in various human infections and 
relationships between serotype, genotype, 
and antimicrobial susceptibility. J. Clin. 
Microbiol., 38(1), 79–84. 
Pancholi, V., & Fischetti, V. A. (1992). A 
major surface protein on group A 
streptococci is a glyceraldehyde-3-
phosphate-dehydrogenase with multiple 
binding activity. J. Exp. Med., 176(2), 
415–426. 
Pandey, N., Chauhan, A., & Jain, N. (2018). 
TLR4 Polymorphisms and Expression in 
Solid Cancers. Mol. Diagn. Ther., 22(6), 
683–702. 
Papapanou, P. N., Sanz, M., Buduneli, N., 
Dietrich, T., Feres, M., Fine, D. H., 
Flemmig, T. F., Garcia, R., Giannobile, 
W. V., Graziani, F., Greenwell, H., 
Herrera, D., Kao, R. T., Kebschull, M., 
Kinane, D. F., Kirkwood, K. L., Kocher, 
T., … Tonetti, M. S. (2018). 
Periodontitis: Consensus report of 
workgroup 2 of the 2017 World 
Workshop on the Classification of 
Periodontal and Peri-Implant Diseases 
and Conditions. J. Periodontol., 89, 
S173–S182. 
Papenfort, K., & Bassler, B. L. (2016). 
Quorum sensing signal–response systems 
in Gram-negative bacteria. Nat. Rev. 
Microbiol., 14(9), 576–588. 
Papo, N., & Shai, Y. (2005). A Molecular 
Mechanism for Lipopolysaccharide 
Protection of Gram-negative Bacteria 
from Antimicrobial Peptides. J. Biol. 
Chem., 280(11), 10378–10387. 
Parkin, J., & Cohen, B. (2001). An 
overview of the immune system. Lancet, 
357(9270), 1777–1789. 
Parsek, M. R., & Greenberg, E. P. (2000). 
Acyl-homoserine lactone quorum sensing 
in Gram-negative bacteria: A signaling 
mechanism involved in associations with 
higher organisms. Proc. Natl. Acad. Sci., 
97(16), 8789–8793. 
Paturel, L., Casalta, J. P., Habib, G., Nezri, 
M., & Raoult, D. (2004). Actinobacillus 
actinomycetemcomitans endocarditis. 
Clin. Microbiol. Infect., 10(2), 98–118. 
Perks, B., & Shute, J. K. (2000). DNA and 
actin bind and inhibit interleukin-8. Am. 
J. Respir. Crit. Care Med., 162(5), 1767–
1772. 
Pesci, E. C., Milbank, J. B. J., Pearson, J. P., 
McKnight, S., Kende, A. S., Greenberg, 
E. P., & Iglewski, B. H. (1999). 
Quinolone signaling in the cell-to-cell 
communication system of Pseudomonas 
aeruginosa. Proc. Natl. Acad. Sci., 
96(20), 11229–11234. 
Pietiäinen, M., Kopra, K. A. E., 
Vuorenkoski, J., Salminen, A., Paju, S., 
Mäntylä, P., Buhlin, K., Liljestrand, J. 
M., Nieminen, M. S., Sinisalo, J., 
Hyvärinen, K., & Pussinen, P. J. (2018). 
A. actinomycetemcomitans serotypes 
associate with periodontal and coronary 
artery disease status. J. Clin. 
Periodontol., 45, 413–421. 
Porat, R., Clark, B. D., Wolff, S. M., & 
Dinarello, C. A. (1991). Enhancement of 
growth of virulent strains of Escherichia 
coli by interleukin-1. Science (80-. )., 
254(5030), 430–432. 
Pretzl, B., Sälzer, S., Ehmke, B., 
Schlagenhauf, U., Dannewitz, B., 
Dommisch, H., Eickholz, P., & Jockel-
Schneider, Y. (2018). Administration of 
systemic antibiotics during non-surgical 
periodontal therapy—a consensus report. 
Clin. Oral Investig. 
Pöllänen, M. T., Laine, M. A., Ihalin, R., & 
Uitto, V.-J. (2012). Host-Bacteria 
Crosstalk at the Dentogingival Junction. 
Int. J. Dent., 2012, 1–14. 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   90 16.5.2019   9.13
References  91 
 
 
 
Raetz, C. R. H., & Whitfield, C. (2002). 
Lipopolysaccharide Endotoxins. Annu. 
Rev. Biochem., 71(1), 635–700. 
Rahamat-Langendoen, J. C., Van Vonderen, 
M. G. A., Engström, L. J., Manson, W. 
L., Van Winkelhoff, A. J., & Mooi-
Kokenberg, E. A. N. M. (2011). Brain 
abscess associated with Aggregatibacter 
actinomycetemcomitans: Case report and 
review of literature. J. Clin. Periodontol., 
38(8), 702–706. 
Ramsey, M. M., Rumbaugh, K. P., & 
Whiteley, M. (2011). Metabolite cross-
feeding enhances virulence in a model 
polymicrobial infection. PLoS Pathog., 
7(3), e1002012. 
Rawling, E. G., Brinkman, F. S. L., & 
Hancock, R. E. W. (1998). Roles of the 
carboxy-terminal half of Pseudomonas 
aeruginosa major outer membrane protein 
OprF in cell shape, growth in low-
osmolarity medium, and peptidoglycan 
association. J. Bacteriol., 180(14), 3556–
3562. 
Redfield, R. J., Schrag, M. R., & Dean, A. 
M. (1997). The evolution of bacterial 
transformation: Sex with poor relations. 
Genetics, 146(1), 27–38. 
Revest, M., Egmann, G., Cattoir, V., & 
Tattevin, P. (2016). HACEK 
endocarditis: state-of-the-art. Expert Rev. 
Anti. Infect. Ther., 14(5), 523–530. 
Rosan, B., Slots, J., Lamont, R. J., 
Listgarten, M. A., & Nelson, G. M. 
(1988). Actinobacillus 
actinomycetemcomitans fimbriae. Oral 
Microbiol. Immunol., 3(2), 58–63. 
Rossi, D., & Zlotnik, A. (2000). The 
Biology of Chemokines and their 
Receptors. Annu. Rev. Immunol., 18(1), 
217–242. 
Rouser, G., Fleischer, S., & Yamamoto, A. 
(1970). Two dimensional thin layer 
chromatographic separation of polar 
lipids and determination of phospholipids 
by phosphorus analysis of spots. Lipids, 
5(5), 494–496. 
Saarela, M., Asikainen, S., Alaluusua, S., 
Pyhälä, L., Lai, C. H., & Jousimies-
Somer, H. (1992). Frequency and 
stability of mono- or poly-infection by 
Actinobacillus actinomycetemcomitans 
serotypes a, b, c, d or e. Oral Microbiol 
Immunol, 7(5), 277–279. 
Smith, H. O., Gwinn, M. L., & Salzberg, S. 
L. (1999). DNA uptake signal sequences 
in naturally transformable bacteria. Res. 
Microbiol., 150(9–10), 603–616. 
Spreter, T., Yip, C. K., Sanowar, S., André, 
I., Kimbrough, T. G., Vuckovic, M., 
Pfuetzner, R. A., Deng, W., Yu, A. C., 
Finlay, B. B., Baker, D., Miller, S. I., & 
Strynadka, N. C. J. (2009). A conserved 
structural motif mediates formation of the 
periplasmic rings in the type III secretion 
system. Nat. Struct. Mol. Biol., 16(5), 
468–476. 
Srinivas, N., Jetter, P., Ueberbacher, B. J., 
Werneburg, M., Zerbe, K., Steinmann, J., 
Van der Meijden, B., Bernardini, F., 
Lederer, A., Dias, R. L. A., Misson, P. E., 
Henze, H., Zumbrunn, J., Gombert, F. O., 
Obrecht, D., Hunziker, P., Schauer, S., … 
Robinson, J. A. (2010). Peptidomimetic 
Antibiotics Target Outer-Membrane 
Biogenesis in Pseudomonas aeruginosa. 
Science (80-. )., 327(5968), 1010–1013. 
Sugai, M., Kawamoto, T., Pérès, S. Y., 
Ueno, Y., Komatsuzawa, H., Fujiwara, 
T., Kurihara, H., Suginaka, H., & 
Oswald, E. (1998). The cell cycle-
specific growth-inhibitory factor 
produced by Actinobacillus 
actinomycetemcomitans is a cytolethal 
distending toxin. Infect. Immun., 66(10), 
5008–5019. 
Sugawara, E., Nestorovich, E. M., 
Bezrukov, S. M., & Nikaido, H. (2006). 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   91 16.5.2019   9.13
92 References 
 
 
 
Pseudomonas aeruginosa porin OprF 
exists in two different conformations. J. 
Biol. Chem., 281(24), 16220–16229. 
Sutherland, I. W. (2001). Biofilm 
exopolysaccharides: A strong and sticky 
framework. Microbiology, 147(1), 3–9. 
Takada, K., Saito, M., Tsuzukibashi, O., 
Kawashima, Y., Ishida, S., & Hirasawa, 
M. (2010). Characterization of a new 
serotype g isolate of Aggregatibacter 
actinomycetemcomitans. Mol. Oral 
Microbiol., 25(3), 200–206. 
Tanaka, A., Fujise, O., Chen, C., Miura, M., 
Hamachi, T., & Maeda, K. (2012). A 
novel gene required for natural 
competence in Aggregatibacter 
actinomycetemcomitans . J. Periodontal 
Res., 47(1), 129–134. 
Tang, G., Kawai, T., Komatsuzawa, H., & 
Mintz, K. P. (2012). Lipopolysaccharides 
mediate leukotoxin secretion in 
Aggregatibacter actinomycetemcomitans. 
Mol. Oral Microbiol., 27(2), 70–82. 
Tarry, M., Jääskeläinen, M., Paino, A., 
Tuominen, H., Ihalin, R., & Högbom, M. 
(2011). The extra-membranous domains 
of the competence protein HofQ show 
DNA binding, flexibility and a shared 
fold with type i KH domains. J. Mol. 
Biol., 409(4), 642–653. 
Tonetti, M. S., Imboden, M. A., & Lang, N. 
P. (1998). Neutrophil Migration Into the 
Gingival Sulcus Is Associated With 
Transepithelial Gradients of Interleukin-8 
and ICAM-1. J. Periodontol., 69(10), 
1139–1147. 
Tristan, C., Shahani, N., Sedlak, T. W., & 
Sawa, A. (2011). The diverse functions of 
GAPDH: Views from different 
subcellular compartments. Cell. Signal., 
23(2), 317–323. 
Uchida, Y., Shiba, H., Komatsuzawa, H., 
Takemoto, T., Sakata, M., Fujita, T., 
Kawaguchi, H., Sugai, M., & Kurihara, 
H. (2001). Expression of IL-1β and IL-8 
by human gingival epithelial cells in 
response to Actinobacillus 
actinomycetemcomitans. Cytokine, 14(3), 
152–161. 
Uversky, V. N. (2011). Intrinsically 
disordered proteins from A to Z. Int. J. 
Biochem. Cell Biol., 43(8), 1090–1103. 
Venketaraman, V., Lin, A. K., Le, A., 
Kachlany, S. C., Connell, N. D., & 
Kaplan, J. B. (2008). Both leukotoxin and 
poly-N-acetylglucosamine surface 
polysaccharide protect Aggregatibacter 
actinomycetemcomitans cells from 
macrophage killing . Microb. Pathog., 
45(3), 173–180. 
von Wintersdorff, C. J. H., Penders, J., van 
Niekerk, J. M., Mills, N. D., Majumder, 
S., van Alphen, L. B., Savelkoul, P. H. 
M., & Wolffs, P. F. G. (2016). 
Dissemination of Antimicrobial 
Resistance in Microbial Ecosystems 
through Horizontal Gene Transfer. Front. 
Microbiol., 7, 173. 
Walker, T. S., Tomlin, K. L., Worthen, G. 
S., Poch, K. R., Lieber, J. G., Saavedra, 
M. T., Fessler, M. B., Malcolm, K. C., 
Vasil, M. L., & Nick, J. A. (2005). 
Enhanced Pseudomonas aeruginosa 
biofilm development mediated by human 
neutrophils. Infect. Immun., 73(6), 3693–
3701. 
Wang, P. L., Azuma, Y., Shinohara, M., & 
Ohura, K. (2000). Toll-like receptor 4-
mediated signal pathway induced by 
Porphyromonas gingivalis 
lipopolysaccharide in human gingival 
fibroblasts. Biochem. Biophys. Res. 
Commun., 273(3), 1161–1167. 
Wang, Y., & Chen, C. (2005). Mutation 
analysis of the flp operon in 
Actinobacillus actinomycetemcomitans. 
Gene, 351, 61–71. 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   92 16.5.2019   9.13
References  93 
 
 
 
Wang, Y., Goodman, S. D., Redfield, R. J., 
& Chen, C. (2002). Natural 
transformation and DNA uptake signal 
sequences in Actinobacillus 
actinomycetemcomitans. J. Bacteriol., 
184(13), 3442–3449. 
Wang, Y., Shi, W., Chen, W., & Chen, C. 
(2003). Type IV pilus gene homologs 
pilABCD are required for natural 
transformation in Actinobacillus 
actinomycetemcomitans. Gene, 312(1–2), 
249–255. 
Weigel, W. A., Demuth, D. R., Torres-
Escobar, A., & Juárez-Rodríguez, M. D. 
(2015). Aggregatibacter 
actinomycetemcomitans QseBC is 
activated by catecholamines and iron and 
regulates genes encoding proteins 
associated with anaerobic respiration and 
metabolism. Mol. Oral Microbiol., 30(5), 
384–398. 
Whitchurch, C. B. (2002). Extracellular 
DNA Required for Bacterial Biofilm 
Formation. Science, 295(5559), 1487–
1487. 
Whiteley, M., Diggle, S. P., & Greenberg, 
E. P. (2017). Progress in and promise of 
bacterial quorum sensing research. 
Nature, 551(7680), 313–320. 
Winzer, K., Falconer, C., Garber, N. C., 
Diggle, S. P., Camara, M., & Williams, 
P. (2000). The Pseudomonas aeruginosa 
lectins PA-IL and PA-IIL are controlled 
by quorum sensing and by RpoS. J. 
Bacteriol., 182(22), 6401–6411. 
Wu, J., & Xi, C. (2009). Evaluation of 
different methods for extracting 
extracellular DNA from the biofilm 
matrix. Appl. Environ. Microbiol., 
75(16), 5390–5395. 
Wu, L., Estrada, O., Zaborina, O., Bains, 
M., Shen, L., Kohler, J. E., Patel, N., 
Musch, M. W., Chang, E. B., Fu, Y.-X. 
X., Jacobs, M. a, Nishimura, M. I., 
Hancock, R. E. W., Turner, J. R., & 
Alverdy, J. C. (2005). Recognition of 
host immune activation by Pseudomonas 
aeruginosa. Science, 309(5735), 774–777. 
Yoshimura, A., Hara, Y., Kaneko, T., & 
Kato, I. (1997). Secretion of IL-1beta, 
TNF-alpha, IL-8 and IL-1ra by human 
polymorphonuclear leukocytes in 
response to lipopolysaccharides from 
periodontopathic bacteria. J. Periodontal 
Res., 32(3), 279–286. 
Zambon, J. J. (1985). Actinobacillus 
actinomycetemcomitans in human 
periodontal disease. J. Clin. Periodontol., 
12(1), 1–20. 
Zambon, J. J., Slots, J., & Genco, R. J. 
(1983). Serology of oral Actinobacillus 
actinomycetemcomitans and serotype 
distribution in human periodontal disease. 
Infect. Immun., 41(1), 19–27. 
Zav’yalov, V. P., Chernovskaya, T. V, 
Navolotskaya, E. V, Karlyshev, A. V, 
MacIntyre, S., Vasiliev, A. M., & 
Abramov, V. M. (1995). Specific high 
affinity binding of human interleukin 1 
beta by Caf1A usher protein of Yersinia 
pestis . FEBS Lett., 371(1), 65–68. 
Zavialov, A. V., Berglund, J., Pudney, A. 
F., Fooks, L. J., Ibrahim, T. M., 
MacIntyre, S., & Knight, S. D. (2003). 
Structure and biogenesis of the capsular 
F1 antigen from Yersinia pestis: 
Preserved folding energy drives fiber 
formation. Cell, 113(5), 587–596. 
Zhang, G., Meredith, T. C., & Kahne, D. 
(2013). On the essentiality of 
lipopolysaccharide to Gram-negative 
bacteria. Curr. Opin. Microbiol., 16(6), 
779–785. 
Zijnge, V., Kieselbach, T., & Oscarsson, J. 
(2012). Proteomics of protein secretion 
by Aggregatibacter 
actinomycetemcomitans. PLoS One, 7(7), 
e41662. 
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_sisus_B5_1605.indd   93 16.5.2019   9.13

ISBN 978-951-29-7685-0 (PRINT)
ISBN 978-951-29-7686-7 (PDF)
ISSN 0082-7002 (Print)
ISSN 2343-3175 (Online)
Gr
an
o 
O
y 
- T
ur
ku
, F
in
la
nd
 2
01
9
31121003_Vaitoskirja_Tuuli_Ahlstrand_Luonnontiet_ja_tekn_tdk_kansi_wire_B5.indd   2 15.5.2019   13.59
